data_2na2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2na2 _Structure_validation_residue.Date_analyzed 2016-12-16 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo . . . . . 0 N--CA 1.494 1.534 0 CA-C-O 120.906 0.294 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.5 mt -69.75 -12.45 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.368 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 96.2 p -59.61 -24.32 63.72 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.686 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -63.25 -51.6 65.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.824 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.24 -48.93 66.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.089 0.471 . . . . 0.0 110.943 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -58.92 -20.5 52.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.676 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -56.8 -44.4 81.9 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.193 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.3 m -65.07 -39.73 93.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 110.521 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.45 ' SG ' ' CG ' ' A' ' 78' ' ' ASN . 51.8 t -59.9 -40.73 89.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.906 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -50.08 -47.63 53.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.176 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.4 m -71.4 -38.45 71.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.162 0.506 . . . . 0.0 110.431 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 48.33 75.13 0.15 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.844 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -75.85 105.44 6.89 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.268 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.1 m -139.44 133.65 31.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.92 0.39 . . . . 0.0 110.94 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -69.11 136.65 52.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.319 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.46 -8.74 76.09 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -89.28 138.19 31.65 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.926 0.393 . . . . 0.0 110.567 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -64.93 148.85 97.31 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.18 149.03 70.11 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.451 2.101 . . . . 0.0 112.105 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 26' ' ' ILE . 48.4 t0 -159.08 151.41 21.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.088 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.516 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 17.3 tt -135.1 89.07 24.78 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.735 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.2 148.29 14.89 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.509 2.139 . . . . 0.0 111.695 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.2 tp -138.21 133.73 33.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.129 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.509 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 41.4 p90 -93.61 123.75 37.15 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -149.9 151.59 33.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.231 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.6 p -51.9 129.67 27.4 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -87.68 -52.91 5.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.066 0.46 . . . . 0.0 110.408 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -162.43 155.52 20.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.539 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.0 p -109.31 146.81 33.71 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.2 m -138.72 165.04 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.513 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.6 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 71.38 39.48 61.61 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 36' ' ' GLY . 41.3 Cg_endo -66.47 -20.22 54.42 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.681 2.254 . . . . 0.0 111.902 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -59.66 -44.59 93.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.897 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -119.16 -108.42 0.36 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.343 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.99 131.11 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.161 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -77.96 135.87 37.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.219 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.2 p -124.38 147.67 48.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.995 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -113.32 131.79 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.649 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.7 m -113.68 126.22 55.01 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.541 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.11 148.1 33.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.39 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.19 122.91 14.28 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.241 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.33 128.69 39.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -112.8 141.27 46.8 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.488 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -144.8 130.27 18.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.559 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 mttm 59.08 17.74 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.595 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.39 13.04 62.19 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -133.53 144.05 49.13 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.811 0.338 . . . . 0.0 110.32 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -65.39 126.19 27.46 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.8 tt -104.73 -27.64 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.198 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.37 148.08 13.86 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.1 t -154.15 140.27 18.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.91 0.386 . . . . 0.0 110.628 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.62 171.95 31.76 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -144.83 153.12 41.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.921 0.391 . . . . 0.0 110.49 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.93 174.22 46.9 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 -7.44 21.24 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 123.014 2.476 . . . . 0.0 112.154 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.8 p -150.06 156.57 41.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.182 0.515 . . . . 0.0 110.632 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.78 -40.72 98.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.603 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.02 -45.49 90.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.398 0.618 . . . . 0.0 110.369 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -71.01 -41.02 71.45 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.706 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.42 94.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.603 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 67' ' ' MET . 4.7 ptmm? -64.18 -39.76 94.67 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.527 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 67' ' ' MET . 19.4 tmm? -59.5 -44.65 93.06 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.848 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.31 -40.66 94.74 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.52 -45.44 94.2 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.705 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.81 99.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.205 0.526 . . . . 0.0 110.463 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.9 ttt -62.34 -37.75 86.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.548 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -59.42 -45.17 92.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 109.988 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.6 95.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.197 0.522 . . . . 0.0 109.947 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.8 tt -59.88 -45.07 93.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.471 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.27 -39.38 93.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.619 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -77.67 -10.34 59.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 20.4 t80 67.98 133.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.378 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.45 ' CG ' ' SG ' ' A' ' 14' ' ' CYS . 32.7 m120 -79.15 144.69 34.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.427 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.8 t80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.751 -179.657 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 CA-C-O 121.268 0.445 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.489 ' CD1' ' N ' ' A' ' 7' ' ' ILE . 2.6 mp -67.79 -19.74 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.272 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -48.42 -33.11 8.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.99 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -60.87 -44.51 96.94 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.647 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.75 -39.22 64.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.412 0.625 . . . . 0.0 110.28 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -56.66 -25.28 53.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.506 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -53.15 -36.95 61.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.479 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.18 -47.91 83.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.019 0.438 . . . . 0.0 110.598 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.8 t -60.75 -41.59 95.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.011 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.62 -42.61 99.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.287 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.7 t -83.62 -5.68 59.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.664 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.4 ' C ' ' CD2' ' A' ' 17' ' ' LEU . 2.5 tt -74.81 96.45 3.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.754 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -71.08 150.51 45.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.321 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.6 m -94.92 120.38 35.04 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.482 0.658 . . . . 0.0 110.942 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -68.9 139.34 55.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.323 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.65 2.23 84.82 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -137.17 155.38 49.63 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.501 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.48 149.28 95.41 Favored Pre-proline 0 N--CA 1.451 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.387 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.37 163.46 29.45 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.805 2.336 . . . . 0.0 111.768 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.36 166.7 29.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 26' ' ' ILE . 16.0 tt -128.61 91.74 42.61 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 121.069 0.461 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.67 133.69 14.4 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.479 2.12 . . . . 0.0 111.727 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.7 tp -138.45 145.59 41.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.218 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -88.79 136.06 33.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.466 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.7 145.9 37.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.347 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.62 110.63 22.87 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.908 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 47.2 mt -106.64 -38.2 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.33 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -85.51 141.98 29.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.359 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -121.85 146.3 47.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.155 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.448 ' O ' ' OG1' ' A' ' 42' ' ' THR . 84.4 t -137.08 159.64 36.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.568 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 37' ' ' PRO . . . 74.76 88.34 0.22 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 36' ' ' GLY . 52.0 Cg_exo -52.97 -137.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.037 2.491 . . . . 0.0 112.585 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 39' ' ' HIS . 46.3 t -59.52 -39.52 84.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.439 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' SER . 77.9 m80 -47.29 -109.83 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.08 0.467 . . . . 0.0 110.867 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.27 136.64 32.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.549 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -86.41 116.72 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.49 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 35' ' ' VAL . 58.7 p -133.66 150.32 51.56 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.516 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -135.13 151.04 50.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.365 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.6 m -112.07 129.4 56.23 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.225 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.3 t -106.09 122.27 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.201 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.14 119.89 40.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.337 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.71 126.23 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.951 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.63 133.95 48.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.869 0.366 . . . . 0.0 110.241 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -144.52 118.51 9.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.162 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.13 18.95 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.96 12.62 73.8 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -136.59 149.56 48.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.811 0.339 . . . . 0.0 110.383 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtm-85 -67.02 139.05 57.63 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.204 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -124.62 -21.3 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.507 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.62 150.55 18.28 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 42.1 t -152.53 138.97 18.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.438 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.76 161.98 29.49 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -145.84 157.87 43.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.867 0.365 . . . . 0.0 110.789 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.58 178.58 44.58 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.8 -7.65 21.59 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.826 2.351 . . . . 0.0 111.988 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.0 t -151.61 160.15 43.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.372 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -62.16 -37.89 86.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.58 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.24 -46.89 82.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.559 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -64.26 -42.97 96.23 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.752 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.43 -42.98 95.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.778 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -61.54 -39.67 91.88 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.716 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 59.5 ttm -58.38 -50.12 74.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.324 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.86 -44.0 48.43 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.275 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.73 -49.1 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.736 0.303 . . . . 0.0 111.173 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.98 -46.74 87.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 ttt -62.1 -37.87 86.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.579 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -57.6 -46.93 83.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.21 -40.78 98.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.067 0.46 . . . . 0.0 110.42 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.63 -43.91 93.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.698 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -62.39 -39.63 93.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.917 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 77' ' ' TYR . 63.1 tttp -70.74 -28.31 64.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.331 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 5.9 t80 83.06 161.13 0.13 Allowed 'General case' 0 C--N 1.334 -0.107 0 O-C-N 123.433 0.458 . . . . 0.0 110.267 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -91.62 111.75 23.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.997 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 79' ' ' PHE . 54.8 t80 . . . . . 0 N--CA 1.463 0.202 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.735 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo . . . . . 0 N--CA 1.496 1.665 0 CA-C-O 121.433 0.514 . . . . 0.0 112.634 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mp -71.3 -11.31 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.313 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.6 p -52.66 -24.6 8.8 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -61.81 -51.73 67.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.854 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.6 mt -64.41 -45.13 88.9 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 110.545 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.5 -42.46 96.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.374 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.22 -40.03 88.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.485 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.9 -40.86 94.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.349 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.48 -50.09 75.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.525 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.38 -38.38 90.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.997 0.427 . . . . 0.0 110.315 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -70.61 -24.49 62.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.426 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.36 120.83 18.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.055 0.455 . . . . 0.0 110.495 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -68.26 144.35 54.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.727 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 22' ' ' LYS . 96.6 m -98.92 127.93 44.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.02 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -67.84 125.87 27.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.48 -10.19 75.36 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 19' ' ' THR . 42.8 mmtm -137.55 144.7 42.22 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.058 0.456 . . . . 0.0 111.021 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.46 151.1 95.67 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.602 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.05 139.29 55.51 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.386 2.057 . . . . 0.0 111.825 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.72 158.33 22.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.441 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.4 mt -91.42 117.9 68.1 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.671 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.81 130.42 13.46 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.312 2.008 . . . . 0.0 112.135 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -140.73 137.41 33.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 25.3 p90 -111.76 106.18 14.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.06 0.457 . . . . 0.0 110.431 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -136.66 151.56 49.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.3 p -107.01 147.96 29.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.202 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.94 -84.08 0.42 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.41 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -83.92 144.11 29.41 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.663 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.2 p -132.34 129.01 38.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.897 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.23 159.91 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.148 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.64 64.27 0.42 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' SER . 71.0 Cg_endo -73.94 157.09 47.55 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.864 2.376 . . . . 0.0 111.72 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.1 m 75.99 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.447 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -174.2 -36.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.599 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.83 136.63 36.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.586 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' A' ' 41' ' ' ARG . 1.5 mpt_? -80.73 139.2 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.914 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.7 p -131.38 150.58 52.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -132.85 149.38 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.387 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.1 m -109.82 128.92 55.63 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.162 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.82 149.6 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.711 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.75 126.74 13.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.311 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.0 t -87.45 131.39 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.414 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.04 138.36 40.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.191 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -144.12 123.89 13.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 54.79 29.53 12.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.22 8.54 87.13 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -132.4 135.7 46.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.876 0.369 . . . . 0.0 110.396 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -69.84 145.94 51.7 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.192 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 54' ' ' ILE . 33.3 pt -114.12 -22.06 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.586 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.94 154.8 24.1 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.2 p -155.21 139.67 16.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.731 0.301 . . . . 0.0 110.495 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.63 174.67 35.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.542 ' N ' ' CD ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -146.24 162.81 37.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.523 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.89 -176.09 47.07 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.91 -29.96 83.97 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 123.005 2.47 . . . . 0.0 112.449 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -136.53 154.4 50.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 110.654 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -63.52 -41.66 98.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.509 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.92 -43.09 99.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.551 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -66.05 -38.31 88.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.531 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.44 -34.79 76.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.148 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 97.4 mttt -56.65 -31.04 63.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.519 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 68.6 mtm -59.06 -46.23 88.77 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.327 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.88 -50.61 23.12 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.309 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.5 83.87 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.982 0.42 . . . . 0.0 111.072 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 66' ' ' LYS . . . -61.94 -44.04 97.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.719 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 66.1 ttp -61.29 -38.94 88.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.811 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.96 -43.68 91.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.423 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -45.43 94.64 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.539 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.5 -42.87 99.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.309 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.64 -39.69 95.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.445 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 77' ' ' TYR . 27.2 mtpp -79.89 -7.37 58.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.711 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' LYS . 97.9 m-85 57.4 113.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.626 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -80.28 146.0 31.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.659 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.7 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.529 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 121.118 0.382 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.441 ' C ' ' N ' ' A' ' 9' ' ' GLN . 4.9 tp -64.82 -15.64 18.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.101 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 t -47.99 -18.86 0.21 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.65 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' A' ' 7' ' ' ILE . 61.8 tt0 -61.39 -57.14 13.47 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.19 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.66 -41.36 96.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.358 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.447 ' NE2' ' N ' ' A' ' 70' ' ' ALA . 10.6 tp-100 -61.38 -54.35 44.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -65.43 -43.22 91.19 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.166 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t -61.96 -49.07 77.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.482 ' SG ' ' OD1' ' A' ' 78' ' ' ASN . 47.6 t -61.1 -45.09 96.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.695 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.78 -40.1 94.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.378 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.4 m -69.64 -38.31 77.12 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.346 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.2 tp 42.76 78.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.251 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -69.78 116.83 10.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.412 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.2 m -139.31 124.22 18.71 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.406 0.622 . . . . 0.0 110.695 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -67.3 142.98 56.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.45 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.09 -5.0 85.97 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.3 134.71 48.97 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 110.076 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 46.1 mp0 -70.34 151.58 95.72 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.03 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -51.25 141.43 39.55 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.059 1.839 . . . . 0.0 112.016 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.54 -174.54 5.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.242 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 pt -116.78 91.7 35.92 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.56 139.09 66.78 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.453 2.102 . . . . 0.0 111.588 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 tp -133.94 124.91 27.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.301 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.553 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 46.0 p90 -131.23 113.2 13.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.247 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -152.69 138.84 18.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.598 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.8 p -75.04 153.18 38.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.298 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.87 -65.67 0.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.411 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 34' ' ' THR . 17.9 tm0? -162.55 144.36 10.55 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.155 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.568 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 97.0 m -98.71 130.96 45.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.394 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.06 158.31 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.221 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 38' ' ' SER . . . -148.58 79.79 0.21 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.538 ' O ' ' CD2' ' A' ' 39' ' ' HIS . 52.4 Cg_exo -52.33 73.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.834 2.356 . . . . 0.0 112.276 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 36' ' ' GLY . 49.2 m 46.16 31.82 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.489 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 37' ' ' PRO . 85.5 m-70 -148.7 -131.54 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.589 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.03 149.28 28.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.504 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -71.0 142.54 50.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.052 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.1 m -126.99 130.59 50.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.145 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.93 140.03 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.204 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -125.8 131.06 52.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.926 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.0 142.76 36.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.283 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.38 125.54 14.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.363 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.31 138.1 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.342 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.83 113.37 24.13 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.956 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.453 ' CZ ' ' NZ ' ' A' ' 50' ' ' LYS . 66.2 t80 -101.4 115.05 29.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.311 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' NZ ' ' CZ ' ' A' ' 49' ' ' PHE . 61.6 mttp 52.39 37.74 23.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.823 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.83 25.11 70.32 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -137.57 136.32 37.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.019 0.438 . . . . 0.0 110.343 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HE ' ' HG ' ' A' ' 56' ' ' CYS . 76.0 ttt-85 -62.46 126.66 28.1 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.447 ' CD1' HD22 ' A' ' 78' ' ' ASN . 15.9 tt -111.35 -35.69 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.702 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.9 148.5 10.94 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.512 ' HG ' ' HE ' ' A' ' 53' ' ' ARG . 31.3 p -155.19 156.0 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.2 162.19 31.67 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -149.54 156.17 41.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 110.603 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.38 177.68 44.63 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.07 -6.78 19.97 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.074 2.516 . . . . 0.0 112.192 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 t -147.91 152.37 37.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.122 0.486 . . . . 0.0 110.415 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -60.83 -36.18 78.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.451 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.95 -42.96 91.07 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.683 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -66.24 -39.93 89.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.404 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.17 99.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.598 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.7 -40.41 94.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.453 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 60.9 tpp -60.32 -49.1 78.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.492 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.27 -41.45 79.0 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.54 72.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.288 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.447 ' N ' ' NE2' ' A' ' 11' ' ' GLN . . . -64.36 -46.79 81.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.273 0.558 . . . . 0.0 110.943 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.1 ttp -62.23 -38.3 88.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.619 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 53' ' ' ARG . 7.8 t0 -58.56 -49.96 75.54 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.302 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.19 98.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.515 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.36 -46.44 88.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.579 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.91 -41.28 97.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.443 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -71.14 -34.19 70.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.514 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 61.99 130.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.57 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.482 ' OD1' ' SG ' ' A' ' 14' ' ' CYS . 30.3 m120 -83.78 140.03 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.513 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.246 179.526 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.496 1.624 0 CA-C-O 121.126 0.386 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.74 -12.2 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.728 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.7 p -59.25 -23.63 62.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.64 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -64.31 -55.5 20.86 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.167 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -64.28 -47.57 79.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.403 0.62 . . . . 0.0 110.977 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -58.76 -24.13 61.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.32 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -56.26 -45.95 79.86 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.16 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.3 m -65.27 -42.48 93.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.104 0.478 . . . . 0.0 110.439 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.63 -42.77 99.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.769 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.9 -40.73 94.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.564 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 17' ' ' LEU . 46.6 p -72.67 -31.51 65.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.829 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 16' ' ' THR . 1.3 tt 34.6 71.48 0.11 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.278 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -70.42 119.33 14.43 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.23 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -139.13 121.66 16.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.525 0.678 . . . . 0.0 110.837 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.19 142.85 54.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.375 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.38 2.37 89.09 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -141.88 126.89 18.35 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.029 0.442 . . . . 0.0 110.04 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.28 120.46 76.99 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.784 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.03 143.48 32.64 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.152 1.901 . . . . 0.0 112.112 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -82.99 176.93 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.041 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.47 88.93 25.54 Favored Pre-proline 0 C--O 1.232 0.168 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.83 130.31 6.64 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.79 2.327 . . . . 0.0 111.79 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.5 tp -140.48 142.5 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.433 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -90.78 135.07 33.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.298 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -146.35 142.84 28.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.836 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -73.0 149.72 43.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.468 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.7 mt -104.59 -58.41 1.89 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.534 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -162.28 165.12 27.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.586 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.4 p -90.48 146.73 23.89 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.112 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.48 162.52 16.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.762 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.76 60.68 3.58 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.48 -24.73 78.81 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.6 2.2 . . . . 0.0 112.004 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.5 m -64.47 144.51 57.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.5 m80 48.43 -123.87 1.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.362 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.7 138.55 33.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.311 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -77.88 153.95 32.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.235 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.4 p -127.61 149.45 50.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.996 0.427 . . . . 0.0 110.025 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -104.63 140.13 38.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.145 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -96.66 132.66 42.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.244 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.0 t -132.18 132.17 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.79 118.97 16.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.108 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.8 t -88.49 136.5 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.136 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -115.8 147.66 40.74 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.091 0.472 . . . . 0.0 110.008 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -144.43 114.78 7.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.231 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 tttp 67.73 20.15 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.55 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.54 13.86 59.22 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -133.78 145.6 49.93 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.755 0.312 . . . . 0.0 110.222 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.65 126.0 27.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.004 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.0 tt -105.54 -26.39 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.811 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.41 155.58 26.89 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.6 t -154.97 139.68 17.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.686 0.279 . . . . 0.0 110.457 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.99 166.78 32.09 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -148.85 162.28 40.15 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.023 0.44 . . . . 0.0 110.655 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.66 177.36 46.42 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.144 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.53 -33.01 97.72 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.856 2.371 . . . . 0.0 112.477 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.5 m -120.42 153.54 36.42 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.096 0.474 . . . . 0.0 110.605 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.4 -40.54 96.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.704 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -60.75 -36.91 80.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -67.78 -41.89 82.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.452 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.85 97.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.283 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -62.28 -42.41 99.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.27 0.557 . . . . 0.0 109.782 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 67' ' ' MET . 18.7 tmm? -61.31 -42.54 98.83 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.046 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.45 -41.28 98.07 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.19 99.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 0.0 110.508 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.57 96.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.111 0.481 . . . . 0.0 110.583 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 ttt -61.69 -38.89 89.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.639 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.503 ' OD1' ' NZ ' ' A' ' 76' ' ' LYS . 67.9 t0 -59.54 -46.56 88.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.166 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 77' ' ' TYR . . . -62.73 -41.67 99.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.972 0.415 . . . . 0.0 110.416 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.89 -48.31 82.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.492 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.86 -44.9 94.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.835 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' NZ ' ' OD1' ' A' ' 72' ' ' ASP . 62.4 mttp -76.61 -23.15 53.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.026 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 73' ' ' ALA . 35.2 t80 41.87 90.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.469 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.43 116.26 21.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.046 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.167 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.496 1.63 0 CA-C-O 121.038 0.349 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.415 ' CD1' ' N ' ' A' ' 7' ' ' ILE . 1.8 mp -66.58 -21.33 28.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.875 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.7 p -56.08 -31.84 63.58 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.51 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -60.7 -48.79 80.2 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.497 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.03 -45.83 83.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.183 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -58.2 -39.99 80.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.222 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -60.13 -40.09 88.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.522 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.8 m -60.75 -40.43 92.44 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.164 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' CZ ' ' A' ' 79' ' ' PHE . 35.3 t -60.89 -39.38 89.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.082 0.468 . . . . 0.0 110.381 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.67 -41.26 94.7 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.4 p -82.98 -7.23 59.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.904 0.383 . . . . 0.0 110.703 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 tt -76.99 129.19 35.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -66.85 142.16 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.732 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' LYS . 85.5 m -91.18 111.24 22.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.225 0.536 . . . . 0.0 110.258 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -67.99 136.92 54.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.766 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.68 -11.81 69.09 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 19' ' ' THR . 56.8 mtmt -144.31 158.73 43.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 110.73 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -67.07 149.12 98.68 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.604 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.22 132.05 26.7 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.125 1.883 . . . . 0.0 111.941 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -93.43 172.36 8.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.153 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.5 mm -115.92 90.84 28.99 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.19 130.93 7.47 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.649 2.233 . . . . 0.0 112.057 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.1 tp -139.27 126.6 21.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.131 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 53.2 p90 -90.86 128.7 36.83 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.219 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -150.31 134.22 16.84 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.354 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.37 134.15 50.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.449 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.2 mt -90.76 -46.11 8.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.696 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.02 165.21 22.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.548 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 t -90.63 147.26 23.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.157 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.438 ' O ' ' OG1' ' A' ' 42' ' ' THR . 61.3 t -128.56 150.61 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.642 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.577 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 70.36 42.08 66.14 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 36' ' ' GLY . 42.8 Cg_endo -65.16 -21.11 62.87 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.596 2.197 . . . . 0.0 111.882 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 95.7 p -63.27 -25.67 68.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.0 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.678 ' CD2' ' H ' ' A' ' 40' ' ' ALA . 25.3 p-80 -135.34 -113.89 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.663 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.678 ' H ' ' CD2' ' A' ' 39' ' ' HIS . . . -74.1 139.8 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.047 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.7 mmm-85 -81.21 127.19 32.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.502 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 35' ' ' VAL . 61.4 p -126.91 149.13 49.94 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -108.25 141.46 39.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.416 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.2 m -105.6 124.07 48.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.78 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.7 t -121.59 128.16 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.388 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 123.82 23.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.903 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.2 t -87.48 130.76 36.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.318 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -109.23 140.94 42.2 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.174 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -144.72 130.74 19.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.985 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? 55.25 26.04 8.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.684 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.74 15.35 77.96 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -135.95 138.7 42.59 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 110.312 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.45 135.97 52.53 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.091 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 44.8 pt -110.54 -21.64 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.575 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.85 152.37 21.94 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.7 t -150.24 133.2 16.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.905 0.384 . . . . 0.0 110.599 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.38 166.6 32.75 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -147.16 163.16 37.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.56 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.39 177.13 46.03 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.79 -9.51 23.21 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.906 2.404 . . . . 0.0 111.953 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 m -146.91 150.01 34.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.074 0.464 . . . . 0.0 110.495 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -62.01 -39.07 90.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.714 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -59.5 -46.51 88.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.224 0.535 . . . . 0.0 110.424 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -64.95 -40.56 95.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.217 0.532 . . . . 0.0 110.534 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.91 97.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.893 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -40.46 93.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.1 mtt -59.52 -44.0 93.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.31 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.59 -43.94 74.14 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.073 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.02 98.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.052 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.86 87.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.153 0.501 . . . . 0.0 110.744 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.6 ttp -62.86 -37.39 86.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.509 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -58.83 -49.0 79.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.365 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 77' ' ' TYR . . . -62.69 -40.18 96.31 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.3 -48.86 79.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.621 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.73 -41.2 98.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.539 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -82.71 -10.67 58.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.431 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.495 ' N ' ' O ' ' A' ' 73' ' ' ALA . 98.9 m-85 43.53 45.19 5.49 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.331 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.525 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 98.5 m-20 -81.83 118.38 22.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.56 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.615 ' CZ ' ' SG ' ' A' ' 14' ' ' CYS . 2.0 m-85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.046 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo . . . . . 0 N--CA 1.497 1.688 0 CA-C-O 120.943 0.31 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.44 -18.22 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.852 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 t -49.2 -30.57 7.11 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -59.99 -50.66 72.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.569 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -47.77 68.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.27 0.557 . . . . 0.0 110.094 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -58.73 -39.77 81.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.301 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -64.29 -39.15 93.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.895 0.379 . . . . 0.0 110.486 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.448 ' O ' ' OG1' ' A' ' 16' ' ' THR . 92.6 m -60.29 -33.57 72.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.64 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.0 m -57.89 -35.93 71.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.48 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 10.3 mp -59.4 -22.61 61.68 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.545 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 13' ' ' CYS . 29.4 p -81.15 1.35 32.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.814 0.34 . . . . 0.0 110.386 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.1 47.06 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.383 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -70.28 116.92 11.18 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.161 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.4 m -140.29 135.43 32.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.346 0.593 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -65.21 132.93 50.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.063 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.15 4.39 62.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -80.93 156.97 25.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.931 0.396 . . . . 0.0 110.07 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 33.5 mp0 -62.66 149.42 89.04 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.21 164.62 31.57 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.564 2.176 . . . . 0.0 111.895 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 69.41 154.33 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.925 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.99 153.74 71.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.592 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.75 134.47 30.27 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.218 1.946 . . . . 0.0 111.685 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.1 tp -139.8 144.45 37.35 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.022 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.539 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 44.4 p90 -89.77 117.71 28.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.302 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -151.57 160.26 43.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.463 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.7 p -84.73 132.92 34.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.125 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.3 mp -93.15 -39.19 11.17 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.32 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -159.6 151.95 21.07 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.793 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.4 p -98.01 147.69 24.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.893 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.98 151.56 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.084 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.43 68.09 0.55 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.61 -9.23 21.2 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.571 2.18 . . . . 0.0 111.957 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.2 p -146.07 -169.92 3.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -60.11 -42.77 95.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.57 147.35 27.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.541 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.91 151.19 33.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.477 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.3 p -130.44 151.12 51.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.093 0.473 . . . . 0.0 110.341 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -123.89 145.81 48.86 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.264 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 t -111.95 141.15 45.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.812 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.6 152.55 37.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.899 0.381 . . . . 0.0 110.273 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.68 128.09 14.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.713 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.59 127.65 40.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.709 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 44.4 p90 -118.6 113.48 21.32 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.247 0.546 . . . . 0.0 110.115 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.644 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 1.4 t80 -102.09 133.2 47.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.937 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? 41.76 27.25 0.06 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.043 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.48 25.57 38.84 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.377 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' PHE . 3.9 tm-20 -136.69 119.56 16.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.952 0.406 . . . . 0.0 110.213 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.425 ' O ' ' OE1' ' A' ' 52' ' ' GLU . 8.3 tmm_? -70.53 128.43 36.09 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.398 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.6 pt -132.09 7.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.6 141.2 6.96 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.32 137.15 14.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.0 110.333 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.65 165.68 33.09 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -149.69 159.59 44.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 110.423 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.12 -178.72 45.86 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.96 -10.8 29.26 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.586 2.191 . . . . 0.0 112.017 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.5 m -147.24 142.95 27.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -63.89 -30.69 71.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.639 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.42 -45.46 94.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.53 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -64.42 -42.5 96.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 0.0 110.464 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.471 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' CE ' ' CD1' ' A' ' 29' ' ' TYR . 66.8 mttt -59.6 -58.97 6.29 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.812 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -57.7 -41.17 81.13 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.404 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.541 ' N ' ' SD ' ' A' ' 67' ' ' MET . . . -69.92 -53.55 14.81 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.178 -1.01 . . . . 0.0 111.65 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.39 97.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.363 . . . . 0.0 111.396 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.0 98.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.497 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.3 ttt -60.07 -39.75 87.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.471 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -60.93 -51.09 70.73 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.518 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.21 94.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.165 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.5 tp -60.99 -48.48 81.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.503 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -67.9 -37.84 82.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.622 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.76 -36.48 84.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -167.62 110.94 0.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.807 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -87.89 124.05 33.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.699 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.644 ' CZ ' ' CE2' ' A' ' 49' ' ' PHE . 1.7 m-85 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.639 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo . . . . . 0 N--CA 1.496 1.644 0 CA-C-O 121.057 0.357 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.473 ' H ' ' CD1' ' A' ' 7' ' ' ILE . 3.9 mp -68.2 -10.37 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.636 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.6 m -55.76 -31.09 62.27 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -62.34 -52.81 62.14 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.596 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.51 -44.88 89.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.867 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -59.43 -37.99 79.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.992 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -58.81 -44.49 90.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.381 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 87.8 m -61.09 -44.2 97.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.291 -0.563 . . . . 0.0 110.327 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.3 m -64.35 -40.63 96.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.967 0.413 . . . . 0.0 111.048 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.443 ' O ' ' OD2' ' A' ' 25' ' ' ASP . 55.3 mt -61.78 -39.63 92.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.137 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.9 p -70.04 -30.67 68.01 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.654 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 tt 52.19 70.72 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.418 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.89 105.12 3.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.624 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.8 m -140.1 131.52 26.87 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.161 0.505 . . . . 0.0 110.627 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.49 141.05 58.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.281 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.07 -4.49 86.28 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -143.56 125.92 15.69 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.873 0.368 . . . . 0.0 110.168 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 23' ' ' GLU . 35.4 mp0 -70.57 149.86 95.49 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.937 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.53 157.41 61.94 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.298 1.999 . . . . 0.0 111.697 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 15' ' ' LEU . 44.6 p-10 -80.99 -172.96 4.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.117 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 pt -128.62 90.32 46.73 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.464 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.63 155.81 27.76 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.385 2.057 . . . . 0.0 111.913 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.565 ' CD2' ' N ' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -138.47 147.78 43.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.011 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -129.47 110.47 11.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.188 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -151.0 133.74 15.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.436 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.423 ' HG1' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -59.88 148.12 36.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.378 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.423 ' N ' ' HG1' ' A' ' 31' ' ' THR . 70.1 mt -88.01 -46.47 9.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.691 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -161.69 163.68 29.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.091 0.472 . . . . 0.0 110.306 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.2 m -105.59 124.4 49.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.504 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.4 t -106.49 140.48 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.951 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.5 73.95 0.35 Allowed Glycine 0 CA--C 1.532 1.131 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.27 -12.8 21.0 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.316 2.011 . . . . 0.0 112.155 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.6 p -155.72 -177.14 6.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.697 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -51.27 -30.53 18.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.467 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.45 135.54 33.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.434 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -82.5 145.86 29.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.185 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.3 p -128.9 148.83 50.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.03 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -116.32 142.39 46.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.411 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.3 m -117.32 128.93 55.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.028 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.22 152.36 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.488 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.51 139.71 33.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.123 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.5 t -86.71 130.22 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.011 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -107.68 134.63 50.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 0.0 110.496 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -144.5 129.73 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.375 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.6 tptp 56.02 19.89 3.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.526 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.09 12.55 73.59 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -135.17 131.08 36.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.937 0.399 . . . . 0.0 110.036 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' NH2' ' SG ' ' A' ' 56' ' ' CYS . 42.6 mtm105 -66.83 140.37 57.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.283 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.1 pt -117.93 -14.67 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.228 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.83 140.41 6.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.401 ' SG ' ' NH2' ' A' ' 53' ' ' ARG . 54.5 m -146.43 133.45 20.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.736 0.303 . . . . 0.0 110.277 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.03 170.58 33.79 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.11 162.96 35.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.115 0.483 . . . . 0.0 110.509 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.08 -169.2 42.33 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.2 -30.0 59.32 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.952 2.434 . . . . 0.0 112.117 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.1 p -156.44 164.08 38.68 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.38 0.61 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -61.78 -24.77 67.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.813 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -55.86 -57.76 10.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.968 0.413 . . . . 0.0 110.58 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -64.04 -39.44 94.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.59 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.15 97.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.635 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -60.64 -42.18 96.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.989 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.8 ttp -59.3 -49.2 78.74 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.28 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.64 -44.18 64.63 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.502 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.09 85.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.724 0.297 . . . . 0.0 111.187 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.05 -44.24 96.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.094 0.473 . . . . 0.0 110.456 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.5 ttt -62.48 -38.14 88.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.928 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -59.83 -46.22 89.94 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.414 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.63 -41.24 96.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 110.577 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.79 -45.59 91.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.442 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -64.1 -39.92 95.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.495 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -75.72 -20.19 58.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.728 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.9 t80 58.26 96.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.564 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 53.4 p-10 -80.05 147.47 31.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.643 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.496 -179.623 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo . . . . . 0 N--CA 1.488 1.16 0 CA-C-O 120.986 0.328 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 1.7 mp -64.11 -9.78 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 86.5 p -55.76 -27.57 51.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.325 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -63.01 -51.97 64.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.01 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.21 -37.45 87.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.936 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -57.17 -47.18 81.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.4 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -62.2 -45.27 94.13 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.571 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 17' ' ' LEU . 51.1 t -63.08 -46.97 84.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.39 -47.46 85.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.407 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.9 mp -61.95 -45.9 91.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.439 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.593 ' HG1' ' NH2' ' A' ' 18' ' ' ARG . 73.8 p -75.41 -32.16 60.65 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.642 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 13' ' ' CYS . 30.2 tp 38.39 67.68 0.39 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.598 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.593 ' NH2' ' HG1' ' A' ' 16' ' ' THR . 82.8 mtt85 -68.35 129.29 39.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.6 m -139.96 135.78 33.13 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.14 132.65 48.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.279 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.14 -10.14 75.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -137.16 123.16 20.24 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.002 0.43 . . . . 0.0 110.307 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.4 149.2 93.78 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.9 145.56 74.84 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.067 1.845 . . . . 0.0 111.902 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.504 ' OD2' ' CD1' ' A' ' 49' ' ' PHE . 43.3 p-10 -82.93 -170.25 2.92 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.237 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.77 91.06 37.9 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -81.58 145.62 14.75 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.432 2.088 . . . . 0.0 111.992 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.41 148.98 43.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.632 ' CD1' ' NZ ' ' A' ' 62' ' ' LYS . 42.5 p90 -95.63 131.39 41.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.341 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -143.45 151.29 40.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.406 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.9 p -72.19 123.81 23.7 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -87.84 -52.72 5.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -160.93 150.4 17.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.579 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -106.47 133.89 50.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -136.89 156.62 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.049 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.65 60.4 0.42 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.7 -25.75 33.65 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.472 2.114 . . . . 0.0 112.146 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.0 p -105.85 -176.18 3.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.442 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.526 ' O ' ' NH2' ' A' ' 41' ' ' ARG . 86.5 t60 -59.38 -47.73 84.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.169 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.51 145.22 28.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.594 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 39' ' ' HIS . 12.3 mpt_? -79.77 146.22 32.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.194 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 73.5 p -130.93 150.37 52.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.282 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.96 146.97 35.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.258 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.4 m -115.53 125.41 52.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.983 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.92 151.39 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.096 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.29 124.13 10.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.628 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.8 m -87.91 151.28 3.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.895 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -128.65 154.28 46.43 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.106 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 66.0 t80 -144.67 120.46 10.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.035 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 tptp 71.2 21.87 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.35 18.34 62.64 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -137.86 143.32 40.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.819 0.343 . . . . 0.0 110.368 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -61.59 127.53 31.9 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 19.1 tt -110.34 -20.3 6.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.739 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.75 148.82 16.06 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.3 t -150.19 128.13 11.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.928 0.394 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.6 161.86 30.81 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -148.42 159.55 43.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 110.733 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.61 -172.82 45.51 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.82 -27.66 72.91 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.885 2.39 . . . . 0.0 112.106 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.4 t -155.26 155.64 34.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.531 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.632 ' NZ ' ' CD1' ' A' ' 29' ' ' TYR . 39.0 ttpt -59.75 -42.72 93.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.552 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -57.12 -39.06 74.36 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.468 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.482 ' NE2' ' CE ' ' A' ' 67' ' ' MET . 72.9 tp60 -74.33 -43.7 55.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.119 0.485 . . . . 0.0 110.911 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.25 62.9 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.945 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CG ' ' N ' ' A' ' 67' ' ' MET . 21.0 pttm -55.13 -42.93 73.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.267 -178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.491 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 78.5 mtm -60.62 -43.42 97.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.442 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.46 -47.45 62.77 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.414 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.38 83.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.117 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.34 74.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.051 0.453 . . . . 0.0 111.202 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.4 ttt -60.54 -36.46 78.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.9 -41.34 95.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 54' ' ' ILE . . . -60.34 -45.51 93.2 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.225 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.8 -43.64 98.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.388 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.3 -40.84 96.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.573 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -75.74 -31.32 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.629 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 13.4 t80 41.96 69.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.406 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -78.42 136.17 37.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.849 -179.373 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 CA-C-O 121.228 0.428 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.464 HD13 HG22 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -63.45 -27.81 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.33 -179.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 t -49.62 -26.79 3.91 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -60.34 -48.15 82.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.176 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -51.4 65.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.143 0.496 . . . . 0.0 110.692 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -59.99 -40.15 88.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.914 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.8 -42.02 98.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.427 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.51 -46.89 88.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.485 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.4 m -61.07 -41.34 96.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -63.38 -39.86 95.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.579 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 m -78.39 -15.74 58.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.163 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.4 tp -75.49 120.04 20.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.086 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -64.77 132.0 48.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.691 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.4 m -98.62 125.24 43.83 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.323 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.93 132.62 46.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.479 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.65 -8.19 80.33 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.77 143.45 38.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.0 0.428 . . . . 0.0 110.704 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -69.96 151.1 96.27 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.713 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -45.53 163.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.575 2.183 . . . . 0.0 111.805 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -145.86 161.39 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.201 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.1 pt -135.72 149.88 70.26 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.541 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.45 146.55 62.47 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.502 2.135 . . . . 0.0 111.821 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.31 110.52 6.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.26 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -94.18 106.05 18.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.261 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -131.74 135.42 46.8 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.429 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.2 t -123.4 142.34 51.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.494 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.46 26.39 1.3 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.283 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -159.15 147.34 17.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 t -133.2 146.94 51.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.135 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.0 t -127.92 153.24 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.446 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 77.47 53.22 5.18 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' OG ' ' A' ' 38' ' ' SER . 56.2 Cg_endo -70.19 157.18 60.37 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.773 2.315 . . . . 0.0 111.832 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 39' ' ' HIS . 4.1 p 73.31 -60.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.501 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.51 ' N ' ' OG ' ' A' ' 38' ' ' SER . 45.2 m170 -81.13 -115.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.327 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.79 108.05 18.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.308 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -78.82 128.56 33.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.375 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 52.4 p -129.12 150.27 50.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.172 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.71 146.49 33.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.311 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.5 p -104.3 142.27 34.84 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.892 0.377 . . . . 0.0 110.159 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.38 142.01 34.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.04 119.93 15.35 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.149 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.5 t -86.93 140.63 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.328 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.13 148.33 35.54 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.926 0.393 . . . . 0.0 110.198 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.609 ' O ' ' N ' ' A' ' 52' ' ' GLU . 29.3 t80 -143.12 114.39 7.87 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.031 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.569 ' CB ' ' HZ3' ' A' ' 50' ' ' LYS . 0.5 OUTLIER 38.22 37.84 0.18 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.557 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.88 22.63 52.41 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.621 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' A' ' 49' ' ' PHE . 80.2 mm-40 -138.12 128.26 25.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.888 0.375 . . . . 0.0 110.483 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -69.95 131.83 45.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.22 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.4 pt -128.88 10.04 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 0.0 110.805 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.34 136.68 4.3 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.9 t -161.15 112.62 1.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.2 175.61 35.34 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -143.37 157.23 44.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 110.519 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.86 -173.94 46.43 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.56 -16.13 52.48 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.519 2.146 . . . . 0.0 111.398 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.5 m -147.77 140.32 24.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.006 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -74.37 -33.83 63.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.552 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.543 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 59.0 mtpt -60.76 -49.92 75.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.555 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -66.78 -38.99 87.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.655 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.0 66.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.908 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 5.2 ptpp? -55.12 -42.77 73.41 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.398 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.48 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 65.7 mtt -60.4 -48.75 80.4 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.792 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.07 -39.36 63.16 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.63 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.18 -48.65 80.82 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.914 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.87 -48.62 79.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.82 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 66.5 ttp -61.1 -44.42 97.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.812 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -61.34 -51.52 68.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.65 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.54 94.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.983 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.53 -44.12 97.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.035 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.78 -47.03 76.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.243 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -80.13 -15.54 56.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.997 0.427 . . . . 0.0 111.077 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -158.04 91.71 1.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.546 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 26.6 p30 -97.35 145.09 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.403 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.348 179.255 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.13 -20.42 43.82 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.702 2.268 . . . . 0.0 111.981 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.78 -178.56 51.25 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -88.22 75.22 8.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.821 0.343 . . . . 0.0 110.638 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 31.4 p-10 -140.53 70.38 31.9 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.413 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.06 140.49 92.77 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.6 2.2 . . . . 0.0 111.987 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.5 mt -69.75 -12.45 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.368 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 96.2 p -59.61 -24.32 63.72 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.686 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -63.25 -51.6 65.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.824 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.24 -48.93 66.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.089 0.471 . . . . 0.0 110.943 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -58.92 -20.5 52.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.676 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -56.8 -44.4 81.9 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.193 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.3 m -65.07 -39.73 93.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 110.521 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.45 ' SG ' ' CG ' ' A' ' 78' ' ' ASN . 51.8 t -59.9 -40.73 89.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.906 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -50.08 -47.63 53.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.176 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.4 m -71.4 -38.45 71.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.162 0.506 . . . . 0.0 110.431 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 48.33 75.13 0.15 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.844 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -75.85 105.44 6.89 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.268 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.1 m -139.44 133.65 31.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.92 0.39 . . . . 0.0 110.94 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -69.11 136.65 52.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.319 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.46 -8.74 76.09 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -89.28 138.19 31.65 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.926 0.393 . . . . 0.0 110.567 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -64.93 148.85 97.31 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.18 149.03 70.11 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.451 2.101 . . . . 0.0 112.105 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 26' ' ' ILE . 48.4 t0 -159.08 151.41 21.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.088 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.516 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 17.3 tt -135.1 89.07 24.78 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.735 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.2 148.29 14.89 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.509 2.139 . . . . 0.0 111.695 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.2 tp -138.21 133.73 33.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.129 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.509 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 41.4 p90 -93.61 123.75 37.15 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -149.9 151.59 33.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.231 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.6 p -51.9 129.67 27.4 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -87.68 -52.91 5.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.066 0.46 . . . . 0.0 110.408 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -162.43 155.52 20.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.539 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.0 p -109.31 146.81 33.71 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.2 m -138.72 165.04 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.513 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.6 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 71.38 39.48 61.61 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 36' ' ' GLY . 41.3 Cg_endo -66.47 -20.22 54.42 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.681 2.254 . . . . 0.0 111.902 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -59.66 -44.59 93.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.897 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -119.16 -108.42 0.36 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.343 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.99 131.11 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.161 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -77.96 135.87 37.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.219 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.2 p -124.38 147.67 48.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.995 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -113.32 131.79 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.649 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.7 m -113.68 126.22 55.01 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.541 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.11 148.1 33.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.39 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.19 122.91 14.28 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.241 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.33 128.69 39.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -112.8 141.27 46.8 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.488 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -144.8 130.27 18.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.559 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 mttm 59.08 17.74 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.595 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.39 13.04 62.19 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -133.53 144.05 49.13 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.811 0.338 . . . . 0.0 110.32 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -65.39 126.19 27.46 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.8 tt -104.73 -27.64 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.198 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.37 148.08 13.86 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.1 t -154.15 140.27 18.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.91 0.386 . . . . 0.0 110.628 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.62 171.95 31.76 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -144.83 153.12 41.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.921 0.391 . . . . 0.0 110.49 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.93 174.22 46.9 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 -7.44 21.24 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 123.014 2.476 . . . . 0.0 112.154 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.8 p -150.06 156.57 41.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.182 0.515 . . . . 0.0 110.632 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.78 -40.72 98.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.603 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.02 -45.49 90.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.398 0.618 . . . . 0.0 110.369 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -71.01 -41.02 71.45 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.706 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.42 94.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.603 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 67' ' ' MET . 4.7 ptmm? -64.18 -39.76 94.67 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.527 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 67' ' ' MET . 19.4 tmm? -59.5 -44.65 93.06 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.848 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.31 -40.66 94.74 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.52 -45.44 94.2 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.705 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.81 99.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.205 0.526 . . . . 0.0 110.463 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.9 ttt -62.34 -37.75 86.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.548 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -59.42 -45.17 92.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 109.988 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.6 95.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.197 0.522 . . . . 0.0 109.947 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.8 tt -59.88 -45.07 93.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.471 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.27 -39.38 93.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.619 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -77.67 -10.34 59.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 20.4 t80 67.98 133.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.378 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.45 ' CG ' ' SG ' ' A' ' 14' ' ' CYS . 32.7 m120 -79.15 144.69 34.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.427 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.8 t80 42.33 67.56 3.31 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.751 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.16 140.69 95.13 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.792 2.328 . . . . 0.0 112.055 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -161.82 127.27 3.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.166 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.377 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -56.69 138.28 84.48 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.553 2.169 . . . . 0.0 111.903 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.44 6.48 80.71 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -140.66 117.01 10.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.801 0.334 . . . . 0.0 110.511 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -139.91 147.53 51.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.584 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.15 139.94 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.695 2.263 . . . . 0.0 112.259 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.489 ' CD1' ' N ' ' A' ' 7' ' ' ILE . 2.6 mp -67.79 -19.74 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.272 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -48.42 -33.11 8.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.99 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -60.87 -44.51 96.94 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.647 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.75 -39.22 64.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.412 0.625 . . . . 0.0 110.28 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -56.66 -25.28 53.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.506 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -53.15 -36.95 61.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.479 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.18 -47.91 83.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.019 0.438 . . . . 0.0 110.598 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.8 t -60.75 -41.59 95.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.011 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.62 -42.61 99.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.287 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.7 t -83.62 -5.68 59.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.664 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.4 ' C ' ' CD2' ' A' ' 17' ' ' LEU . 2.5 tt -74.81 96.45 3.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.754 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -71.08 150.51 45.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.321 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.6 m -94.92 120.38 35.04 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.482 0.658 . . . . 0.0 110.942 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -68.9 139.34 55.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.323 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.65 2.23 84.82 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -137.17 155.38 49.63 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.501 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.48 149.28 95.41 Favored Pre-proline 0 N--CA 1.451 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.387 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.37 163.46 29.45 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.805 2.336 . . . . 0.0 111.768 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.36 166.7 29.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 26' ' ' ILE . 16.0 tt -128.61 91.74 42.61 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 121.069 0.461 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.67 133.69 14.4 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.479 2.12 . . . . 0.0 111.727 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.7 tp -138.45 145.59 41.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.218 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -88.79 136.06 33.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.466 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.7 145.9 37.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.347 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.62 110.63 22.87 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.908 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 47.2 mt -106.64 -38.2 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.33 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -85.51 141.98 29.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.359 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -121.85 146.3 47.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.155 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.448 ' O ' ' OG1' ' A' ' 42' ' ' THR . 84.4 t -137.08 159.64 36.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.568 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 37' ' ' PRO . . . 74.76 88.34 0.22 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 36' ' ' GLY . 52.0 Cg_exo -52.97 -137.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.037 2.491 . . . . 0.0 112.585 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 39' ' ' HIS . 46.3 t -59.52 -39.52 84.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.439 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' SER . 77.9 m80 -47.29 -109.83 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.08 0.467 . . . . 0.0 110.867 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.27 136.64 32.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.549 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -86.41 116.72 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.49 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 35' ' ' VAL . 58.7 p -133.66 150.32 51.56 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.516 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -135.13 151.04 50.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.365 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.6 m -112.07 129.4 56.23 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.225 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.3 t -106.09 122.27 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.201 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.14 119.89 40.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.337 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.71 126.23 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.951 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.63 133.95 48.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.869 0.366 . . . . 0.0 110.241 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -144.52 118.51 9.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.162 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.13 18.95 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.96 12.62 73.8 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -136.59 149.56 48.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.811 0.339 . . . . 0.0 110.383 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtm-85 -67.02 139.05 57.63 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.204 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -124.62 -21.3 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.507 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.62 150.55 18.28 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 42.1 t -152.53 138.97 18.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.438 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.76 161.98 29.49 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -145.84 157.87 43.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.867 0.365 . . . . 0.0 110.789 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.58 178.58 44.58 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.8 -7.65 21.59 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.826 2.351 . . . . 0.0 111.988 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.0 t -151.61 160.15 43.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.372 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -62.16 -37.89 86.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.58 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.24 -46.89 82.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.559 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -64.26 -42.97 96.23 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.752 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.43 -42.98 95.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.778 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -61.54 -39.67 91.88 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.716 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 59.5 ttm -58.38 -50.12 74.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.324 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.86 -44.0 48.43 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.275 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.73 -49.1 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.736 0.303 . . . . 0.0 111.173 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.98 -46.74 87.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 ttt -62.1 -37.87 86.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.579 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -57.6 -46.93 83.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.21 -40.78 98.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.067 0.46 . . . . 0.0 110.42 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.63 -43.91 93.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.698 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -62.39 -39.63 93.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.917 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 77' ' ' TYR . 63.1 tttp -70.74 -28.31 64.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.331 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 5.9 t80 83.06 161.13 0.13 Allowed 'General case' 0 C--N 1.334 -0.107 0 O-C-N 123.433 0.458 . . . . 0.0 110.267 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -91.62 111.75 23.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.997 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 79' ' ' PHE . 54.8 t80 40.91 58.32 8.39 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.735 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -62.38 -38.84 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.486 2.124 . . . . 0.0 111.992 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 38.79 49.65 1.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 97.6 mtp . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.437 -179.678 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.39 146.63 89.23 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.918 2.412 . . . . 0.0 111.942 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.13 112.43 4.04 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 5' ' ' ASP . 99.2 m-20 -63.16 -39.62 95.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.149 -0.221 . . . . 0.0 110.773 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 4' ' ' ASN . 63.4 t0 -35.84 99.12 0.17 Allowed Pre-proline 0 CA--C 1.533 0.296 0 O-C-N 123.498 0.499 . . . . 0.0 110.665 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.39 135.61 61.12 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.514 2.143 . . . . 0.0 112.634 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mp -71.3 -11.31 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.313 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.6 p -52.66 -24.6 8.8 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -61.81 -51.73 67.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.854 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.6 mt -64.41 -45.13 88.9 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 110.545 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.5 -42.46 96.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.374 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.22 -40.03 88.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.485 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.9 -40.86 94.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.349 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.48 -50.09 75.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.525 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.38 -38.38 90.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.997 0.427 . . . . 0.0 110.315 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -70.61 -24.49 62.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.426 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.36 120.83 18.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.055 0.455 . . . . 0.0 110.495 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -68.26 144.35 54.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.727 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 22' ' ' LYS . 96.6 m -98.92 127.93 44.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.02 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -67.84 125.87 27.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.48 -10.19 75.36 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 19' ' ' THR . 42.8 mmtm -137.55 144.7 42.22 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.058 0.456 . . . . 0.0 111.021 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.46 151.1 95.67 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.602 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.05 139.29 55.51 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.386 2.057 . . . . 0.0 111.825 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.72 158.33 22.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.441 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.4 mt -91.42 117.9 68.1 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.671 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.81 130.42 13.46 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.312 2.008 . . . . 0.0 112.135 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -140.73 137.41 33.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 25.3 p90 -111.76 106.18 14.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.06 0.457 . . . . 0.0 110.431 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -136.66 151.56 49.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.3 p -107.01 147.96 29.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.202 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.94 -84.08 0.42 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.41 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -83.92 144.11 29.41 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.663 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.2 p -132.34 129.01 38.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.897 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.23 159.91 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.148 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.64 64.27 0.42 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' SER . 71.0 Cg_endo -73.94 157.09 47.55 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.864 2.376 . . . . 0.0 111.72 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.1 m 75.99 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.447 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -174.2 -36.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.599 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.83 136.63 36.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.586 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' A' ' 41' ' ' ARG . 1.5 mpt_? -80.73 139.2 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.914 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.7 p -131.38 150.58 52.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -132.85 149.38 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.387 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.1 m -109.82 128.92 55.63 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.162 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.82 149.6 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.711 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.75 126.74 13.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.311 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.0 t -87.45 131.39 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.414 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.04 138.36 40.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.191 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -144.12 123.89 13.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 54.79 29.53 12.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.22 8.54 87.13 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -132.4 135.7 46.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.876 0.369 . . . . 0.0 110.396 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -69.84 145.94 51.7 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.192 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 54' ' ' ILE . 33.3 pt -114.12 -22.06 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.586 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.94 154.8 24.1 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.2 p -155.21 139.67 16.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.731 0.301 . . . . 0.0 110.495 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.63 174.67 35.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.542 ' N ' ' CD ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -146.24 162.81 37.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.523 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.89 -176.09 47.07 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.91 -29.96 83.97 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 123.005 2.47 . . . . 0.0 112.449 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -136.53 154.4 50.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 110.654 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -63.52 -41.66 98.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.509 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.92 -43.09 99.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.551 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -66.05 -38.31 88.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.531 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.44 -34.79 76.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.148 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 97.4 mttt -56.65 -31.04 63.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.519 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 68.6 mtm -59.06 -46.23 88.77 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.327 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.88 -50.61 23.12 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.309 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.5 83.87 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.982 0.42 . . . . 0.0 111.072 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 66' ' ' LYS . . . -61.94 -44.04 97.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.719 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 66.1 ttp -61.29 -38.94 88.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.811 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.96 -43.68 91.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.423 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -45.43 94.64 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.539 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.5 -42.87 99.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.309 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.64 -39.69 95.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.445 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 77' ' ' TYR . 27.2 mtpp -79.89 -7.37 58.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.711 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' LYS . 97.9 m-85 57.4 113.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.626 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -80.28 146.0 31.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.659 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.414 ' N ' ' CD ' ' A' ' 80' ' ' PRO . 37.7 t80 45.63 56.14 15.3 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.529 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 79' ' ' PHE . 38.1 Cg_endo -68.29 151.73 76.27 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.627 2.218 . . . . 0.0 112.107 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -161.16 160.99 30.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.562 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 79.4 mtm . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.456 -179.796 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.14 -33.76 85.18 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.993 2.462 . . . . 0.0 111.789 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.77 61.09 2.5 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.91 -38.76 89.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.703 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -130.5 81.52 67.67 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.32 -176.82 3.12 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.632 2.221 . . . . 0.0 112.311 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.441 ' C ' ' N ' ' A' ' 9' ' ' GLN . 4.9 tp -64.82 -15.64 18.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.101 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 t -47.99 -18.86 0.21 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.65 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' A' ' 7' ' ' ILE . 61.8 tt0 -61.39 -57.14 13.47 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.19 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.66 -41.36 96.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.358 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.447 ' NE2' ' N ' ' A' ' 70' ' ' ALA . 10.6 tp-100 -61.38 -54.35 44.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -65.43 -43.22 91.19 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.166 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t -61.96 -49.07 77.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.482 ' SG ' ' OD1' ' A' ' 78' ' ' ASN . 47.6 t -61.1 -45.09 96.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.695 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.78 -40.1 94.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.378 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.4 m -69.64 -38.31 77.12 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.346 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.2 tp 42.76 78.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.251 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -69.78 116.83 10.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.412 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.2 m -139.31 124.22 18.71 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.406 0.622 . . . . 0.0 110.695 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -67.3 142.98 56.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.45 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.09 -5.0 85.97 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.3 134.71 48.97 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 110.076 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 46.1 mp0 -70.34 151.58 95.72 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.03 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -51.25 141.43 39.55 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.059 1.839 . . . . 0.0 112.016 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.54 -174.54 5.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.242 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 pt -116.78 91.7 35.92 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.56 139.09 66.78 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.453 2.102 . . . . 0.0 111.588 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 tp -133.94 124.91 27.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.301 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.553 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 46.0 p90 -131.23 113.2 13.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.247 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -152.69 138.84 18.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.598 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.8 p -75.04 153.18 38.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.298 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.87 -65.67 0.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.411 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 34' ' ' THR . 17.9 tm0? -162.55 144.36 10.55 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.155 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.568 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 97.0 m -98.71 130.96 45.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.394 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.06 158.31 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.221 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 38' ' ' SER . . . -148.58 79.79 0.21 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.538 ' O ' ' CD2' ' A' ' 39' ' ' HIS . 52.4 Cg_exo -52.33 73.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.834 2.356 . . . . 0.0 112.276 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 36' ' ' GLY . 49.2 m 46.16 31.82 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.489 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 37' ' ' PRO . 85.5 m-70 -148.7 -131.54 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.589 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.03 149.28 28.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.504 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -71.0 142.54 50.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.052 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.1 m -126.99 130.59 50.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.145 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.93 140.03 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.204 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -125.8 131.06 52.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.926 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.0 142.76 36.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.283 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.38 125.54 14.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.363 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.31 138.1 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.342 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.83 113.37 24.13 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.956 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.453 ' CZ ' ' NZ ' ' A' ' 50' ' ' LYS . 66.2 t80 -101.4 115.05 29.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.311 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' NZ ' ' CZ ' ' A' ' 49' ' ' PHE . 61.6 mttp 52.39 37.74 23.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.823 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.83 25.11 70.32 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -137.57 136.32 37.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.019 0.438 . . . . 0.0 110.343 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HE ' ' HG ' ' A' ' 56' ' ' CYS . 76.0 ttt-85 -62.46 126.66 28.1 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.447 ' CD1' HD22 ' A' ' 78' ' ' ASN . 15.9 tt -111.35 -35.69 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.702 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.9 148.5 10.94 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.512 ' HG ' ' HE ' ' A' ' 53' ' ' ARG . 31.3 p -155.19 156.0 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.2 162.19 31.67 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -149.54 156.17 41.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 110.603 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.38 177.68 44.63 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.07 -6.78 19.97 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.074 2.516 . . . . 0.0 112.192 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 t -147.91 152.37 37.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.122 0.486 . . . . 0.0 110.415 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -60.83 -36.18 78.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.451 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.95 -42.96 91.07 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.683 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -66.24 -39.93 89.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.404 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.17 99.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.598 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.7 -40.41 94.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.453 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 60.9 tpp -60.32 -49.1 78.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.492 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.27 -41.45 79.0 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.54 72.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.288 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.447 ' N ' ' NE2' ' A' ' 11' ' ' GLN . . . -64.36 -46.79 81.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.273 0.558 . . . . 0.0 110.943 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.1 ttp -62.23 -38.3 88.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.619 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 53' ' ' ARG . 7.8 t0 -58.56 -49.96 75.54 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.302 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.19 98.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.515 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.36 -46.44 88.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.579 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.91 -41.28 97.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.443 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -71.14 -34.19 70.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.514 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 61.99 130.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.57 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.482 ' OD1' ' SG ' ' A' ' 14' ' ' CYS . 30.3 m120 -83.78 140.03 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.513 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -159.03 70.71 3.52 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.246 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.43 -41.81 72.33 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.728 2.285 . . . . 0.0 111.965 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 45.92 35.48 2.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.482 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 C--O 1.219 -0.552 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.595 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.77 -32.26 90.86 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.847 2.364 . . . . 0.0 111.888 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.55 -131.05 51.86 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 51.27 46.27 26.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 110.28 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.68 147.43 95.77 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.867 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.81 156.37 63.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.648 2.232 . . . . 0.0 111.991 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.74 -12.2 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.728 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.7 p -59.25 -23.63 62.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.64 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -64.31 -55.5 20.86 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.167 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -64.28 -47.57 79.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.403 0.62 . . . . 0.0 110.977 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -58.76 -24.13 61.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.32 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -56.26 -45.95 79.86 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.16 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.3 m -65.27 -42.48 93.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.104 0.478 . . . . 0.0 110.439 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.63 -42.77 99.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.769 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.9 -40.73 94.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.564 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 17' ' ' LEU . 46.6 p -72.67 -31.51 65.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.829 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 16' ' ' THR . 1.3 tt 34.6 71.48 0.11 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.278 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -70.42 119.33 14.43 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.23 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -139.13 121.66 16.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.525 0.678 . . . . 0.0 110.837 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.19 142.85 54.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.375 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.38 2.37 89.09 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -141.88 126.89 18.35 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.029 0.442 . . . . 0.0 110.04 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.28 120.46 76.99 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.784 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.03 143.48 32.64 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.152 1.901 . . . . 0.0 112.112 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -82.99 176.93 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.041 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.47 88.93 25.54 Favored Pre-proline 0 C--O 1.232 0.168 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.83 130.31 6.64 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.79 2.327 . . . . 0.0 111.79 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.5 tp -140.48 142.5 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.433 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -90.78 135.07 33.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.298 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -146.35 142.84 28.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.836 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -73.0 149.72 43.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.468 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.7 mt -104.59 -58.41 1.89 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.534 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -162.28 165.12 27.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.586 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.4 p -90.48 146.73 23.89 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.112 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.48 162.52 16.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.762 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.76 60.68 3.58 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.48 -24.73 78.81 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.6 2.2 . . . . 0.0 112.004 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.5 m -64.47 144.51 57.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.5 m80 48.43 -123.87 1.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.362 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.7 138.55 33.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.311 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -77.88 153.95 32.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.235 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.4 p -127.61 149.45 50.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.996 0.427 . . . . 0.0 110.025 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -104.63 140.13 38.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.145 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -96.66 132.66 42.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.244 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.0 t -132.18 132.17 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.79 118.97 16.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.108 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.8 t -88.49 136.5 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.136 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -115.8 147.66 40.74 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.091 0.472 . . . . 0.0 110.008 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -144.43 114.78 7.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.231 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 tttp 67.73 20.15 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.55 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.54 13.86 59.22 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -133.78 145.6 49.93 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.755 0.312 . . . . 0.0 110.222 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.65 126.0 27.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.004 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.0 tt -105.54 -26.39 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.811 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.41 155.58 26.89 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.6 t -154.97 139.68 17.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.686 0.279 . . . . 0.0 110.457 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.99 166.78 32.09 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -148.85 162.28 40.15 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.023 0.44 . . . . 0.0 110.655 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.66 177.36 46.42 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.144 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.53 -33.01 97.72 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.856 2.371 . . . . 0.0 112.477 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.5 m -120.42 153.54 36.42 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.096 0.474 . . . . 0.0 110.605 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.4 -40.54 96.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.704 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -60.75 -36.91 80.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -67.78 -41.89 82.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.452 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.85 97.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.283 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -62.28 -42.41 99.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.27 0.557 . . . . 0.0 109.782 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 67' ' ' MET . 18.7 tmm? -61.31 -42.54 98.83 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.046 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.45 -41.28 98.07 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.19 99.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 0.0 110.508 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.57 96.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.111 0.481 . . . . 0.0 110.583 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 ttt -61.69 -38.89 89.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.639 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.503 ' OD1' ' NZ ' ' A' ' 76' ' ' LYS . 67.9 t0 -59.54 -46.56 88.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.166 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 77' ' ' TYR . . . -62.73 -41.67 99.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.972 0.415 . . . . 0.0 110.416 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.89 -48.31 82.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.492 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.86 -44.9 94.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.835 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' NZ ' ' OD1' ' A' ' 72' ' ' ASP . 62.4 mttp -76.61 -23.15 53.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.026 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 73' ' ' ALA . 35.2 t80 41.87 90.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.469 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.43 116.26 21.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.046 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -72.85 149.51 90.21 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.167 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.78 -17.13 58.63 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.686 2.257 . . . . 0.0 112.216 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -155.99 156.51 34.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.306 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.2 tpt . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.547 -179.659 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.42 149.61 62.91 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.63 2.22 . . . . 0.0 112.005 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 4' ' ' ASN . . . 160.55 -77.31 0.18 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.42 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 65.9 t30 50.8 177.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.33 . . . . 0.0 110.45 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.42 ' H ' ' CG ' ' A' ' 4' ' ' ASN . 81.1 m-20 -91.51 147.97 36.45 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.798 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.28 162.98 40.33 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.592 2.194 . . . . 0.0 111.875 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.415 ' CD1' ' N ' ' A' ' 7' ' ' ILE . 1.8 mp -66.58 -21.33 28.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.875 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.7 p -56.08 -31.84 63.58 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.51 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -60.7 -48.79 80.2 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.497 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.03 -45.83 83.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.183 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -58.2 -39.99 80.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.222 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -60.13 -40.09 88.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.522 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.8 m -60.75 -40.43 92.44 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.164 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' CZ ' ' A' ' 79' ' ' PHE . 35.3 t -60.89 -39.38 89.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.082 0.468 . . . . 0.0 110.381 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.67 -41.26 94.7 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.4 p -82.98 -7.23 59.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.904 0.383 . . . . 0.0 110.703 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 tt -76.99 129.19 35.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -66.85 142.16 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.732 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' LYS . 85.5 m -91.18 111.24 22.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.225 0.536 . . . . 0.0 110.258 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -67.99 136.92 54.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.766 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.68 -11.81 69.09 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 19' ' ' THR . 56.8 mtmt -144.31 158.73 43.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 110.73 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -67.07 149.12 98.68 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.604 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.22 132.05 26.7 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.125 1.883 . . . . 0.0 111.941 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -93.43 172.36 8.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.153 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.5 mm -115.92 90.84 28.99 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.19 130.93 7.47 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.649 2.233 . . . . 0.0 112.057 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.1 tp -139.27 126.6 21.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.131 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 53.2 p90 -90.86 128.7 36.83 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.219 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -150.31 134.22 16.84 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.354 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.37 134.15 50.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.449 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.2 mt -90.76 -46.11 8.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.696 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.02 165.21 22.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.548 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 t -90.63 147.26 23.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.157 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.438 ' O ' ' OG1' ' A' ' 42' ' ' THR . 61.3 t -128.56 150.61 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.642 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.577 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 70.36 42.08 66.14 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 36' ' ' GLY . 42.8 Cg_endo -65.16 -21.11 62.87 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.596 2.197 . . . . 0.0 111.882 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 95.7 p -63.27 -25.67 68.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.0 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.678 ' CD2' ' H ' ' A' ' 40' ' ' ALA . 25.3 p-80 -135.34 -113.89 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.663 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.678 ' H ' ' CD2' ' A' ' 39' ' ' HIS . . . -74.1 139.8 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.047 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.7 mmm-85 -81.21 127.19 32.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.502 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 35' ' ' VAL . 61.4 p -126.91 149.13 49.94 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -108.25 141.46 39.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.416 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.2 m -105.6 124.07 48.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.78 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.7 t -121.59 128.16 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.388 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 123.82 23.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.903 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.2 t -87.48 130.76 36.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.318 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -109.23 140.94 42.2 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.174 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -144.72 130.74 19.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.985 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? 55.25 26.04 8.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.684 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.74 15.35 77.96 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -135.95 138.7 42.59 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 110.312 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.45 135.97 52.53 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.091 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 44.8 pt -110.54 -21.64 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.575 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.85 152.37 21.94 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.7 t -150.24 133.2 16.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.905 0.384 . . . . 0.0 110.599 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.38 166.6 32.75 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -147.16 163.16 37.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.56 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.39 177.13 46.03 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.79 -9.51 23.21 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.906 2.404 . . . . 0.0 111.953 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 m -146.91 150.01 34.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.074 0.464 . . . . 0.0 110.495 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -62.01 -39.07 90.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.714 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -59.5 -46.51 88.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.224 0.535 . . . . 0.0 110.424 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -64.95 -40.56 95.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.217 0.532 . . . . 0.0 110.534 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.91 97.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.893 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -40.46 93.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.1 mtt -59.52 -44.0 93.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.31 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.59 -43.94 74.14 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.073 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.02 98.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.052 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.86 87.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.153 0.501 . . . . 0.0 110.744 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.6 ttp -62.86 -37.39 86.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.509 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -58.83 -49.0 79.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.365 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 77' ' ' TYR . . . -62.69 -40.18 96.31 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.3 -48.86 79.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.621 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.73 -41.2 98.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.539 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -82.71 -10.67 58.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.431 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.495 ' N ' ' O ' ' A' ' 73' ' ' ALA . 98.9 m-85 43.53 45.19 5.49 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.331 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.525 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 98.5 m-20 -81.83 118.38 22.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.56 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.615 ' CZ ' ' SG ' ' A' ' 14' ' ' CYS . 2.0 m-85 -167.24 -62.46 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.046 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 79' ' ' PHE . 37.4 Cg_endo -63.54 151.03 86.94 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.326 2.018 . . . . 0.0 111.835 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' A' ' 81' ' ' GLN . 5.1 pp0? -159.49 14.77 0.15 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.588 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 C--O 1.222 -0.364 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.009 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.421 ' C ' ' H ' ' A' ' 4' ' ' ASN . 62.2 Cg_exo -53.5 -39.89 80.68 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.759 2.306 . . . . 0.0 111.83 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.68 -41.16 1.65 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 2' ' ' PRO . 49.9 p30 -83.07 -1.32 52.47 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.736 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -135.1 151.04 74.58 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.029 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.8 146.2 21.63 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.049 1.833 . . . . 0.0 112.123 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp -66.44 -18.22 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.852 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 t -49.2 -30.57 7.11 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -59.99 -50.66 72.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.569 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -47.77 68.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.27 0.557 . . . . 0.0 110.094 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -58.73 -39.77 81.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.301 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -64.29 -39.15 93.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.895 0.379 . . . . 0.0 110.486 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.448 ' O ' ' OG1' ' A' ' 16' ' ' THR . 92.6 m -60.29 -33.57 72.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.64 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.0 m -57.89 -35.93 71.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.48 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 15' ' ' LEU . 10.3 mp -59.4 -22.61 61.68 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.545 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 13' ' ' CYS . 29.4 p -81.15 1.35 32.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.814 0.34 . . . . 0.0 110.386 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.1 47.06 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.383 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -70.28 116.92 11.18 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.161 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.4 m -140.29 135.43 32.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.346 0.593 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -65.21 132.93 50.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.063 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.15 4.39 62.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -80.93 156.97 25.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.931 0.396 . . . . 0.0 110.07 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 33.5 mp0 -62.66 149.42 89.04 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.21 164.62 31.57 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.564 2.176 . . . . 0.0 111.895 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 69.41 154.33 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.925 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.99 153.74 71.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.592 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.75 134.47 30.27 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.218 1.946 . . . . 0.0 111.685 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.1 tp -139.8 144.45 37.35 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.022 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.539 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 44.4 p90 -89.77 117.71 28.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.302 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -151.57 160.26 43.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.463 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.7 p -84.73 132.92 34.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.125 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.3 mp -93.15 -39.19 11.17 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.32 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -159.6 151.95 21.07 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.793 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.4 p -98.01 147.69 24.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.893 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.98 151.56 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.084 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.43 68.09 0.55 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.61 -9.23 21.2 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.571 2.18 . . . . 0.0 111.957 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.2 p -146.07 -169.92 3.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -60.11 -42.77 95.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.57 147.35 27.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.541 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.91 151.19 33.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.477 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.3 p -130.44 151.12 51.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.093 0.473 . . . . 0.0 110.341 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -123.89 145.81 48.86 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.264 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 t -111.95 141.15 45.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.812 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.6 152.55 37.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.899 0.381 . . . . 0.0 110.273 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.68 128.09 14.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.713 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.59 127.65 40.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.709 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 44.4 p90 -118.6 113.48 21.32 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.247 0.546 . . . . 0.0 110.115 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.644 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 1.4 t80 -102.09 133.2 47.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.937 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? 41.76 27.25 0.06 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.043 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.48 25.57 38.84 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.377 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' PHE . 3.9 tm-20 -136.69 119.56 16.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.952 0.406 . . . . 0.0 110.213 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.425 ' O ' ' OE1' ' A' ' 52' ' ' GLU . 8.3 tmm_? -70.53 128.43 36.09 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.398 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.6 pt -132.09 7.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.6 141.2 6.96 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.32 137.15 14.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.0 110.333 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.65 165.68 33.09 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -149.69 159.59 44.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 110.423 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.12 -178.72 45.86 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.96 -10.8 29.26 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.586 2.191 . . . . 0.0 112.017 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.5 m -147.24 142.95 27.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -63.89 -30.69 71.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.639 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.42 -45.46 94.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.53 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -64.42 -42.5 96.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 0.0 110.464 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.471 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' CE ' ' CD1' ' A' ' 29' ' ' TYR . 66.8 mttt -59.6 -58.97 6.29 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.812 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -57.7 -41.17 81.13 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.404 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.541 ' N ' ' SD ' ' A' ' 67' ' ' MET . . . -69.92 -53.55 14.81 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.178 -1.01 . . . . 0.0 111.65 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.39 97.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.363 . . . . 0.0 111.396 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.0 98.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.497 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.3 ttt -60.07 -39.75 87.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.471 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -60.93 -51.09 70.73 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.518 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.21 94.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.165 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.5 tp -60.99 -48.48 81.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.503 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -67.9 -37.84 82.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.622 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.76 -36.48 84.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -167.62 110.94 0.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.807 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -87.89 124.05 33.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.699 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.644 ' CZ ' ' CE2' ' A' ' 49' ' ' PHE . 1.7 m-85 -74.38 -60.17 1.46 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.639 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 79' ' ' PHE . 34.9 Cg_endo -62.82 138.84 71.17 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.902 1.735 . . . . 0.0 111.921 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -70.72 -40.27 72.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.605 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.517 179.826 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.77 -21.85 57.67 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.792 2.328 . . . . 0.0 111.92 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.98 -158.79 48.69 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -84.33 -174.38 5.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.774 0.321 . . . . 0.0 110.305 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -126.47 81.91 67.19 Favored Pre-proline 0 N--CA 1.467 0.388 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.426 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.46 145.35 88.81 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.804 2.336 . . . . 0.0 112.059 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.473 ' H ' ' CD1' ' A' ' 7' ' ' ILE . 3.9 mp -68.2 -10.37 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.636 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.6 m -55.76 -31.09 62.27 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -62.34 -52.81 62.14 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.596 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.51 -44.88 89.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.867 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -59.43 -37.99 79.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.992 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -58.81 -44.49 90.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.381 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 87.8 m -61.09 -44.2 97.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.291 -0.563 . . . . 0.0 110.327 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.3 m -64.35 -40.63 96.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.967 0.413 . . . . 0.0 111.048 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.443 ' O ' ' OD2' ' A' ' 25' ' ' ASP . 55.3 mt -61.78 -39.63 92.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.137 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.9 p -70.04 -30.67 68.01 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.654 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 tt 52.19 70.72 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.418 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.89 105.12 3.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.624 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.8 m -140.1 131.52 26.87 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.161 0.505 . . . . 0.0 110.627 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.49 141.05 58.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.281 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.07 -4.49 86.28 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -143.56 125.92 15.69 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.873 0.368 . . . . 0.0 110.168 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 23' ' ' GLU . 35.4 mp0 -70.57 149.86 95.49 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.937 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.53 157.41 61.94 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.298 1.999 . . . . 0.0 111.697 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 15' ' ' LEU . 44.6 p-10 -80.99 -172.96 4.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.117 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 pt -128.62 90.32 46.73 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.464 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.63 155.81 27.76 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.385 2.057 . . . . 0.0 111.913 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.565 ' CD2' ' N ' ' A' ' 28' ' ' LEU . 0.9 OUTLIER -138.47 147.78 43.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.011 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -129.47 110.47 11.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.188 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -151.0 133.74 15.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.436 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.423 ' HG1' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -59.88 148.12 36.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.378 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.423 ' N ' ' HG1' ' A' ' 31' ' ' THR . 70.1 mt -88.01 -46.47 9.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.691 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -161.69 163.68 29.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.091 0.472 . . . . 0.0 110.306 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.2 m -105.59 124.4 49.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.504 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.4 t -106.49 140.48 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.951 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.5 73.95 0.35 Allowed Glycine 0 CA--C 1.532 1.131 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.27 -12.8 21.0 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.316 2.011 . . . . 0.0 112.155 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.6 p -155.72 -177.14 6.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.697 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -51.27 -30.53 18.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.467 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.45 135.54 33.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.434 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -82.5 145.86 29.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.185 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.3 p -128.9 148.83 50.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.03 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -116.32 142.39 46.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.411 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.3 m -117.32 128.93 55.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.028 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.22 152.36 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.488 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.51 139.71 33.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.123 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.5 t -86.71 130.22 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.011 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -107.68 134.63 50.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 0.0 110.496 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -144.5 129.73 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.375 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.6 tptp 56.02 19.89 3.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.526 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.09 12.55 73.59 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -135.17 131.08 36.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.937 0.399 . . . . 0.0 110.036 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.401 ' NH2' ' SG ' ' A' ' 56' ' ' CYS . 42.6 mtm105 -66.83 140.37 57.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.283 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.1 pt -117.93 -14.67 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.228 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.83 140.41 6.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.401 ' SG ' ' NH2' ' A' ' 53' ' ' ARG . 54.5 m -146.43 133.45 20.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.736 0.303 . . . . 0.0 110.277 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.03 170.58 33.79 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.11 162.96 35.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.115 0.483 . . . . 0.0 110.509 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.08 -169.2 42.33 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.2 -30.0 59.32 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.952 2.434 . . . . 0.0 112.117 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.1 p -156.44 164.08 38.68 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.38 0.61 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -61.78 -24.77 67.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.813 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -55.86 -57.76 10.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.968 0.413 . . . . 0.0 110.58 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -64.04 -39.44 94.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.59 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.15 97.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.635 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -60.64 -42.18 96.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.989 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.8 ttp -59.3 -49.2 78.74 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.28 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.64 -44.18 64.63 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.502 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.09 85.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.724 0.297 . . . . 0.0 111.187 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.05 -44.24 96.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.094 0.473 . . . . 0.0 110.456 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.5 ttt -62.48 -38.14 88.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.928 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -59.83 -46.22 89.94 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.414 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.63 -41.24 96.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 110.577 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.79 -45.59 91.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.442 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -64.1 -39.92 95.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.495 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -75.72 -20.19 58.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.728 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.9 t80 58.26 96.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.564 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 53.4 p-10 -80.05 147.47 31.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.643 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.411 ' C ' ' H ' ' A' ' 81' ' ' GLN . 22.0 t80 50.48 57.7 17.44 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.496 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 82' ' ' MET . 46.6 Cg_endo -71.34 38.83 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.656 2.237 . . . . 0.0 112.45 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.411 ' H ' ' C ' ' A' ' 79' ' ' PHE . 35.3 tt0 70.0 -42.98 0.53 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.434 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.503 ' H ' ' C ' ' A' ' 80' ' ' PRO . 50.7 tpp . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.361 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -53.03 -38.31 80.01 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.746 2.297 . . . . 0.0 112.053 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.17 -19.26 73.85 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 61.1 t30 -75.35 -178.07 3.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.846 0.355 . . . . 0.0 110.434 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.456 ' H ' ' CG ' ' A' ' 4' ' ' ASN . 61.9 t0 -131.98 73.68 77.94 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.57 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -80.4 -158.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.707 2.272 . . . . 0.0 111.839 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 1.7 mp -64.11 -9.78 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 86.5 p -55.76 -27.57 51.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.325 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -63.01 -51.97 64.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.01 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.21 -37.45 87.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.936 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -57.17 -47.18 81.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.4 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -62.2 -45.27 94.13 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.571 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 17' ' ' LEU . 51.1 t -63.08 -46.97 84.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.39 -47.46 85.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.407 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.9 mp -61.95 -45.9 91.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.439 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.593 ' HG1' ' NH2' ' A' ' 18' ' ' ARG . 73.8 p -75.41 -32.16 60.65 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.642 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 13' ' ' CYS . 30.2 tp 38.39 67.68 0.39 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.598 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.593 ' NH2' ' HG1' ' A' ' 16' ' ' THR . 82.8 mtt85 -68.35 129.29 39.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.6 m -139.96 135.78 33.13 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.14 132.65 48.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.279 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.14 -10.14 75.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -137.16 123.16 20.24 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.002 0.43 . . . . 0.0 110.307 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.4 149.2 93.78 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.9 145.56 74.84 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.067 1.845 . . . . 0.0 111.902 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.504 ' OD2' ' CD1' ' A' ' 49' ' ' PHE . 43.3 p-10 -82.93 -170.25 2.92 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.237 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.77 91.06 37.9 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -81.58 145.62 14.75 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.432 2.088 . . . . 0.0 111.992 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.41 148.98 43.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.632 ' CD1' ' NZ ' ' A' ' 62' ' ' LYS . 42.5 p90 -95.63 131.39 41.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.341 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -143.45 151.29 40.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.406 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.9 p -72.19 123.81 23.7 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -87.84 -52.72 5.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -160.93 150.4 17.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.579 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -106.47 133.89 50.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -136.89 156.62 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.049 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.65 60.4 0.42 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.7 -25.75 33.65 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.472 2.114 . . . . 0.0 112.146 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.0 p -105.85 -176.18 3.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.442 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.526 ' O ' ' NH2' ' A' ' 41' ' ' ARG . 86.5 t60 -59.38 -47.73 84.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.169 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.51 145.22 28.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.594 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 39' ' ' HIS . 12.3 mpt_? -79.77 146.22 32.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.194 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 73.5 p -130.93 150.37 52.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.282 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.96 146.97 35.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.258 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.4 m -115.53 125.41 52.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.983 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.92 151.39 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.096 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.29 124.13 10.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.628 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.8 m -87.91 151.28 3.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.895 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -128.65 154.28 46.43 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.106 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 66.0 t80 -144.67 120.46 10.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.035 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 tptp 71.2 21.87 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.35 18.34 62.64 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -137.86 143.32 40.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.819 0.343 . . . . 0.0 110.368 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -61.59 127.53 31.9 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 19.1 tt -110.34 -20.3 6.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.739 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.75 148.82 16.06 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.3 t -150.19 128.13 11.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.928 0.394 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.6 161.86 30.81 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -148.42 159.55 43.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 110.733 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.61 -172.82 45.51 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.82 -27.66 72.91 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.885 2.39 . . . . 0.0 112.106 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.4 t -155.26 155.64 34.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.531 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.632 ' NZ ' ' CD1' ' A' ' 29' ' ' TYR . 39.0 ttpt -59.75 -42.72 93.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.552 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -57.12 -39.06 74.36 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.468 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.482 ' NE2' ' CE ' ' A' ' 67' ' ' MET . 72.9 tp60 -74.33 -43.7 55.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.119 0.485 . . . . 0.0 110.911 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.25 62.9 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.945 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CG ' ' N ' ' A' ' 67' ' ' MET . 21.0 pttm -55.13 -42.93 73.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.267 -178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.491 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 78.5 mtm -60.62 -43.42 97.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.442 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.46 -47.45 62.77 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.414 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.38 83.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.117 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.34 74.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.051 0.453 . . . . 0.0 111.202 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.4 ttt -60.54 -36.46 78.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.9 -41.34 95.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 54' ' ' ILE . . . -60.34 -45.51 93.2 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.225 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.8 -43.64 98.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.388 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.3 -40.84 96.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.573 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -75.74 -31.32 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.629 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 13.4 t80 41.96 69.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.406 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -78.42 136.17 37.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -75.35 145.58 79.96 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.849 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.09 -26.65 21.23 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.407 2.071 . . . . 0.0 112.221 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -77.89 152.17 33.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.666 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.574 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -57.15 140.07 91.76 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.762 2.308 . . . . 0.0 111.852 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.57 94.19 0.57 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -158.97 178.24 10.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.493 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.62 150.02 96.83 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.443 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.25 -167.49 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.752 2.301 . . . . 0.0 112.038 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.464 HD13 HG22 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -63.45 -27.81 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.33 -179.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 t -49.62 -26.79 3.91 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -60.34 -48.15 82.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.176 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -51.4 65.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.143 0.496 . . . . 0.0 110.692 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -59.99 -40.15 88.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.914 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.8 -42.02 98.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.427 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.51 -46.89 88.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.485 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.4 m -61.07 -41.34 96.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -63.38 -39.86 95.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.579 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 m -78.39 -15.74 58.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.163 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.4 tp -75.49 120.04 20.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.086 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -64.77 132.0 48.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.691 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.4 m -98.62 125.24 43.83 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.323 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.93 132.62 46.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.479 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.65 -8.19 80.33 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.77 143.45 38.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.0 0.428 . . . . 0.0 110.704 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -69.96 151.1 96.27 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.713 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -45.53 163.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.575 2.183 . . . . 0.0 111.805 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -145.86 161.39 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.201 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.1 pt -135.72 149.88 70.26 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.541 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.45 146.55 62.47 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.502 2.135 . . . . 0.0 111.821 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.31 110.52 6.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.26 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -94.18 106.05 18.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.261 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -131.74 135.42 46.8 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.429 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.2 t -123.4 142.34 51.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.494 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.46 26.39 1.3 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.283 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -159.15 147.34 17.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 t -133.2 146.94 51.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.135 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.0 t -127.92 153.24 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.614 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 77.47 53.22 5.18 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' OG ' ' A' ' 38' ' ' SER . 56.2 Cg_endo -70.19 157.18 60.37 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.773 2.315 . . . . 0.0 111.832 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 39' ' ' HIS . 4.1 p 73.31 -60.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.501 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.51 ' N ' ' OG ' ' A' ' 38' ' ' SER . 45.2 m170 -81.13 -115.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.327 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.79 108.05 18.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.308 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -78.82 128.56 33.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.375 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 52.4 p -129.12 150.27 50.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.172 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.71 146.49 33.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.311 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.5 p -104.3 142.27 34.84 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.892 0.377 . . . . 0.0 110.159 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.38 142.01 34.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.04 119.93 15.35 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.149 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.5 t -86.93 140.63 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.328 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.13 148.33 35.54 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.926 0.393 . . . . 0.0 110.198 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.609 ' O ' ' N ' ' A' ' 52' ' ' GLU . 29.3 t80 -143.12 114.39 7.87 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.031 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.569 ' CB ' ' HZ3' ' A' ' 50' ' ' LYS . 0.5 OUTLIER 38.22 37.84 0.18 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.557 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.88 22.63 52.41 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.621 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' A' ' 49' ' ' PHE . 80.2 mm-40 -138.12 128.26 25.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.888 0.375 . . . . 0.0 110.483 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -69.95 131.83 45.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.22 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.4 pt -128.88 10.04 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 0.0 110.805 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.34 136.68 4.3 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 50.9 t -161.15 112.62 1.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.2 175.61 35.34 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -143.37 157.23 44.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 110.519 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.86 -173.94 46.43 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.56 -16.13 52.48 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.519 2.146 . . . . 0.0 111.398 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.5 m -147.77 140.32 24.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.006 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -74.37 -33.83 63.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.552 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.543 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 59.0 mtpt -60.76 -49.92 75.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.555 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -66.78 -38.99 87.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.655 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.0 66.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.908 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 5.2 ptpp? -55.12 -42.77 73.41 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.398 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.48 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 65.7 mtt -60.4 -48.75 80.4 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.792 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.07 -39.36 63.16 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.63 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.18 -48.65 80.82 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.914 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.87 -48.62 79.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.82 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 66.5 ttp -61.1 -44.42 97.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.812 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -61.34 -51.52 68.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.65 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.54 94.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.983 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.53 -44.12 97.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.035 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.78 -47.03 76.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.243 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -80.13 -15.54 56.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.997 0.427 . . . . 0.0 111.077 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -158.04 91.71 1.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.546 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 26.6 p30 -97.35 145.09 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.403 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -158.52 59.55 1.55 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.348 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.42 167.01 26.52 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.936 2.424 . . . . 0.0 111.876 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -70.63 124.3 23.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.551 -179.896 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo . . . . . 0 N--CA 1.494 1.534 0 CA-C-O 120.906 0.294 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.5 mt -69.75 -12.45 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.368 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 96.2 p -59.61 -24.32 63.72 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.686 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -63.25 -51.6 65.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.824 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.24 -48.93 66.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.089 0.471 . . . . 0.0 110.943 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.403 ' O ' HD13 ' A' ' 15' ' ' LEU . 90.2 mm-40 -58.92 -20.5 52.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.676 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -56.8 -44.4 81.9 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.193 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.3 m -65.07 -39.73 93.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 110.521 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.45 ' SG ' ' CG ' ' A' ' 78' ' ' ASN . 51.8 t -59.9 -40.73 89.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.906 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 11' ' ' GLN . 6.3 mp -50.08 -47.63 53.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.176 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.4 m -71.4 -38.45 71.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.162 0.506 . . . . 0.0 110.431 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER 48.33 75.13 0.15 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.844 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -75.85 105.44 6.89 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.268 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.1 m -139.44 133.65 31.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.92 0.39 . . . . 0.0 110.94 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -69.11 136.65 52.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.319 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.46 -8.74 76.09 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -89.28 138.19 31.65 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.926 0.393 . . . . 0.0 110.567 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -64.93 148.85 97.31 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.18 149.03 70.11 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.451 2.101 . . . . 0.0 112.105 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 26' ' ' ILE . 48.4 t0 -159.08 151.41 21.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.088 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 26' ' ' ILE . 17.3 tt -135.1 89.07 24.78 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.735 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.2 148.29 14.89 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.509 2.139 . . . . 0.0 111.695 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.2 tp -138.21 133.73 33.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.129 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.509 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 41.4 p90 -93.61 123.75 37.15 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -149.9 151.59 33.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.231 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.6 p -51.9 129.67 27.4 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -87.68 -52.91 5.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.066 0.46 . . . . 0.0 110.408 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -162.43 155.52 20.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.539 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.404 HG22 ' CD2' ' A' ' 43' ' ' TYR . 73.0 p -109.31 146.81 33.71 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.2 m -138.72 165.04 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.513 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.6 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 71.38 39.48 61.61 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 36' ' ' GLY . 41.3 Cg_endo -66.47 -20.22 54.42 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.681 2.254 . . . . 0.0 111.902 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -59.66 -44.59 93.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.897 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -119.16 -108.42 0.36 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.343 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.99 131.11 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.161 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -77.96 135.87 37.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.219 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.2 p -124.38 147.67 48.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.995 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.404 ' CD2' HG22 ' A' ' 34' ' ' THR . 96.4 m-85 -113.32 131.79 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.649 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.7 m -113.68 126.22 55.01 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.541 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.11 148.1 33.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.39 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.19 122.91 14.28 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.241 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.33 128.69 39.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -112.8 141.27 46.8 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.488 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -144.8 130.27 18.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.559 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 mttm 59.08 17.74 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.595 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.39 13.04 62.19 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -133.53 144.05 49.13 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.811 0.338 . . . . 0.0 110.32 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -65.39 126.19 27.46 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.8 tt -104.73 -27.64 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.198 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.37 148.08 13.86 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.1 t -154.15 140.27 18.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.91 0.386 . . . . 0.0 110.628 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.62 171.95 31.76 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -144.83 153.12 41.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.921 0.391 . . . . 0.0 110.49 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.93 174.22 46.9 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 -7.44 21.24 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 123.014 2.476 . . . . 0.0 112.154 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.8 p -150.06 156.57 41.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.182 0.515 . . . . 0.0 110.632 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.78 -40.72 98.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.603 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.02 -45.49 90.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.398 0.618 . . . . 0.0 110.369 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -71.01 -41.02 71.45 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.706 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.42 94.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.603 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 67' ' ' MET . 4.7 ptmm? -64.18 -39.76 94.67 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.527 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 67' ' ' MET . 19.4 tmm? -59.5 -44.65 93.06 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.848 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.31 -40.66 94.74 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.52 -45.44 94.2 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.705 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.81 99.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.205 0.526 . . . . 0.0 110.463 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.9 ttt -62.34 -37.75 86.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.548 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -59.42 -45.17 92.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 109.988 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.6 95.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.197 0.522 . . . . 0.0 109.947 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.8 tt -59.88 -45.07 93.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.471 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.27 -39.38 93.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.619 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -77.67 -10.34 59.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 20.4 t80 67.98 133.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.378 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.45 ' CG ' ' SG ' ' A' ' 14' ' ' CYS . 32.7 m120 -79.15 144.69 34.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.427 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.8 t80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.751 -179.657 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 CA-C-O 121.268 0.445 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.715 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.6 mp -67.79 -19.74 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.272 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -48.42 -33.11 8.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.99 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -60.87 -44.51 96.94 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.647 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.1 tt -73.75 -39.22 64.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.412 0.625 . . . . 0.0 110.28 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -56.66 -25.28 53.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.506 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -53.15 -36.95 61.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.479 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.18 -47.91 83.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.019 0.438 . . . . 0.0 110.598 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.8 t -60.75 -41.59 95.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.011 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.62 -42.61 99.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.287 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.7 t -83.62 -5.68 59.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.664 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 17' ' ' LEU . 2.5 tt -74.81 96.45 3.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.754 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -71.08 150.51 45.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.321 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.425 HG21 ' HD2' ' A' ' 22' ' ' LYS . 62.6 m -94.92 120.38 35.04 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.482 0.658 . . . . 0.0 110.942 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -68.9 139.34 55.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.323 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.65 2.23 84.82 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HD2' HG21 ' A' ' 19' ' ' THR . 99.4 mttt -137.17 155.38 49.63 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.501 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.48 149.28 95.41 Favored Pre-proline 0 N--CA 1.451 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.387 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.37 163.46 29.45 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.805 2.336 . . . . 0.0 111.768 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.36 166.7 29.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 26' ' ' ILE . 16.0 tt -128.61 91.74 42.61 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 121.069 0.461 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.67 133.69 14.4 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.479 2.12 . . . . 0.0 111.727 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.7 tp -138.45 145.59 41.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.218 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -88.79 136.06 33.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.466 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.7 145.9 37.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.347 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.62 110.63 22.87 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.908 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 47.2 mt -106.64 -38.2 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.33 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -85.51 141.98 29.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.359 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -121.85 146.3 47.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.155 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 36' ' ' GLY . 84.4 t -137.08 159.64 36.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.568 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.544 ' N ' HG12 ' A' ' 35' ' ' VAL . . . 74.76 88.34 0.22 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 36' ' ' GLY . 52.0 Cg_exo -52.97 -137.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.037 2.491 . . . . 0.0 112.585 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 39' ' ' HIS . 46.3 t -59.52 -39.52 84.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.439 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' SER . 77.9 m80 -47.29 -109.83 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.08 0.467 . . . . 0.0 110.867 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.27 136.64 32.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.549 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -86.41 116.72 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.49 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.45 ' HG1' ' C ' ' A' ' 35' ' ' VAL . 58.7 p -133.66 150.32 51.56 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.516 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -135.13 151.04 50.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.365 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.6 m -112.07 129.4 56.23 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.225 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.3 t -106.09 122.27 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.201 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.14 119.89 40.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.337 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.71 126.23 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.951 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.63 133.95 48.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.869 0.366 . . . . 0.0 110.241 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -144.52 118.51 9.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.162 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.13 18.95 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.96 12.62 73.8 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -136.59 149.56 48.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.811 0.339 . . . . 0.0 110.383 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtm-85 -67.02 139.05 57.63 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.204 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -124.62 -21.3 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.507 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.62 150.55 18.28 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 42.1 t -152.53 138.97 18.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.438 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.76 161.98 29.49 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -145.84 157.87 43.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.867 0.365 . . . . 0.0 110.789 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.58 178.58 44.58 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.8 -7.65 21.59 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.826 2.351 . . . . 0.0 111.988 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.0 t -151.61 160.15 43.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.372 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -62.16 -37.89 86.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.58 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.24 -46.89 82.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.559 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -64.26 -42.97 96.23 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.752 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.43 -42.98 95.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.778 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -61.54 -39.67 91.88 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.716 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 59.5 ttm -58.38 -50.12 74.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.324 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.86 -44.0 48.43 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.275 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.73 -49.1 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.736 0.303 . . . . 0.0 111.173 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.98 -46.74 87.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 ttt -62.1 -37.87 86.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.579 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -57.6 -46.93 83.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.21 -40.78 98.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.067 0.46 . . . . 0.0 110.42 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.63 -43.91 93.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.698 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -62.39 -39.63 93.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.917 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 77' ' ' TYR . 63.1 tttp -70.74 -28.31 64.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.331 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 5.9 t80 83.06 161.13 0.13 Allowed 'General case' 0 C--N 1.334 -0.107 0 O-C-N 123.433 0.458 . . . . 0.0 110.267 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -91.62 111.75 23.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.997 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 79' ' ' PHE . 54.8 t80 . . . . . 0 N--CA 1.463 0.202 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.735 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo . . . . . 0 N--CA 1.496 1.665 0 CA-C-O 121.433 0.514 . . . . 0.0 112.634 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.2 mp -71.3 -11.31 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.313 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.6 p -52.66 -24.6 8.8 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -61.81 -51.73 67.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.854 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.6 mt -64.41 -45.13 88.9 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 110.545 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -60.5 -42.46 96.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.374 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.22 -40.03 88.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.485 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.9 -40.86 94.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.349 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.48 -50.09 75.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.525 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.38 -38.38 90.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.997 0.427 . . . . 0.0 110.315 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -70.61 -24.49 62.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.426 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.36 120.83 18.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.055 0.455 . . . . 0.0 110.495 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -68.26 144.35 54.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.727 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 22' ' ' LYS . 96.6 m -98.92 127.93 44.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.02 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -67.84 125.87 27.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.48 -10.19 75.36 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 19' ' ' THR . 42.8 mmtm -137.55 144.7 42.22 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.058 0.456 . . . . 0.0 111.021 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.46 151.1 95.67 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.602 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.05 139.29 55.51 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.386 2.057 . . . . 0.0 111.825 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.72 158.33 22.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.441 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.4 mt -91.42 117.9 68.1 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.671 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.81 130.42 13.46 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.312 2.008 . . . . 0.0 112.135 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -140.73 137.41 33.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 25.3 p90 -111.76 106.18 14.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.06 0.457 . . . . 0.0 110.431 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -136.66 151.56 49.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.3 p -107.01 147.96 29.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.202 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.94 -84.08 0.42 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.41 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -83.92 144.11 29.41 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.663 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.2 p -132.34 129.01 38.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.897 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' OG1' ' A' ' 42' ' ' THR . 32.1 m -138.23 159.91 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.148 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.64 64.27 0.42 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' SER . 71.0 Cg_endo -73.94 157.09 47.55 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.864 2.376 . . . . 0.0 111.72 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.1 m 75.99 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.447 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -174.2 -36.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.599 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.83 136.63 36.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.586 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' A' ' 41' ' ' ARG . 1.5 mpt_? -80.73 139.2 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.914 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.426 ' OG1' HG23 ' A' ' 35' ' ' VAL . 80.7 p -131.38 150.58 52.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -132.85 149.38 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.387 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.1 m -109.82 128.92 55.63 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.162 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.82 149.6 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.711 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.75 126.74 13.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.311 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.0 t -87.45 131.39 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.414 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.04 138.36 40.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.191 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -144.12 123.89 13.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 54.79 29.53 12.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.22 8.54 87.13 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -132.4 135.7 46.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.876 0.369 . . . . 0.0 110.396 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -69.84 145.94 51.7 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.192 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.3 pt -114.12 -22.06 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.586 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.94 154.8 24.1 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.2 p -155.21 139.67 16.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.731 0.301 . . . . 0.0 110.495 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.63 174.67 35.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.542 ' N ' ' CD ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -146.24 162.81 37.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.523 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.89 -176.09 47.07 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.91 -29.96 83.97 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 123.005 2.47 . . . . 0.0 112.449 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -136.53 154.4 50.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 110.654 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -63.52 -41.66 98.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.509 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.92 -43.09 99.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.551 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -66.05 -38.31 88.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.531 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.44 -34.79 76.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.148 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 97.4 mttt -56.65 -31.04 63.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.519 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 68.6 mtm -59.06 -46.23 88.77 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.327 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.88 -50.61 23.12 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.309 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.5 83.87 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.982 0.42 . . . . 0.0 111.072 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 66' ' ' LYS . . . -61.94 -44.04 97.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.719 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 66.1 ttp -61.29 -38.94 88.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.811 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.96 -43.68 91.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.423 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -45.43 94.64 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.539 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.5 -42.87 99.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.309 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.64 -39.69 95.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.445 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 77' ' ' TYR . 27.2 mtpp -79.89 -7.37 58.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.711 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' LYS . 97.9 m-85 57.4 113.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.626 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -80.28 146.0 31.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.659 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.7 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.529 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 121.118 0.382 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.622 HD13 ' SD ' ' A' ' 67' ' ' MET . 4.9 tp -64.82 -15.64 18.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.101 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 t -47.99 -18.86 0.21 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.65 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' A' ' 7' ' ' ILE . 61.8 tt0 -61.39 -57.14 13.47 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.19 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 74' ' ' LEU . 85.1 mt -64.66 -41.36 96.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.358 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.592 ' O ' HD13 ' A' ' 15' ' ' LEU . 10.6 tp-100 -61.38 -54.35 44.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -65.43 -43.22 91.19 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.166 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t -61.96 -49.07 77.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.632 ' SG ' ' ND2' ' A' ' 78' ' ' ASN . 47.6 t -61.1 -45.09 96.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.695 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.592 HD13 ' O ' ' A' ' 11' ' ' GLN . 7.1 mp -61.78 -40.1 94.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.378 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.4 m -69.64 -38.31 77.12 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.346 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.2 tp 42.76 78.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.251 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -69.78 116.83 10.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.412 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.2 m -139.31 124.22 18.71 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.406 0.622 . . . . 0.0 110.695 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -67.3 142.98 56.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.45 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.09 -5.0 85.97 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.3 134.71 48.97 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 110.076 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 46.1 mp0 -70.34 151.58 95.72 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.03 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -51.25 141.43 39.55 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.059 1.839 . . . . 0.0 112.016 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.54 -174.54 5.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.242 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 pt -116.78 91.7 35.92 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.56 139.09 66.78 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.453 2.102 . . . . 0.0 111.588 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 tp -133.94 124.91 27.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.301 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.553 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 46.0 p90 -131.23 113.2 13.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.247 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -152.69 138.84 18.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.598 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.8 p -75.04 153.18 38.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.298 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.87 -65.67 0.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.411 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 34' ' ' THR . 17.9 tm0? -162.55 144.36 10.55 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.155 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.568 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 97.0 m -98.71 130.96 45.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.394 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.06 158.31 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.221 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 38' ' ' SER . . . -148.58 79.79 0.21 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.538 ' O ' ' CD2' ' A' ' 39' ' ' HIS . 52.4 Cg_exo -52.33 73.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.834 2.356 . . . . 0.0 112.276 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 36' ' ' GLY . 49.2 m 46.16 31.82 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.489 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 37' ' ' PRO . 85.5 m-70 -148.7 -131.54 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.589 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.03 149.28 28.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.504 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -71.0 142.54 50.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.052 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.1 m -126.99 130.59 50.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.145 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.93 140.03 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.204 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -125.8 131.06 52.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.926 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.0 142.76 36.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.283 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.38 125.54 14.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.363 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.31 138.1 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.342 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.83 113.37 24.13 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.956 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CZ ' ' NZ ' ' A' ' 50' ' ' LYS . 66.2 t80 -101.4 115.05 29.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.311 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' NZ ' ' CZ ' ' A' ' 49' ' ' PHE . 61.6 mttp 52.39 37.74 23.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.823 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.83 25.11 70.32 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -137.57 136.32 37.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.019 0.438 . . . . 0.0 110.343 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 76.0 ttt-85 -62.46 126.66 28.1 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.9 tt -111.35 -35.69 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.702 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.9 148.5 10.94 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 31.3 p -155.19 156.0 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.2 162.19 31.67 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -149.54 156.17 41.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 110.603 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.38 177.68 44.63 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.07 -6.78 19.97 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.074 2.516 . . . . 0.0 112.192 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 t -147.91 152.37 37.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.122 0.486 . . . . 0.0 110.415 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -60.83 -36.18 78.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.451 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.95 -42.96 91.07 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.683 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -66.24 -39.93 89.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.404 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.17 99.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.598 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.7 -40.41 94.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.453 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.622 ' SD ' HD13 ' A' ' 7' ' ' ILE . 60.9 tpp -60.32 -49.1 78.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.492 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.27 -41.45 79.0 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.54 72.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.288 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 11' ' ' GLN . . . -64.36 -46.79 81.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.273 0.558 . . . . 0.0 110.943 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.1 ttp -62.23 -38.3 88.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.619 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 53' ' ' ARG . 7.8 t0 -58.56 -49.96 75.54 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.302 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB1' ' SG ' ' A' ' 14' ' ' CYS . . . -63.46 -41.19 98.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.515 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 10' ' ' LEU . 50.9 tp -59.36 -46.44 88.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.579 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.91 -41.28 97.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.443 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -71.14 -34.19 70.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.514 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 61.99 130.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.57 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.632 ' ND2' ' SG ' ' A' ' 14' ' ' CYS . 68.6 m-80 -83.78 140.03 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.513 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.246 179.526 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.496 1.624 0 CA-C-O 121.126 0.386 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.8 mp -67.74 -12.2 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.728 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.7 p -59.25 -23.63 62.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.64 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -64.31 -55.5 20.86 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.167 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -64.28 -47.57 79.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.403 0.62 . . . . 0.0 110.977 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -58.76 -24.13 61.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.32 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -56.26 -45.95 79.86 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.16 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.3 m -65.27 -42.48 93.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.104 0.478 . . . . 0.0 110.439 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.63 -42.77 99.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.769 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.9 -40.73 94.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.564 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 17' ' ' LEU . 46.6 p -72.67 -31.51 65.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.829 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 16' ' ' THR . 1.3 tt 34.6 71.48 0.11 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.278 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -70.42 119.33 14.43 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.23 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -139.13 121.66 16.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.525 0.678 . . . . 0.0 110.837 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.19 142.85 54.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.375 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.38 2.37 89.09 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -141.88 126.89 18.35 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.029 0.442 . . . . 0.0 110.04 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.28 120.46 76.99 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.784 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.03 143.48 32.64 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.152 1.901 . . . . 0.0 112.112 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -82.99 176.93 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.041 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.47 88.93 25.54 Favored Pre-proline 0 C--O 1.232 0.168 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.83 130.31 6.64 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.79 2.327 . . . . 0.0 111.79 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 28' ' ' LEU . 20.5 tp -140.48 142.5 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.433 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -90.78 135.07 33.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.298 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -146.35 142.84 28.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.836 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.505 HG21 ' HZ2' ' A' ' 62' ' ' LYS . 67.5 p -73.0 149.72 43.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.468 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.7 mt -104.59 -58.41 1.89 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.534 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -162.28 165.12 27.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.586 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.4 p -90.48 146.73 23.89 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.112 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.558 HG22 ' N ' ' A' ' 36' ' ' GLY . 14.9 p -143.48 162.52 16.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.762 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.558 ' N ' HG22 ' A' ' 35' ' ' VAL . . . 73.76 60.68 3.58 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.48 -24.73 78.81 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.6 2.2 . . . . 0.0 112.004 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.5 m -64.47 144.51 57.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.5 m80 48.43 -123.87 1.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.362 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.7 138.55 33.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.311 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -77.88 153.95 32.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.235 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.4 p -127.61 149.45 50.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.996 0.427 . . . . 0.0 110.025 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -104.63 140.13 38.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.145 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -96.66 132.66 42.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.244 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.0 t -132.18 132.17 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.79 118.97 16.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.108 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.8 t -88.49 136.5 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.136 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -115.8 147.66 40.74 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.091 0.472 . . . . 0.0 110.008 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -144.43 114.78 7.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.231 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 tttp 67.73 20.15 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.55 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.54 13.86 59.22 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -133.78 145.6 49.93 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.755 0.312 . . . . 0.0 110.222 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.65 126.0 27.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.004 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.0 tt -105.54 -26.39 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.811 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.41 155.58 26.89 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.6 t -154.97 139.68 17.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.686 0.279 . . . . 0.0 110.457 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.99 166.78 32.09 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -148.85 162.28 40.15 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.023 0.44 . . . . 0.0 110.655 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.66 177.36 46.42 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.144 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.53 -33.01 97.72 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.856 2.371 . . . . 0.0 112.477 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.5 m -120.42 153.54 36.42 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.096 0.474 . . . . 0.0 110.605 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.505 ' HZ2' HG21 ' A' ' 31' ' ' THR . 68.1 mttm -62.4 -40.54 96.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.704 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -60.75 -36.91 80.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -67.78 -41.89 82.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.452 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.85 97.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.283 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -62.28 -42.41 99.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.27 0.557 . . . . 0.0 109.782 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 67' ' ' MET . 18.7 tmm? -61.31 -42.54 98.83 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.046 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.45 -41.28 98.07 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.19 99.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 0.0 110.508 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.57 96.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.111 0.481 . . . . 0.0 110.583 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 ttt -61.69 -38.89 89.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.639 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' OD1' ' NZ ' ' A' ' 76' ' ' LYS . 67.9 t0 -59.54 -46.56 88.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.166 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 77' ' ' TYR . . . -62.73 -41.67 99.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.972 0.415 . . . . 0.0 110.416 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 74' ' ' LEU . 6.5 tt -60.89 -48.31 82.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.492 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.86 -44.9 94.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.835 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 72' ' ' ASP . 62.4 mttp -76.61 -23.15 53.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.026 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 73' ' ' ALA . 35.2 t80 41.87 90.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.469 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.43 116.26 21.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.046 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.167 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.496 1.63 0 CA-C-O 121.038 0.349 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.56 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.8 mp -66.58 -21.33 28.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.875 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.7 p -56.08 -31.84 63.58 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.51 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -60.7 -48.79 80.2 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.497 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.532 ' O ' HD13 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -65.03 -45.83 83.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.183 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -58.2 -39.99 80.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.222 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -60.13 -40.09 88.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.522 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.8 m -60.75 -40.43 92.44 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.164 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.577 ' SG ' ' CZ ' ' A' ' 79' ' ' PHE . 35.3 t -60.89 -39.38 89.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.082 0.468 . . . . 0.0 110.381 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.67 -41.26 94.7 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.4 p -82.98 -7.23 59.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.904 0.383 . . . . 0.0 110.703 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 tt -76.99 129.19 35.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -66.85 142.16 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.732 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' LYS . 85.5 m -91.18 111.24 22.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.225 0.536 . . . . 0.0 110.258 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -67.99 136.92 54.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.766 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.68 -11.81 69.09 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 19' ' ' THR . 56.8 mtmt -144.31 158.73 43.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 110.73 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -67.07 149.12 98.68 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.604 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.22 132.05 26.7 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.125 1.883 . . . . 0.0 111.941 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -93.43 172.36 8.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.153 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.5 mm -115.92 90.84 28.99 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.19 130.93 7.47 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.649 2.233 . . . . 0.0 112.057 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.1 tp -139.27 126.6 21.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.131 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 53.2 p90 -90.86 128.7 36.83 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.219 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -150.31 134.22 16.84 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.354 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 31' ' ' THR . 0.2 OUTLIER -55.37 134.15 50.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.449 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.2 mt -90.76 -46.11 8.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.696 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.02 165.21 22.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.548 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 t -90.63 147.26 23.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.157 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.56 150.61 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.642 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.577 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 70.36 42.08 66.14 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 36' ' ' GLY . 42.8 Cg_endo -65.16 -21.11 62.87 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.596 2.197 . . . . 0.0 111.882 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 95.7 p -63.27 -25.67 68.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.0 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.703 ' CD2' ' H ' ' A' ' 40' ' ' ALA . 25.3 p-80 -135.34 -113.89 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.663 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.703 ' H ' ' CD2' ' A' ' 39' ' ' HIS . . . -74.1 139.8 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.047 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.7 mmm-85 -81.21 127.19 32.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.502 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.4 p -126.91 149.13 49.94 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -108.25 141.46 39.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.416 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.2 m -105.6 124.07 48.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.78 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.7 t -121.59 128.16 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.388 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 123.82 23.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.903 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.416 HG11 HD11 ' A' ' 54' ' ' ILE . 94.2 t -87.48 130.76 36.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.318 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -109.23 140.94 42.2 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.174 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -144.72 130.74 19.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.985 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? 55.25 26.04 8.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.684 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.74 15.35 77.96 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -135.95 138.7 42.59 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 110.312 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.45 135.97 52.53 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.091 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.528 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 44.8 pt -110.54 -21.64 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.575 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.85 152.37 21.94 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.7 t -150.24 133.2 16.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.905 0.384 . . . . 0.0 110.599 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.38 166.6 32.75 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -147.16 163.16 37.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.56 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.39 177.13 46.03 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.79 -9.51 23.21 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.906 2.404 . . . . 0.0 111.953 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 m -146.91 150.01 34.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.074 0.464 . . . . 0.0 110.495 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -62.01 -39.07 90.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.714 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -59.5 -46.51 88.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.224 0.535 . . . . 0.0 110.424 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -64.95 -40.56 95.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.217 0.532 . . . . 0.0 110.534 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.91 97.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.893 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 67' ' ' MET . 0.0 OUTLIER -60.95 -40.46 93.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.402 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 62.1 mtt -59.52 -44.0 93.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.31 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.59 -43.94 74.14 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.073 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.02 98.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.052 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.86 87.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.153 0.501 . . . . 0.0 110.744 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.6 ttp -62.86 -37.39 86.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.509 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -58.83 -49.0 79.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.365 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 54' ' ' ILE . . . -62.69 -40.18 96.31 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.3 -48.86 79.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.621 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.73 -41.2 98.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.539 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -82.71 -10.67 58.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.431 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.495 ' N ' ' O ' ' A' ' 73' ' ' ALA . 98.9 m-85 43.53 45.19 5.49 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.331 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.525 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 98.5 m-20 -81.83 118.38 22.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.56 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CZ ' ' SG ' ' A' ' 14' ' ' CYS . 2.0 m-85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.046 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo . . . . . 0 N--CA 1.497 1.688 0 CA-C-O 120.943 0.31 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.5 mp -66.44 -18.22 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.852 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 t -49.2 -30.57 7.11 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -59.99 -50.66 72.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.569 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -67.66 -47.77 68.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.27 0.557 . . . . 0.0 110.094 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -58.73 -39.77 81.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.301 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -64.29 -39.15 93.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.895 0.379 . . . . 0.0 110.486 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.6 m -60.29 -33.57 72.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.64 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.0 m -57.89 -35.93 71.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.48 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 15' ' ' LEU . 10.3 mp -59.4 -22.61 61.68 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.545 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.4 p -81.15 1.35 32.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.814 0.34 . . . . 0.0 110.386 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.1 47.06 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.383 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -70.28 116.92 11.18 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.161 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.4 m -140.29 135.43 32.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.346 0.593 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -65.21 132.93 50.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.063 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.15 4.39 62.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -80.93 156.97 25.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.931 0.396 . . . . 0.0 110.07 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -62.66 149.42 89.04 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.21 164.62 31.57 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.564 2.176 . . . . 0.0 111.895 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 69.41 154.33 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.925 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.61 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.1 pp -138.99 153.74 71.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.592 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.75 134.47 30.27 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.218 1.946 . . . . 0.0 111.685 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.1 tp -139.8 144.45 37.35 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.022 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.539 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 44.4 p90 -89.77 117.71 28.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.302 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -151.57 160.26 43.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.463 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.7 p -84.73 132.92 34.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.125 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 32' ' ' LEU . 11.3 mp -93.15 -39.19 11.17 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.32 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.55 ' O ' HG22 ' A' ' 44' ' ' THR . 36.5 tt0 -159.6 151.95 21.07 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.793 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.4 p -98.01 147.69 24.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.893 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.98 151.56 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.084 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.43 68.09 0.55 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.61 -9.23 21.2 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.571 2.18 . . . . 0.0 111.957 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.2 p -146.07 -169.92 3.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -60.11 -42.77 95.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.57 147.35 27.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.541 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.91 151.19 33.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.477 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.3 p -130.44 151.12 51.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.093 0.473 . . . . 0.0 110.341 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -123.89 145.81 48.86 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.264 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 33' ' ' GLN . 7.0 t -111.95 141.15 45.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.812 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.6 152.55 37.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.899 0.381 . . . . 0.0 110.273 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.68 128.09 14.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.713 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.59 127.65 40.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.709 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 48' ' ' TYR . 44.4 p90 -118.6 113.48 21.32 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.247 0.546 . . . . 0.0 110.115 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.644 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 1.4 t80 -102.09 133.2 47.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.937 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? 41.76 27.25 0.06 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.043 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.48 25.57 38.84 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.377 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' PHE . 3.9 tm-20 -136.69 119.56 16.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.952 0.406 . . . . 0.0 110.213 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.425 ' O ' ' OE1' ' A' ' 52' ' ' GLU . 8.3 tmm_? -70.53 128.43 36.09 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.398 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.6 pt -132.09 7.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.6 141.2 6.96 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.32 137.15 14.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.0 110.333 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.65 165.68 33.09 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -149.69 159.59 44.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 110.423 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.12 -178.72 45.86 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.96 -10.8 29.26 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.586 2.191 . . . . 0.0 112.017 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.5 m -147.24 142.95 27.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -63.89 -30.69 71.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.639 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.42 -45.46 94.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.53 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -64.42 -42.5 96.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 0.0 110.464 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.471 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' CE ' ' CD1' ' A' ' 29' ' ' TYR . 66.8 mttt -59.6 -58.97 6.29 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.812 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -57.7 -41.17 81.13 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.404 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.541 ' N ' ' SD ' ' A' ' 67' ' ' MET . . . -69.92 -53.55 14.81 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.178 -1.01 . . . . 0.0 111.65 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.39 97.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.363 . . . . 0.0 111.396 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.0 98.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.497 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.3 ttt -60.07 -39.75 87.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.471 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -60.93 -51.09 70.73 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.518 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.21 94.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.165 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.5 tp -60.99 -48.48 81.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.503 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -67.9 -37.84 82.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.622 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.76 -36.48 84.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -167.62 110.94 0.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.807 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -87.89 124.05 33.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.699 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.644 ' CZ ' ' CE2' ' A' ' 49' ' ' PHE . 1.7 m-85 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.639 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo . . . . . 0 N--CA 1.496 1.644 0 CA-C-O 121.057 0.357 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.794 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.9 mp -68.2 -10.37 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.636 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.6 m -55.76 -31.09 62.27 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -62.34 -52.81 62.14 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.596 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.51 -44.88 89.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.867 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.434 ' NE2' ' HB3' ' A' ' 73' ' ' ALA . 12.3 tp-100 -59.43 -37.99 79.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.992 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -58.81 -44.49 90.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.381 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 87.8 m -61.09 -44.2 97.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.291 -0.563 . . . . 0.0 110.327 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.3 m -64.35 -40.63 96.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.967 0.413 . . . . 0.0 111.048 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.443 ' O ' ' OD2' ' A' ' 25' ' ' ASP . 55.3 mt -61.78 -39.63 92.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.137 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.9 p -70.04 -30.67 68.01 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.654 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 tt 52.19 70.72 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.418 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.89 105.12 3.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.624 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.8 m -140.1 131.52 26.87 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.161 0.505 . . . . 0.0 110.627 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.49 141.05 58.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.281 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.07 -4.49 86.28 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -143.56 125.92 15.69 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.873 0.368 . . . . 0.0 110.168 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 35.4 mp0 -70.57 149.86 95.49 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.937 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.53 157.41 61.94 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.298 1.999 . . . . 0.0 111.697 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 15' ' ' LEU . 44.6 p-10 -80.99 -172.96 4.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.117 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 pt -128.62 90.32 46.73 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.464 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.63 155.81 27.76 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.385 2.057 . . . . 0.0 111.913 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.831 ' N ' HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -138.47 147.78 43.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.011 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -129.47 110.47 11.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.188 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -151.0 133.74 15.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.436 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.427 ' H ' HG22 ' A' ' 31' ' ' THR . 0.1 OUTLIER -59.88 148.12 36.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.378 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.1 mt -88.01 -46.47 9.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.691 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -161.69 163.68 29.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.091 0.472 . . . . 0.0 110.306 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.2 m -105.59 124.4 49.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.504 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.4 t -106.49 140.48 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.951 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.5 73.95 0.35 Allowed Glycine 0 CA--C 1.532 1.131 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.27 -12.8 21.0 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.316 2.011 . . . . 0.0 112.155 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.6 p -155.72 -177.14 6.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.697 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -51.27 -30.53 18.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.467 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.45 135.54 33.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.434 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -82.5 145.86 29.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.185 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.3 p -128.9 148.83 50.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.03 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -116.32 142.39 46.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.411 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.3 m -117.32 128.93 55.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.028 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.22 152.36 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.488 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.51 139.71 33.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.123 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.5 t -86.71 130.22 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.011 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -107.68 134.63 50.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 0.0 110.496 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -144.5 129.73 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.375 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.6 tptp 56.02 19.89 3.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.526 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.09 12.55 73.59 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -135.17 131.08 36.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.937 0.399 . . . . 0.0 110.036 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' NH2' ' SG ' ' A' ' 56' ' ' CYS . 42.6 mtm105 -66.83 140.37 57.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.283 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.1 pt -117.93 -14.67 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.228 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.83 140.41 6.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.401 ' SG ' ' NH2' ' A' ' 53' ' ' ARG . 54.5 m -146.43 133.45 20.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.736 0.303 . . . . 0.0 110.277 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.03 170.58 33.79 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.11 162.96 35.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.115 0.483 . . . . 0.0 110.509 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.08 -169.2 42.33 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.2 -30.0 59.32 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.952 2.434 . . . . 0.0 112.117 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.1 p -156.44 164.08 38.68 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.38 0.61 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -61.78 -24.77 67.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.813 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -55.86 -57.76 10.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.968 0.413 . . . . 0.0 110.58 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -64.04 -39.44 94.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.59 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.15 97.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.635 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -60.64 -42.18 96.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.989 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.8 ttp -59.3 -49.2 78.74 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.28 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.64 -44.18 64.63 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.502 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.09 85.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.724 0.297 . . . . 0.0 111.187 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.05 -44.24 96.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.094 0.473 . . . . 0.0 110.456 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.5 ttt -62.48 -38.14 88.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.928 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -59.83 -46.22 89.94 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.414 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB3' ' NE2' ' A' ' 11' ' ' GLN . . . -64.63 -41.24 96.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 110.577 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.79 -45.59 91.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.442 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -64.1 -39.92 95.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.495 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -75.72 -20.19 58.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.728 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.9 t80 58.26 96.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.564 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 53.4 p-10 -80.05 147.47 31.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.643 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.496 -179.623 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo . . . . . 0 N--CA 1.488 1.16 0 CA-C-O 120.986 0.328 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.7 mp -64.11 -9.78 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 86.5 p -55.76 -27.57 51.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.325 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -63.01 -51.97 64.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.01 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.21 -37.45 87.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.936 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.474 ' O ' HD13 ' A' ' 15' ' ' LEU . 65.0 tt0 -57.17 -47.18 81.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.4 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -62.2 -45.27 94.13 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.571 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 17' ' ' LEU . 51.1 t -63.08 -46.97 84.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.39 -47.46 85.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.407 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 11' ' ' GLN . 8.9 mp -61.95 -45.9 91.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.439 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.8 p -75.41 -32.16 60.65 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.642 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 13' ' ' CYS . 30.2 tp 38.39 67.68 0.39 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.598 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -68.35 129.29 39.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.6 m -139.96 135.78 33.13 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.14 132.65 48.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.279 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.14 -10.14 75.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -137.16 123.16 20.24 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.002 0.43 . . . . 0.0 110.307 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.4 149.2 93.78 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.9 145.56 74.84 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.067 1.845 . . . . 0.0 111.902 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.504 ' OD2' ' CD1' ' A' ' 49' ' ' PHE . 43.3 p-10 -82.93 -170.25 2.92 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.237 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.77 91.06 37.9 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -81.58 145.62 14.75 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.432 2.088 . . . . 0.0 111.992 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.41 148.98 43.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.632 ' CD1' ' NZ ' ' A' ' 62' ' ' LYS . 42.5 p90 -95.63 131.39 41.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.341 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -143.45 151.29 40.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.406 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.9 p -72.19 123.81 23.7 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -87.84 -52.72 5.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -160.93 150.4 17.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.579 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -106.47 133.89 50.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -136.89 156.62 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.049 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.65 60.4 0.42 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.7 -25.75 33.65 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.472 2.114 . . . . 0.0 112.146 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.0 p -105.85 -176.18 3.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.442 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.526 ' O ' ' NH2' ' A' ' 41' ' ' ARG . 86.5 t60 -59.38 -47.73 84.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.169 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.51 145.22 28.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.594 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 39' ' ' HIS . 12.3 mpt_? -79.77 146.22 32.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.194 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 73.5 p -130.93 150.37 52.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.282 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.96 146.97 35.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.258 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.4 m -115.53 125.41 52.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.983 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.92 151.39 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.096 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.29 124.13 10.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.628 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 47' ' ' VAL . 4.8 m -87.91 151.28 3.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.895 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -128.65 154.28 46.43 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.106 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 66.0 t80 -144.67 120.46 10.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.035 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 tptp 71.2 21.87 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.35 18.34 62.64 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -137.86 143.32 40.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.819 0.343 . . . . 0.0 110.368 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -61.59 127.53 31.9 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 19.1 tt -110.34 -20.3 6.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.739 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.75 148.82 16.06 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.3 t -150.19 128.13 11.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.928 0.394 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.6 161.86 30.81 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -148.42 159.55 43.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 110.733 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.61 -172.82 45.51 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.82 -27.66 72.91 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.885 2.39 . . . . 0.0 112.106 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.4 t -155.26 155.64 34.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.531 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.632 ' NZ ' ' CD1' ' A' ' 29' ' ' TYR . 39.0 ttpt -59.75 -42.72 93.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.552 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -57.12 -39.06 74.36 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.468 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.7 tp-100 -74.33 -43.7 55.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.119 0.485 . . . . 0.0 110.911 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.25 62.9 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.945 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CG ' ' N ' ' A' ' 67' ' ' MET . 21.0 pttm -55.13 -42.93 73.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.267 -178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.491 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 78.5 mtm -60.62 -43.42 97.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.442 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.46 -47.45 62.77 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.414 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.38 83.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.117 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.34 74.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.051 0.453 . . . . 0.0 111.202 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.4 ttt -60.54 -36.46 78.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.9 -41.34 95.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 54' ' ' ILE . . . -60.34 -45.51 93.2 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.225 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.8 -43.64 98.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.388 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.3 -40.84 96.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.573 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -75.74 -31.32 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.629 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 13.4 t80 41.96 69.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.406 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 54' ' ' ILE . 94.1 m-20 -78.42 136.17 37.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.849 -179.373 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 CA-C-O 121.228 0.428 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.533 HD13 ' O ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -63.45 -27.81 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.33 -179.272 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 t -49.62 -26.79 3.91 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -60.34 -48.15 82.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.176 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -63.61 -51.4 65.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.143 0.496 . . . . 0.0 110.692 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -59.99 -40.15 88.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.914 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.8 -42.02 98.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.427 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.51 -46.89 88.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.485 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.4 m -61.07 -41.34 96.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -63.38 -39.86 95.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.579 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 m -78.39 -15.74 58.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.163 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.4 tp -75.49 120.04 20.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.086 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -64.77 132.0 48.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.691 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.425 HG21 ' HZ1' ' A' ' 50' ' ' LYS . 89.4 m -98.62 125.24 43.83 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.323 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.93 132.62 46.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.479 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.65 -8.19 80.33 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.77 143.45 38.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.0 0.428 . . . . 0.0 110.704 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -69.96 151.1 96.27 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.713 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -45.53 163.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.575 2.183 . . . . 0.0 111.805 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -145.86 161.39 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.201 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.1 pt -135.72 149.88 70.26 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.541 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.45 146.55 62.47 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.502 2.135 . . . . 0.0 111.821 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.31 110.52 6.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.26 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -94.18 106.05 18.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.261 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -131.74 135.42 46.8 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.429 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.2 t -123.4 142.34 51.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.494 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.46 26.39 1.3 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.283 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -159.15 147.34 17.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 t -133.2 146.94 51.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.135 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 36' ' ' GLY . 82.0 t -127.92 153.24 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.614 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.446 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 77.47 53.22 5.18 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' OG ' ' A' ' 38' ' ' SER . 56.2 Cg_endo -70.19 157.18 60.37 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.773 2.315 . . . . 0.0 111.832 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 39' ' ' HIS . 4.1 p 73.31 -60.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.501 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.51 ' N ' ' OG ' ' A' ' 38' ' ' SER . 45.2 m170 -81.13 -115.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.327 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.79 108.05 18.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.308 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -78.82 128.56 33.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.375 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 52.4 p -129.12 150.27 50.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.172 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.71 146.49 33.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.311 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.5 p -104.3 142.27 34.84 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.892 0.377 . . . . 0.0 110.159 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.38 142.01 34.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.04 119.93 15.35 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.149 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.5 t -86.93 140.63 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.328 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.13 148.33 35.54 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.926 0.393 . . . . 0.0 110.198 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.609 ' O ' ' N ' ' A' ' 52' ' ' GLU . 29.3 t80 -143.12 114.39 7.87 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.031 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.477 ' HZ2' ' CB ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER 38.22 37.84 0.18 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.557 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.88 22.63 52.41 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.621 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' A' ' 49' ' ' PHE . 80.2 mm-40 -138.12 128.26 25.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.888 0.375 . . . . 0.0 110.483 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -69.95 131.83 45.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.22 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.4 pt -128.88 10.04 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 0.0 110.805 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.34 136.68 4.3 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.474 ' N ' ' HB1' ' A' ' 69' ' ' ALA . 50.9 t -161.15 112.62 1.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.2 175.61 35.34 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -143.37 157.23 44.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 110.519 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.86 -173.94 46.43 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.56 -16.13 52.48 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.519 2.146 . . . . 0.0 111.398 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.5 m -147.77 140.32 24.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.006 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -74.37 -33.83 63.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.552 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.495 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 59.0 mtpt -60.76 -49.92 75.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.555 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -66.78 -38.99 87.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.655 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.0 66.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.908 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 5.2 ptpp? -55.12 -42.77 73.41 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.398 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.48 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 65.7 mtt -60.4 -48.75 80.4 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.792 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.07 -39.36 63.16 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.63 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' HB1' ' N ' ' A' ' 56' ' ' CYS . . . -60.18 -48.65 80.82 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.914 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.87 -48.62 79.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.82 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 66.5 ttp -61.1 -44.42 97.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.812 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -61.34 -51.52 68.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.65 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.54 94.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.983 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.53 -44.12 97.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.035 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.78 -47.03 76.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.243 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -80.13 -15.54 56.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.997 0.427 . . . . 0.0 111.077 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -158.04 91.71 1.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.546 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 26.6 p30 -97.35 145.09 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.403 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.348 179.255 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.13 -20.42 43.82 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.702 2.268 . . . . 0.0 111.981 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.78 -178.56 51.25 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -88.22 75.22 8.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.821 0.343 . . . . 0.0 110.638 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 31.4 p-10 -140.53 70.38 31.9 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.413 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.06 140.49 92.77 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.6 2.2 . . . . 0.0 111.987 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.5 mt -69.75 -12.45 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.368 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 96.2 p -59.61 -24.32 63.72 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.686 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -63.25 -51.6 65.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.824 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.24 -48.93 66.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.089 0.471 . . . . 0.0 110.943 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.403 ' O ' HD13 ' A' ' 15' ' ' LEU . 90.2 mm-40 -58.92 -20.5 52.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.676 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -56.8 -44.4 81.9 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.193 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.3 m -65.07 -39.73 93.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 110.521 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.45 ' SG ' ' CG ' ' A' ' 78' ' ' ASN . 51.8 t -59.9 -40.73 89.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.906 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 11' ' ' GLN . 6.3 mp -50.08 -47.63 53.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.176 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.4 m -71.4 -38.45 71.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.162 0.506 . . . . 0.0 110.431 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER 48.33 75.13 0.15 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.844 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -75.85 105.44 6.89 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.268 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.1 m -139.44 133.65 31.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.92 0.39 . . . . 0.0 110.94 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -69.11 136.65 52.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.319 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.46 -8.74 76.09 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -89.28 138.19 31.65 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.926 0.393 . . . . 0.0 110.567 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -64.93 148.85 97.31 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.18 149.03 70.11 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.451 2.101 . . . . 0.0 112.105 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 26' ' ' ILE . 48.4 t0 -159.08 151.41 21.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.088 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 26' ' ' ILE . 17.3 tt -135.1 89.07 24.78 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.735 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.2 148.29 14.89 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.509 2.139 . . . . 0.0 111.695 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.2 tp -138.21 133.73 33.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.129 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.509 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 41.4 p90 -93.61 123.75 37.15 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -149.9 151.59 33.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.231 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.6 p -51.9 129.67 27.4 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -87.68 -52.91 5.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.066 0.46 . . . . 0.0 110.408 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -162.43 155.52 20.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.539 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.404 HG22 ' CD2' ' A' ' 43' ' ' TYR . 73.0 p -109.31 146.81 33.71 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.2 m -138.72 165.04 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.513 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.6 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 71.38 39.48 61.61 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 36' ' ' GLY . 41.3 Cg_endo -66.47 -20.22 54.42 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.681 2.254 . . . . 0.0 111.902 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -59.66 -44.59 93.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.897 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -119.16 -108.42 0.36 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.343 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.99 131.11 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.161 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -77.96 135.87 37.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.219 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.2 p -124.38 147.67 48.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.995 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.404 ' CD2' HG22 ' A' ' 34' ' ' THR . 96.4 m-85 -113.32 131.79 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.649 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.7 m -113.68 126.22 55.01 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.541 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.11 148.1 33.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.39 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.19 122.91 14.28 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.241 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.33 128.69 39.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -112.8 141.27 46.8 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.488 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -144.8 130.27 18.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.559 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 mttm 59.08 17.74 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.595 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.39 13.04 62.19 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -133.53 144.05 49.13 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.811 0.338 . . . . 0.0 110.32 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -65.39 126.19 27.46 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.8 tt -104.73 -27.64 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.198 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.37 148.08 13.86 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.1 t -154.15 140.27 18.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.91 0.386 . . . . 0.0 110.628 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.62 171.95 31.76 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -144.83 153.12 41.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.921 0.391 . . . . 0.0 110.49 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.93 174.22 46.9 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 -7.44 21.24 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 123.014 2.476 . . . . 0.0 112.154 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.8 p -150.06 156.57 41.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.182 0.515 . . . . 0.0 110.632 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.78 -40.72 98.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.603 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.02 -45.49 90.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.398 0.618 . . . . 0.0 110.369 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -71.01 -41.02 71.45 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.706 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.42 94.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.603 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 67' ' ' MET . 4.7 ptmm? -64.18 -39.76 94.67 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.527 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 67' ' ' MET . 19.4 tmm? -59.5 -44.65 93.06 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.848 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.31 -40.66 94.74 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.52 -45.44 94.2 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.705 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.81 99.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.205 0.526 . . . . 0.0 110.463 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.9 ttt -62.34 -37.75 86.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.548 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -59.42 -45.17 92.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 109.988 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.6 95.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.197 0.522 . . . . 0.0 109.947 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.8 tt -59.88 -45.07 93.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.471 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.27 -39.38 93.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.619 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -77.67 -10.34 59.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 20.4 t80 67.98 133.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.378 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.45 ' CG ' ' SG ' ' A' ' 14' ' ' CYS . 32.7 m120 -79.15 144.69 34.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.427 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.8 t80 42.33 67.56 3.31 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.751 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.16 140.69 95.13 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.792 2.328 . . . . 0.0 112.055 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -161.82 127.27 3.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.166 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.377 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -56.69 138.28 84.48 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.553 2.169 . . . . 0.0 111.903 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.44 6.48 80.71 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -140.66 117.01 10.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.801 0.334 . . . . 0.0 110.511 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -139.91 147.53 51.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.584 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.15 139.94 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.695 2.263 . . . . 0.0 112.259 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.715 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.6 mp -67.79 -19.74 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.272 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -48.42 -33.11 8.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.99 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -60.87 -44.51 96.94 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.647 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.1 tt -73.75 -39.22 64.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.412 0.625 . . . . 0.0 110.28 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -56.66 -25.28 53.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.506 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -53.15 -36.95 61.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.479 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.18 -47.91 83.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.019 0.438 . . . . 0.0 110.598 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.8 t -60.75 -41.59 95.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.011 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.62 -42.61 99.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.287 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.7 t -83.62 -5.68 59.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.664 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 17' ' ' LEU . 2.5 tt -74.81 96.45 3.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.754 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -71.08 150.51 45.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.321 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.425 HG21 ' HD2' ' A' ' 22' ' ' LYS . 62.6 m -94.92 120.38 35.04 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.482 0.658 . . . . 0.0 110.942 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -68.9 139.34 55.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.323 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.65 2.23 84.82 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HD2' HG21 ' A' ' 19' ' ' THR . 99.4 mttt -137.17 155.38 49.63 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.501 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.48 149.28 95.41 Favored Pre-proline 0 N--CA 1.451 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.387 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.37 163.46 29.45 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.805 2.336 . . . . 0.0 111.768 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.36 166.7 29.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 26' ' ' ILE . 16.0 tt -128.61 91.74 42.61 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 121.069 0.461 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.67 133.69 14.4 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.479 2.12 . . . . 0.0 111.727 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.7 tp -138.45 145.59 41.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.218 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -88.79 136.06 33.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.466 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.7 145.9 37.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.347 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.62 110.63 22.87 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.908 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 47.2 mt -106.64 -38.2 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.33 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -85.51 141.98 29.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.359 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -121.85 146.3 47.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.155 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 36' ' ' GLY . 84.4 t -137.08 159.64 36.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.568 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.544 ' N ' HG12 ' A' ' 35' ' ' VAL . . . 74.76 88.34 0.22 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 36' ' ' GLY . 52.0 Cg_exo -52.97 -137.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.037 2.491 . . . . 0.0 112.585 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 39' ' ' HIS . 46.3 t -59.52 -39.52 84.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.439 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' SER . 77.9 m80 -47.29 -109.83 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.08 0.467 . . . . 0.0 110.867 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.27 136.64 32.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.549 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -86.41 116.72 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.49 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.45 ' HG1' ' C ' ' A' ' 35' ' ' VAL . 58.7 p -133.66 150.32 51.56 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.516 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -135.13 151.04 50.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.365 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.6 m -112.07 129.4 56.23 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.225 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.3 t -106.09 122.27 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.201 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.14 119.89 40.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.337 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.71 126.23 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.951 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.63 133.95 48.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.869 0.366 . . . . 0.0 110.241 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -144.52 118.51 9.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.162 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.13 18.95 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.96 12.62 73.8 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -136.59 149.56 48.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.811 0.339 . . . . 0.0 110.383 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtm-85 -67.02 139.05 57.63 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.204 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -124.62 -21.3 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.507 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.62 150.55 18.28 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 42.1 t -152.53 138.97 18.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.438 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.76 161.98 29.49 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -145.84 157.87 43.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.867 0.365 . . . . 0.0 110.789 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.58 178.58 44.58 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.8 -7.65 21.59 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.826 2.351 . . . . 0.0 111.988 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.0 t -151.61 160.15 43.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.372 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -62.16 -37.89 86.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.58 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.24 -46.89 82.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.559 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -64.26 -42.97 96.23 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.752 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.43 -42.98 95.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.778 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -61.54 -39.67 91.88 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.716 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 59.5 ttm -58.38 -50.12 74.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.324 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.86 -44.0 48.43 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.275 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.73 -49.1 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.736 0.303 . . . . 0.0 111.173 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.98 -46.74 87.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 ttt -62.1 -37.87 86.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.579 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -57.6 -46.93 83.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.21 -40.78 98.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.067 0.46 . . . . 0.0 110.42 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.63 -43.91 93.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.698 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -62.39 -39.63 93.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.917 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 77' ' ' TYR . 63.1 tttp -70.74 -28.31 64.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.331 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 5.9 t80 83.06 161.13 0.13 Allowed 'General case' 0 C--N 1.334 -0.107 0 O-C-N 123.433 0.458 . . . . 0.0 110.267 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -91.62 111.75 23.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.997 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 79' ' ' PHE . 54.8 t80 40.91 58.32 8.39 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.735 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -62.38 -38.84 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.486 2.124 . . . . 0.0 111.992 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 38.79 49.65 1.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 97.6 mtp . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.437 -179.678 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.39 146.63 89.23 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.918 2.412 . . . . 0.0 111.942 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.13 112.43 4.04 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 5' ' ' ASP . 99.2 m-20 -63.16 -39.62 95.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.149 -0.221 . . . . 0.0 110.773 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 4' ' ' ASN . 63.4 t0 -35.84 99.12 0.17 Allowed Pre-proline 0 CA--C 1.533 0.296 0 O-C-N 123.498 0.499 . . . . 0.0 110.665 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.39 135.61 61.12 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.514 2.143 . . . . 0.0 112.634 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.2 mp -71.3 -11.31 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.313 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.6 p -52.66 -24.6 8.8 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -61.81 -51.73 67.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.854 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.6 mt -64.41 -45.13 88.9 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 110.545 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -60.5 -42.46 96.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.374 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.22 -40.03 88.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.485 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.9 -40.86 94.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.349 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.48 -50.09 75.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.525 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.38 -38.38 90.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.997 0.427 . . . . 0.0 110.315 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -70.61 -24.49 62.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.426 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.36 120.83 18.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.055 0.455 . . . . 0.0 110.495 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -68.26 144.35 54.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.727 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 22' ' ' LYS . 96.6 m -98.92 127.93 44.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.02 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -67.84 125.87 27.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.48 -10.19 75.36 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 19' ' ' THR . 42.8 mmtm -137.55 144.7 42.22 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.058 0.456 . . . . 0.0 111.021 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.46 151.1 95.67 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.602 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.05 139.29 55.51 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.386 2.057 . . . . 0.0 111.825 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.72 158.33 22.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.441 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.4 mt -91.42 117.9 68.1 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.671 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.81 130.42 13.46 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.312 2.008 . . . . 0.0 112.135 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -140.73 137.41 33.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 25.3 p90 -111.76 106.18 14.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.06 0.457 . . . . 0.0 110.431 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -136.66 151.56 49.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.3 p -107.01 147.96 29.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.202 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.94 -84.08 0.42 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.41 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -83.92 144.11 29.41 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.663 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.2 p -132.34 129.01 38.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.897 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' OG1' ' A' ' 42' ' ' THR . 32.1 m -138.23 159.91 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.148 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.64 64.27 0.42 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' SER . 71.0 Cg_endo -73.94 157.09 47.55 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.864 2.376 . . . . 0.0 111.72 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.1 m 75.99 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.447 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -174.2 -36.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.599 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.83 136.63 36.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.586 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' A' ' 41' ' ' ARG . 1.5 mpt_? -80.73 139.2 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.914 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.426 ' OG1' HG23 ' A' ' 35' ' ' VAL . 80.7 p -131.38 150.58 52.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -132.85 149.38 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.387 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.1 m -109.82 128.92 55.63 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.162 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.82 149.6 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.711 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.75 126.74 13.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.311 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.0 t -87.45 131.39 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.414 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.04 138.36 40.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.191 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -144.12 123.89 13.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 54.79 29.53 12.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.22 8.54 87.13 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -132.4 135.7 46.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.876 0.369 . . . . 0.0 110.396 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -69.84 145.94 51.7 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.192 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.3 pt -114.12 -22.06 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.586 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.94 154.8 24.1 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.2 p -155.21 139.67 16.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.731 0.301 . . . . 0.0 110.495 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.63 174.67 35.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.542 ' N ' ' CD ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -146.24 162.81 37.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.523 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.89 -176.09 47.07 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.91 -29.96 83.97 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 123.005 2.47 . . . . 0.0 112.449 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -136.53 154.4 50.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 110.654 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -63.52 -41.66 98.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.509 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.92 -43.09 99.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.551 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -66.05 -38.31 88.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.531 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.44 -34.79 76.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.148 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 97.4 mttt -56.65 -31.04 63.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.519 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 68.6 mtm -59.06 -46.23 88.77 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.327 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.88 -50.61 23.12 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.309 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.5 83.87 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.982 0.42 . . . . 0.0 111.072 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 66' ' ' LYS . . . -61.94 -44.04 97.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.719 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 66.1 ttp -61.29 -38.94 88.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.811 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.96 -43.68 91.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.423 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -45.43 94.64 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.539 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.5 -42.87 99.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.309 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.64 -39.69 95.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.445 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 77' ' ' TYR . 27.2 mtpp -79.89 -7.37 58.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.711 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' LYS . 97.9 m-85 57.4 113.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.626 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -80.28 146.0 31.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.659 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.414 ' N ' ' CD ' ' A' ' 80' ' ' PRO . 37.7 t80 45.63 56.14 15.3 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.529 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 79' ' ' PHE . 38.1 Cg_endo -68.29 151.73 76.27 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.627 2.218 . . . . 0.0 112.107 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -161.16 160.99 30.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.562 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 79.4 mtm . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.456 -179.796 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.14 -33.76 85.18 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.993 2.462 . . . . 0.0 111.789 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.77 61.09 2.5 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.91 -38.76 89.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.703 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -130.5 81.52 67.67 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.32 -176.82 3.12 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.632 2.221 . . . . 0.0 112.311 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.622 HD13 ' SD ' ' A' ' 67' ' ' MET . 4.9 tp -64.82 -15.64 18.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.101 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 t -47.99 -18.86 0.21 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.65 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' A' ' 7' ' ' ILE . 61.8 tt0 -61.39 -57.14 13.47 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.19 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 74' ' ' LEU . 85.1 mt -64.66 -41.36 96.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.358 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.592 ' O ' HD13 ' A' ' 15' ' ' LEU . 10.6 tp-100 -61.38 -54.35 44.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -65.43 -43.22 91.19 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.166 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t -61.96 -49.07 77.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.632 ' SG ' ' ND2' ' A' ' 78' ' ' ASN . 47.6 t -61.1 -45.09 96.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.695 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.592 HD13 ' O ' ' A' ' 11' ' ' GLN . 7.1 mp -61.78 -40.1 94.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.378 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.4 m -69.64 -38.31 77.12 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.346 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.2 tp 42.76 78.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.251 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -69.78 116.83 10.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.412 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.2 m -139.31 124.22 18.71 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.406 0.622 . . . . 0.0 110.695 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -67.3 142.98 56.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.45 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.09 -5.0 85.97 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.3 134.71 48.97 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 110.076 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 46.1 mp0 -70.34 151.58 95.72 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.03 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -51.25 141.43 39.55 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.059 1.839 . . . . 0.0 112.016 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.54 -174.54 5.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.242 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 pt -116.78 91.7 35.92 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.56 139.09 66.78 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.453 2.102 . . . . 0.0 111.588 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 tp -133.94 124.91 27.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.301 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.553 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 46.0 p90 -131.23 113.2 13.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.247 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -152.69 138.84 18.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.598 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.8 p -75.04 153.18 38.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.298 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.87 -65.67 0.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.411 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 34' ' ' THR . 17.9 tm0? -162.55 144.36 10.55 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.155 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.568 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 97.0 m -98.71 130.96 45.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.394 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.06 158.31 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.221 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 38' ' ' SER . . . -148.58 79.79 0.21 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.538 ' O ' ' CD2' ' A' ' 39' ' ' HIS . 52.4 Cg_exo -52.33 73.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.834 2.356 . . . . 0.0 112.276 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 36' ' ' GLY . 49.2 m 46.16 31.82 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.489 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 37' ' ' PRO . 85.5 m-70 -148.7 -131.54 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.589 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.03 149.28 28.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.504 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -71.0 142.54 50.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.052 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.1 m -126.99 130.59 50.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.145 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.93 140.03 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.204 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -125.8 131.06 52.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.926 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.0 142.76 36.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.283 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.38 125.54 14.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.363 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.31 138.1 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.342 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.83 113.37 24.13 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.956 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CZ ' ' NZ ' ' A' ' 50' ' ' LYS . 66.2 t80 -101.4 115.05 29.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.311 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' NZ ' ' CZ ' ' A' ' 49' ' ' PHE . 61.6 mttp 52.39 37.74 23.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.823 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.83 25.11 70.32 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -137.57 136.32 37.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.019 0.438 . . . . 0.0 110.343 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 76.0 ttt-85 -62.46 126.66 28.1 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.9 tt -111.35 -35.69 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.702 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.9 148.5 10.94 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 31.3 p -155.19 156.0 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.2 162.19 31.67 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -149.54 156.17 41.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 110.603 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.38 177.68 44.63 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.07 -6.78 19.97 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.074 2.516 . . . . 0.0 112.192 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 t -147.91 152.37 37.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.122 0.486 . . . . 0.0 110.415 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -60.83 -36.18 78.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.451 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.95 -42.96 91.07 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.683 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -66.24 -39.93 89.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.404 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.17 99.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.598 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.7 -40.41 94.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.453 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.622 ' SD ' HD13 ' A' ' 7' ' ' ILE . 60.9 tpp -60.32 -49.1 78.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.492 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.27 -41.45 79.0 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.54 72.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.288 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 11' ' ' GLN . . . -64.36 -46.79 81.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.273 0.558 . . . . 0.0 110.943 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.1 ttp -62.23 -38.3 88.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.619 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 53' ' ' ARG . 7.8 t0 -58.56 -49.96 75.54 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.302 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB1' ' SG ' ' A' ' 14' ' ' CYS . . . -63.46 -41.19 98.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.515 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 10' ' ' LEU . 50.9 tp -59.36 -46.44 88.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.579 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.91 -41.28 97.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.443 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -71.14 -34.19 70.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.514 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 61.99 130.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.57 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.632 ' ND2' ' SG ' ' A' ' 14' ' ' CYS . 68.6 m-80 -83.78 140.03 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.513 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -159.03 70.71 3.52 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.246 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.43 -41.81 72.33 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.728 2.285 . . . . 0.0 111.965 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 45.92 35.48 2.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.482 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 C--O 1.219 -0.552 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.595 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.77 -32.26 90.86 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.847 2.364 . . . . 0.0 111.888 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.55 -131.05 51.86 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 51.27 46.27 26.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 110.28 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.68 147.43 95.77 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.867 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.81 156.37 63.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.648 2.232 . . . . 0.0 111.991 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.8 mp -67.74 -12.2 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.728 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.7 p -59.25 -23.63 62.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.64 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -64.31 -55.5 20.86 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.167 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -64.28 -47.57 79.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.403 0.62 . . . . 0.0 110.977 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -58.76 -24.13 61.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.32 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -56.26 -45.95 79.86 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.16 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.3 m -65.27 -42.48 93.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.104 0.478 . . . . 0.0 110.439 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.63 -42.77 99.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.769 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.9 -40.73 94.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.564 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 17' ' ' LEU . 46.6 p -72.67 -31.51 65.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.829 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 16' ' ' THR . 1.3 tt 34.6 71.48 0.11 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.278 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -70.42 119.33 14.43 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.23 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -139.13 121.66 16.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.525 0.678 . . . . 0.0 110.837 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.19 142.85 54.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.375 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.38 2.37 89.09 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -141.88 126.89 18.35 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.029 0.442 . . . . 0.0 110.04 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.28 120.46 76.99 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.784 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.03 143.48 32.64 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.152 1.901 . . . . 0.0 112.112 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -82.99 176.93 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.041 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.47 88.93 25.54 Favored Pre-proline 0 C--O 1.232 0.168 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.83 130.31 6.64 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.79 2.327 . . . . 0.0 111.79 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 28' ' ' LEU . 20.5 tp -140.48 142.5 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.433 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -90.78 135.07 33.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.298 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -146.35 142.84 28.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.836 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.505 HG21 ' HZ2' ' A' ' 62' ' ' LYS . 67.5 p -73.0 149.72 43.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.468 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.7 mt -104.59 -58.41 1.89 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.534 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -162.28 165.12 27.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.586 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.4 p -90.48 146.73 23.89 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.112 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.558 HG22 ' N ' ' A' ' 36' ' ' GLY . 14.9 p -143.48 162.52 16.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.762 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.558 ' N ' HG22 ' A' ' 35' ' ' VAL . . . 73.76 60.68 3.58 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.48 -24.73 78.81 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.6 2.2 . . . . 0.0 112.004 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.5 m -64.47 144.51 57.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.5 m80 48.43 -123.87 1.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.362 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.7 138.55 33.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.311 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -77.88 153.95 32.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.235 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.4 p -127.61 149.45 50.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.996 0.427 . . . . 0.0 110.025 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -104.63 140.13 38.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.145 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -96.66 132.66 42.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.244 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.0 t -132.18 132.17 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.79 118.97 16.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.108 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.8 t -88.49 136.5 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.136 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -115.8 147.66 40.74 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.091 0.472 . . . . 0.0 110.008 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -144.43 114.78 7.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.231 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 tttp 67.73 20.15 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.55 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.54 13.86 59.22 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -133.78 145.6 49.93 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.755 0.312 . . . . 0.0 110.222 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.65 126.0 27.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.004 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.0 tt -105.54 -26.39 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.811 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.41 155.58 26.89 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.6 t -154.97 139.68 17.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.686 0.279 . . . . 0.0 110.457 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.99 166.78 32.09 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -148.85 162.28 40.15 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.023 0.44 . . . . 0.0 110.655 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.66 177.36 46.42 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.144 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.53 -33.01 97.72 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.856 2.371 . . . . 0.0 112.477 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.5 m -120.42 153.54 36.42 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.096 0.474 . . . . 0.0 110.605 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.505 ' HZ2' HG21 ' A' ' 31' ' ' THR . 68.1 mttm -62.4 -40.54 96.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.704 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -60.75 -36.91 80.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -67.78 -41.89 82.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.452 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.85 97.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.283 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -62.28 -42.41 99.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.27 0.557 . . . . 0.0 109.782 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 67' ' ' MET . 18.7 tmm? -61.31 -42.54 98.83 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.046 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.45 -41.28 98.07 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.19 99.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 0.0 110.508 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.57 96.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.111 0.481 . . . . 0.0 110.583 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 ttt -61.69 -38.89 89.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.639 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' OD1' ' NZ ' ' A' ' 76' ' ' LYS . 67.9 t0 -59.54 -46.56 88.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.166 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 77' ' ' TYR . . . -62.73 -41.67 99.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.972 0.415 . . . . 0.0 110.416 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 74' ' ' LEU . 6.5 tt -60.89 -48.31 82.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.492 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.86 -44.9 94.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.835 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 72' ' ' ASP . 62.4 mttp -76.61 -23.15 53.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.026 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 73' ' ' ALA . 35.2 t80 41.87 90.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.469 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.43 116.26 21.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.046 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -72.85 149.51 90.21 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.167 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.78 -17.13 58.63 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.686 2.257 . . . . 0.0 112.216 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -155.99 156.51 34.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.306 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.2 tpt . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.547 -179.659 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.42 149.61 62.91 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.63 2.22 . . . . 0.0 112.005 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 4' ' ' ASN . . . 160.55 -77.31 0.18 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 3' ' ' GLY . 65.9 t30 50.8 177.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.33 . . . . 0.0 110.45 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -91.51 147.97 36.45 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.798 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.28 162.98 40.33 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.592 2.194 . . . . 0.0 111.875 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.56 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.8 mp -66.58 -21.33 28.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.875 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.7 p -56.08 -31.84 63.58 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.51 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -60.7 -48.79 80.2 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.497 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -65.03 -45.83 83.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.183 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -58.2 -39.99 80.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.222 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -60.13 -40.09 88.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.522 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.8 m -60.75 -40.43 92.44 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.164 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.577 ' SG ' ' CZ ' ' A' ' 79' ' ' PHE . 35.3 t -60.89 -39.38 89.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.082 0.468 . . . . 0.0 110.381 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.67 -41.26 94.7 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.4 p -82.98 -7.23 59.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.904 0.383 . . . . 0.0 110.703 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 tt -76.99 129.19 35.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -66.85 142.16 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.732 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' LYS . 85.5 m -91.18 111.24 22.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.225 0.536 . . . . 0.0 110.258 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -67.99 136.92 54.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.766 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.68 -11.81 69.09 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 19' ' ' THR . 56.8 mtmt -144.31 158.73 43.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 110.73 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -67.07 149.12 98.68 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.604 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.22 132.05 26.7 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.125 1.883 . . . . 0.0 111.941 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -93.43 172.36 8.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.153 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.5 mm -115.92 90.84 28.99 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.19 130.93 7.47 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.649 2.233 . . . . 0.0 112.057 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.1 tp -139.27 126.6 21.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.131 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 53.2 p90 -90.86 128.7 36.83 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.219 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -150.31 134.22 16.84 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.354 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 31' ' ' THR . 0.2 OUTLIER -55.37 134.15 50.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.449 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.2 mt -90.76 -46.11 8.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.696 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.02 165.21 22.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.548 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 t -90.63 147.26 23.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.157 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.56 150.61 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.642 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.577 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 70.36 42.08 66.14 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 36' ' ' GLY . 42.8 Cg_endo -65.16 -21.11 62.87 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.596 2.197 . . . . 0.0 111.882 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 95.7 p -63.27 -25.67 68.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.0 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.703 ' CD2' ' H ' ' A' ' 40' ' ' ALA . 25.3 p-80 -135.34 -113.89 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.663 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.703 ' H ' ' CD2' ' A' ' 39' ' ' HIS . . . -74.1 139.8 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.047 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.7 mmm-85 -81.21 127.19 32.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.502 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.4 p -126.91 149.13 49.94 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -108.25 141.46 39.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.416 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.2 m -105.6 124.07 48.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.78 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.7 t -121.59 128.16 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.388 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 123.82 23.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.903 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.416 HG11 HD11 ' A' ' 54' ' ' ILE . 94.2 t -87.48 130.76 36.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.318 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -109.23 140.94 42.2 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.174 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -144.72 130.74 19.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.985 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? 55.25 26.04 8.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.684 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.74 15.35 77.96 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -135.95 138.7 42.59 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 110.312 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.45 135.97 52.53 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.091 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.528 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 44.8 pt -110.54 -21.64 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.575 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.85 152.37 21.94 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.7 t -150.24 133.2 16.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.905 0.384 . . . . 0.0 110.599 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.38 166.6 32.75 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -147.16 163.16 37.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.56 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.39 177.13 46.03 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.79 -9.51 23.21 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.906 2.404 . . . . 0.0 111.953 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 m -146.91 150.01 34.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.074 0.464 . . . . 0.0 110.495 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -62.01 -39.07 90.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.714 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -59.5 -46.51 88.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.224 0.535 . . . . 0.0 110.424 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -64.95 -40.56 95.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.217 0.532 . . . . 0.0 110.534 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.91 97.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.893 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 67' ' ' MET . 0.0 OUTLIER -60.95 -40.46 93.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.402 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 62.1 mtt -59.52 -44.0 93.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.31 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.59 -43.94 74.14 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.073 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.02 98.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.052 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.86 87.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.153 0.501 . . . . 0.0 110.744 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.6 ttp -62.86 -37.39 86.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.509 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -58.83 -49.0 79.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.365 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 54' ' ' ILE . . . -62.69 -40.18 96.31 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.3 -48.86 79.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.621 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.73 -41.2 98.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.539 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -82.71 -10.67 58.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.431 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.495 ' N ' ' O ' ' A' ' 73' ' ' ALA . 98.9 m-85 43.53 45.19 5.49 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.331 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.525 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 98.5 m-20 -81.83 118.38 22.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.56 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CZ ' ' SG ' ' A' ' 14' ' ' CYS . 2.0 m-85 -167.24 -62.46 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.046 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 79' ' ' PHE . 37.4 Cg_endo -63.54 151.03 86.94 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.326 2.018 . . . . 0.0 111.835 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' A' ' 81' ' ' GLN . 5.1 pp0? -159.49 14.77 0.15 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.588 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 C--O 1.222 -0.364 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.009 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -53.5 -39.89 80.68 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.759 2.306 . . . . 0.0 111.83 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.68 -41.16 1.65 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -83.07 -1.32 52.47 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.736 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -135.1 151.04 74.58 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.029 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.8 146.2 21.63 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.049 1.833 . . . . 0.0 112.123 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.5 mp -66.44 -18.22 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.852 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 t -49.2 -30.57 7.11 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -59.99 -50.66 72.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.569 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -67.66 -47.77 68.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.27 0.557 . . . . 0.0 110.094 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -58.73 -39.77 81.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.301 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -64.29 -39.15 93.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.895 0.379 . . . . 0.0 110.486 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.6 m -60.29 -33.57 72.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.64 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.0 m -57.89 -35.93 71.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.48 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 15' ' ' LEU . 10.3 mp -59.4 -22.61 61.68 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.545 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.4 p -81.15 1.35 32.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.814 0.34 . . . . 0.0 110.386 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.1 47.06 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.383 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -70.28 116.92 11.18 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.161 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.4 m -140.29 135.43 32.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.346 0.593 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -65.21 132.93 50.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.063 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.15 4.39 62.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -80.93 156.97 25.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.931 0.396 . . . . 0.0 110.07 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -62.66 149.42 89.04 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.21 164.62 31.57 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.564 2.176 . . . . 0.0 111.895 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 69.41 154.33 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.925 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.61 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.1 pp -138.99 153.74 71.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.592 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.75 134.47 30.27 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.218 1.946 . . . . 0.0 111.685 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.1 tp -139.8 144.45 37.35 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.022 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.539 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 44.4 p90 -89.77 117.71 28.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.302 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -151.57 160.26 43.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.463 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.7 p -84.73 132.92 34.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.125 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 32' ' ' LEU . 11.3 mp -93.15 -39.19 11.17 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.32 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.55 ' O ' HG22 ' A' ' 44' ' ' THR . 36.5 tt0 -159.6 151.95 21.07 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.793 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.4 p -98.01 147.69 24.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.893 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.98 151.56 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.084 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.43 68.09 0.55 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.61 -9.23 21.2 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.571 2.18 . . . . 0.0 111.957 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.2 p -146.07 -169.92 3.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -60.11 -42.77 95.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.57 147.35 27.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.541 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.91 151.19 33.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.477 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.3 p -130.44 151.12 51.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.093 0.473 . . . . 0.0 110.341 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -123.89 145.81 48.86 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.264 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 33' ' ' GLN . 7.0 t -111.95 141.15 45.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.812 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.6 152.55 37.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.899 0.381 . . . . 0.0 110.273 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.68 128.09 14.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.713 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.59 127.65 40.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.709 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 48' ' ' TYR . 44.4 p90 -118.6 113.48 21.32 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.247 0.546 . . . . 0.0 110.115 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.644 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 1.4 t80 -102.09 133.2 47.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.937 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? 41.76 27.25 0.06 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.043 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.48 25.57 38.84 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.377 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' PHE . 3.9 tm-20 -136.69 119.56 16.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.952 0.406 . . . . 0.0 110.213 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.425 ' O ' ' OE1' ' A' ' 52' ' ' GLU . 8.3 tmm_? -70.53 128.43 36.09 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.398 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.6 pt -132.09 7.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.6 141.2 6.96 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.32 137.15 14.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.0 110.333 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.65 165.68 33.09 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -149.69 159.59 44.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 110.423 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.12 -178.72 45.86 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.96 -10.8 29.26 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.586 2.191 . . . . 0.0 112.017 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.5 m -147.24 142.95 27.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -63.89 -30.69 71.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.639 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.42 -45.46 94.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.53 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -64.42 -42.5 96.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 0.0 110.464 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.471 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' CE ' ' CD1' ' A' ' 29' ' ' TYR . 66.8 mttt -59.6 -58.97 6.29 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.812 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -57.7 -41.17 81.13 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.404 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.541 ' N ' ' SD ' ' A' ' 67' ' ' MET . . . -69.92 -53.55 14.81 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.178 -1.01 . . . . 0.0 111.65 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.39 97.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.363 . . . . 0.0 111.396 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.0 98.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.497 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.3 ttt -60.07 -39.75 87.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.471 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -60.93 -51.09 70.73 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.518 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.21 94.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.165 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.5 tp -60.99 -48.48 81.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.503 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -67.9 -37.84 82.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.622 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.76 -36.48 84.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -167.62 110.94 0.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.807 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -87.89 124.05 33.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.699 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.644 ' CZ ' ' CE2' ' A' ' 49' ' ' PHE . 1.7 m-85 -74.38 -60.17 1.46 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.639 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 79' ' ' PHE . 34.9 Cg_endo -62.82 138.84 71.17 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.902 1.735 . . . . 0.0 111.921 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -70.72 -40.27 72.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.605 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.517 179.826 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.77 -21.85 57.67 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.792 2.328 . . . . 0.0 111.92 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.98 -158.79 48.69 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -84.33 -174.38 5.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.774 0.321 . . . . 0.0 110.305 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -126.47 81.91 67.19 Favored Pre-proline 0 N--CA 1.467 0.388 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.426 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.46 145.35 88.81 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.804 2.336 . . . . 0.0 112.059 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.794 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.9 mp -68.2 -10.37 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.636 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.6 m -55.76 -31.09 62.27 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -62.34 -52.81 62.14 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.596 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.51 -44.88 89.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.867 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.434 ' NE2' ' HB3' ' A' ' 73' ' ' ALA . 12.3 tp-100 -59.43 -37.99 79.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.992 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -58.81 -44.49 90.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.381 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 87.8 m -61.09 -44.2 97.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.291 -0.563 . . . . 0.0 110.327 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.3 m -64.35 -40.63 96.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.967 0.413 . . . . 0.0 111.048 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.443 ' O ' ' OD2' ' A' ' 25' ' ' ASP . 55.3 mt -61.78 -39.63 92.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.137 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.9 p -70.04 -30.67 68.01 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.654 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 tt 52.19 70.72 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.418 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.89 105.12 3.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.624 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.8 m -140.1 131.52 26.87 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.161 0.505 . . . . 0.0 110.627 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.49 141.05 58.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.281 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.07 -4.49 86.28 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -143.56 125.92 15.69 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.873 0.368 . . . . 0.0 110.168 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 35.4 mp0 -70.57 149.86 95.49 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.937 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.53 157.41 61.94 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.298 1.999 . . . . 0.0 111.697 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 15' ' ' LEU . 44.6 p-10 -80.99 -172.96 4.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.117 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 pt -128.62 90.32 46.73 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.464 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.63 155.81 27.76 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.385 2.057 . . . . 0.0 111.913 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.831 ' N ' HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -138.47 147.78 43.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.011 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -129.47 110.47 11.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.188 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -151.0 133.74 15.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.436 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.427 ' H ' HG22 ' A' ' 31' ' ' THR . 0.1 OUTLIER -59.88 148.12 36.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.378 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.1 mt -88.01 -46.47 9.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.691 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -161.69 163.68 29.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.091 0.472 . . . . 0.0 110.306 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.2 m -105.59 124.4 49.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.504 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.4 t -106.49 140.48 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.951 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.5 73.95 0.35 Allowed Glycine 0 CA--C 1.532 1.131 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.27 -12.8 21.0 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.316 2.011 . . . . 0.0 112.155 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.6 p -155.72 -177.14 6.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.697 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -51.27 -30.53 18.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.467 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.45 135.54 33.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.434 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -82.5 145.86 29.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.185 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.3 p -128.9 148.83 50.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.03 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -116.32 142.39 46.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.411 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.3 m -117.32 128.93 55.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.028 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.22 152.36 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.488 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.51 139.71 33.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.123 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.5 t -86.71 130.22 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.011 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -107.68 134.63 50.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 0.0 110.496 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -144.5 129.73 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.375 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.6 tptp 56.02 19.89 3.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.526 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.09 12.55 73.59 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -135.17 131.08 36.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.937 0.399 . . . . 0.0 110.036 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.401 ' NH2' ' SG ' ' A' ' 56' ' ' CYS . 42.6 mtm105 -66.83 140.37 57.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.283 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.1 pt -117.93 -14.67 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.228 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.83 140.41 6.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.401 ' SG ' ' NH2' ' A' ' 53' ' ' ARG . 54.5 m -146.43 133.45 20.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.736 0.303 . . . . 0.0 110.277 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.03 170.58 33.79 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.11 162.96 35.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.115 0.483 . . . . 0.0 110.509 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.08 -169.2 42.33 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.2 -30.0 59.32 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.952 2.434 . . . . 0.0 112.117 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.1 p -156.44 164.08 38.68 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.38 0.61 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -61.78 -24.77 67.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.813 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -55.86 -57.76 10.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.968 0.413 . . . . 0.0 110.58 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -64.04 -39.44 94.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.59 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.15 97.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.635 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -60.64 -42.18 96.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.989 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.8 ttp -59.3 -49.2 78.74 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.28 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.64 -44.18 64.63 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.502 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.09 85.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.724 0.297 . . . . 0.0 111.187 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.05 -44.24 96.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.094 0.473 . . . . 0.0 110.456 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.5 ttt -62.48 -38.14 88.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.928 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -59.83 -46.22 89.94 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.414 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB3' ' NE2' ' A' ' 11' ' ' GLN . . . -64.63 -41.24 96.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 110.577 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.79 -45.59 91.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.442 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -64.1 -39.92 95.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.495 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -75.72 -20.19 58.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.728 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.9 t80 58.26 96.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.564 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 53.4 p-10 -80.05 147.47 31.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.643 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.0 t80 50.48 57.7 17.44 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.496 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' A' ' 82' ' ' MET . 46.6 Cg_endo -71.34 38.83 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.656 2.237 . . . . 0.0 112.45 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 70.0 -42.98 0.53 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.434 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.469 ' H ' ' C ' ' A' ' 80' ' ' PRO . 50.7 tpp . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.361 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -53.03 -38.31 80.01 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.746 2.297 . . . . 0.0 112.053 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.17 -19.26 73.85 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.416 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 61.1 t30 -75.35 -178.07 3.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.846 0.355 . . . . 0.0 110.434 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.416 ' H ' ' CG ' ' A' ' 4' ' ' ASN . 61.9 t0 -131.98 73.68 77.94 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.57 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -80.4 -158.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.707 2.272 . . . . 0.0 111.839 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.7 mp -64.11 -9.78 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 86.5 p -55.76 -27.57 51.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.325 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -63.01 -51.97 64.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.01 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.21 -37.45 87.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.936 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.474 ' O ' HD13 ' A' ' 15' ' ' LEU . 65.0 tt0 -57.17 -47.18 81.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.4 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -62.2 -45.27 94.13 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.571 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 17' ' ' LEU . 51.1 t -63.08 -46.97 84.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.39 -47.46 85.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.407 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 11' ' ' GLN . 8.9 mp -61.95 -45.9 91.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.439 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.8 p -75.41 -32.16 60.65 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.642 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 13' ' ' CYS . 30.2 tp 38.39 67.68 0.39 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.598 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -68.35 129.29 39.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.6 m -139.96 135.78 33.13 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.14 132.65 48.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.279 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.14 -10.14 75.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -137.16 123.16 20.24 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.002 0.43 . . . . 0.0 110.307 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.4 149.2 93.78 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.9 145.56 74.84 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.067 1.845 . . . . 0.0 111.902 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.504 ' OD2' ' CD1' ' A' ' 49' ' ' PHE . 43.3 p-10 -82.93 -170.25 2.92 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.237 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.77 91.06 37.9 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -81.58 145.62 14.75 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.432 2.088 . . . . 0.0 111.992 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.41 148.98 43.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.632 ' CD1' ' NZ ' ' A' ' 62' ' ' LYS . 42.5 p90 -95.63 131.39 41.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.341 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -143.45 151.29 40.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.406 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.9 p -72.19 123.81 23.7 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -87.84 -52.72 5.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -160.93 150.4 17.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.579 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -106.47 133.89 50.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -136.89 156.62 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.049 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.65 60.4 0.42 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.7 -25.75 33.65 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.472 2.114 . . . . 0.0 112.146 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.0 p -105.85 -176.18 3.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.442 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.526 ' O ' ' NH2' ' A' ' 41' ' ' ARG . 86.5 t60 -59.38 -47.73 84.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.169 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.51 145.22 28.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.594 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 39' ' ' HIS . 12.3 mpt_? -79.77 146.22 32.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.194 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 73.5 p -130.93 150.37 52.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.282 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.96 146.97 35.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.258 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.4 m -115.53 125.41 52.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.983 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.92 151.39 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.096 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.29 124.13 10.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.628 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 47' ' ' VAL . 4.8 m -87.91 151.28 3.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.895 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -128.65 154.28 46.43 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.106 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 66.0 t80 -144.67 120.46 10.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.035 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 tptp 71.2 21.87 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.35 18.34 62.64 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -137.86 143.32 40.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.819 0.343 . . . . 0.0 110.368 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -61.59 127.53 31.9 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 19.1 tt -110.34 -20.3 6.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.739 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.75 148.82 16.06 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.3 t -150.19 128.13 11.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.928 0.394 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.6 161.86 30.81 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -148.42 159.55 43.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 110.733 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.61 -172.82 45.51 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.82 -27.66 72.91 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.885 2.39 . . . . 0.0 112.106 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.4 t -155.26 155.64 34.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.531 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.632 ' NZ ' ' CD1' ' A' ' 29' ' ' TYR . 39.0 ttpt -59.75 -42.72 93.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.552 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -57.12 -39.06 74.36 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.468 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.7 tp-100 -74.33 -43.7 55.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.119 0.485 . . . . 0.0 110.911 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.25 62.9 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.945 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CG ' ' N ' ' A' ' 67' ' ' MET . 21.0 pttm -55.13 -42.93 73.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.267 -178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.491 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 78.5 mtm -60.62 -43.42 97.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.442 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.46 -47.45 62.77 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.414 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.38 83.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.117 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.34 74.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.051 0.453 . . . . 0.0 111.202 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.4 ttt -60.54 -36.46 78.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.9 -41.34 95.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 54' ' ' ILE . . . -60.34 -45.51 93.2 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.225 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.8 -43.64 98.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.388 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.3 -40.84 96.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.573 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -75.74 -31.32 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.629 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 13.4 t80 41.96 69.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.406 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 54' ' ' ILE . 94.1 m-20 -78.42 136.17 37.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -75.35 145.58 79.96 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.849 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.09 -26.65 21.23 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.407 2.071 . . . . 0.0 112.221 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -77.89 152.17 33.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.666 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.574 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -57.15 140.07 91.76 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.762 2.308 . . . . 0.0 111.852 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.57 94.19 0.57 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -158.97 178.24 10.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.493 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.62 150.02 96.83 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.443 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.25 -167.49 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.752 2.301 . . . . 0.0 112.038 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.533 HD13 ' O ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -63.45 -27.81 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.33 -179.272 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 t -49.62 -26.79 3.91 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -60.34 -48.15 82.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.176 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -63.61 -51.4 65.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.143 0.496 . . . . 0.0 110.692 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -59.99 -40.15 88.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.914 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.8 -42.02 98.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.427 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.51 -46.89 88.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.485 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.4 m -61.07 -41.34 96.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -63.38 -39.86 95.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.579 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 m -78.39 -15.74 58.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.163 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.4 tp -75.49 120.04 20.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.086 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -64.77 132.0 48.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.691 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.425 HG21 ' HZ1' ' A' ' 50' ' ' LYS . 89.4 m -98.62 125.24 43.83 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.323 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.93 132.62 46.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.479 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.65 -8.19 80.33 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.77 143.45 38.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.0 0.428 . . . . 0.0 110.704 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -69.96 151.1 96.27 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.713 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -45.53 163.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.575 2.183 . . . . 0.0 111.805 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -145.86 161.39 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.201 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.1 pt -135.72 149.88 70.26 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.541 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.45 146.55 62.47 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.502 2.135 . . . . 0.0 111.821 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.31 110.52 6.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.26 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -94.18 106.05 18.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.261 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -131.74 135.42 46.8 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.429 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.2 t -123.4 142.34 51.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.494 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.46 26.39 1.3 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.283 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -159.15 147.34 17.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 t -133.2 146.94 51.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.135 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 36' ' ' GLY . 82.0 t -127.92 153.24 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.614 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 77.47 53.22 5.18 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' OG ' ' A' ' 38' ' ' SER . 56.2 Cg_endo -70.19 157.18 60.37 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.773 2.315 . . . . 0.0 111.832 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 39' ' ' HIS . 4.1 p 73.31 -60.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.501 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.51 ' N ' ' OG ' ' A' ' 38' ' ' SER . 45.2 m170 -81.13 -115.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.327 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.79 108.05 18.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.308 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -78.82 128.56 33.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.375 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 52.4 p -129.12 150.27 50.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.172 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.71 146.49 33.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.311 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.5 p -104.3 142.27 34.84 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.892 0.377 . . . . 0.0 110.159 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.38 142.01 34.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.04 119.93 15.35 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.149 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.5 t -86.93 140.63 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.328 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.13 148.33 35.54 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.926 0.393 . . . . 0.0 110.198 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.609 ' O ' ' N ' ' A' ' 52' ' ' GLU . 29.3 t80 -143.12 114.39 7.87 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.031 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.477 ' HZ2' ' CB ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER 38.22 37.84 0.18 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.557 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.88 22.63 52.41 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.621 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' A' ' 49' ' ' PHE . 80.2 mm-40 -138.12 128.26 25.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.888 0.375 . . . . 0.0 110.483 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -69.95 131.83 45.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.22 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.4 pt -128.88 10.04 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 0.0 110.805 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.34 136.68 4.3 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.474 ' N ' ' HB1' ' A' ' 69' ' ' ALA . 50.9 t -161.15 112.62 1.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.2 175.61 35.34 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -143.37 157.23 44.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 110.519 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.86 -173.94 46.43 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.56 -16.13 52.48 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.519 2.146 . . . . 0.0 111.398 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.5 m -147.77 140.32 24.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.006 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -74.37 -33.83 63.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.552 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.495 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 59.0 mtpt -60.76 -49.92 75.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.555 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -66.78 -38.99 87.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.655 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.0 66.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.908 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 5.2 ptpp? -55.12 -42.77 73.41 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.398 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.48 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 65.7 mtt -60.4 -48.75 80.4 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.792 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.07 -39.36 63.16 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.63 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' HB1' ' N ' ' A' ' 56' ' ' CYS . . . -60.18 -48.65 80.82 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.914 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.87 -48.62 79.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.82 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 66.5 ttp -61.1 -44.42 97.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.812 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -61.34 -51.52 68.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.65 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.54 94.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.983 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.53 -44.12 97.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.035 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.78 -47.03 76.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.243 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -80.13 -15.54 56.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.997 0.427 . . . . 0.0 111.077 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -158.04 91.71 1.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.546 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 26.6 p30 -97.35 145.09 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.403 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -158.52 59.55 1.55 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.348 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.42 167.01 26.52 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.936 2.424 . . . . 0.0 111.876 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -70.63 124.3 23.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.551 -179.896 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo . . . . . 0 N--CA 1.494 1.534 0 CA-C-O 120.906 0.294 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.5 mt -69.75 -12.45 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.368 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 96.2 p -59.61 -24.32 63.72 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.686 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -63.25 -51.6 65.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.824 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.24 -48.93 66.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.089 0.471 . . . . 0.0 110.943 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.403 ' O ' HD13 ' A' ' 15' ' ' LEU . 90.2 mm-40 -58.92 -20.5 52.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.676 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -56.8 -44.4 81.9 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.193 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.3 m -65.07 -39.73 93.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 110.521 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.45 ' SG ' ' CG ' ' A' ' 78' ' ' ASN . 51.8 t -59.9 -40.73 89.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.906 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 11' ' ' GLN . 6.3 mp -50.08 -47.63 53.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.176 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.4 m -71.4 -38.45 71.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.162 0.506 . . . . 0.0 110.431 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER 48.33 75.13 0.15 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.844 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -75.85 105.44 6.89 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.268 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.1 m -139.44 133.65 31.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.92 0.39 . . . . 0.0 110.94 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -69.11 136.65 52.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.319 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.46 -8.74 76.09 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -89.28 138.19 31.65 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.926 0.393 . . . . 0.0 110.567 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -64.93 148.85 97.31 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.18 149.03 70.11 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.451 2.101 . . . . 0.0 112.105 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 26' ' ' ILE . 48.4 t0 -159.08 151.41 21.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.088 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 26' ' ' ILE . 17.3 tt -135.1 89.07 24.78 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.735 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.2 148.29 14.89 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.509 2.139 . . . . 0.0 111.695 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.2 tp -138.21 133.73 33.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.129 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.509 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 41.4 p90 -93.61 123.75 37.15 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -149.9 151.59 33.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.231 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.6 p -51.9 129.67 27.4 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -87.68 -52.91 5.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.066 0.46 . . . . 0.0 110.408 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -162.43 155.52 20.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.539 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.404 HG22 ' CD2' ' A' ' 43' ' ' TYR . 73.0 p -109.31 146.81 33.71 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.2 m -138.72 165.04 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.513 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.6 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 71.38 39.48 61.61 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 36' ' ' GLY . 41.3 Cg_endo -66.47 -20.22 54.42 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.681 2.254 . . . . 0.0 111.902 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -59.66 -44.59 93.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.897 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -119.16 -108.42 0.36 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.343 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.99 131.11 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.161 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -77.96 135.87 37.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.219 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.2 p -124.38 147.67 48.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.995 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.404 ' CD2' HG22 ' A' ' 34' ' ' THR . 96.4 m-85 -113.32 131.79 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.649 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.7 m -113.68 126.22 55.01 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.541 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.11 148.1 33.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.39 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.19 122.91 14.28 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.241 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.33 128.69 39.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -112.8 141.27 46.8 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.488 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -144.8 130.27 18.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.559 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 mttm 59.08 17.74 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.595 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.39 13.04 62.19 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -133.53 144.05 49.13 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.811 0.338 . . . . 0.0 110.32 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -65.39 126.19 27.46 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.8 tt -104.73 -27.64 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.198 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.37 148.08 13.86 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.1 t -154.15 140.27 18.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.91 0.386 . . . . 0.0 110.628 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.62 171.95 31.76 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -144.83 153.12 41.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.921 0.391 . . . . 0.0 110.49 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.93 174.22 46.9 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 -7.44 21.24 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 123.014 2.476 . . . . 0.0 112.154 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.8 p -150.06 156.57 41.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.182 0.515 . . . . 0.0 110.632 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.78 -40.72 98.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.603 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.02 -45.49 90.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.398 0.618 . . . . 0.0 110.369 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -71.01 -41.02 71.45 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.706 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.42 94.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.603 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 67' ' ' MET . 4.7 ptmm? -64.18 -39.76 94.67 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.527 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 67' ' ' MET . 19.4 tmm? -59.5 -44.65 93.06 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.848 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.31 -40.66 94.74 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.52 -45.44 94.2 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.705 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.81 99.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.205 0.526 . . . . 0.0 110.463 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.9 ttt -62.34 -37.75 86.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.548 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -59.42 -45.17 92.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 109.988 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.6 95.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.197 0.522 . . . . 0.0 109.947 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.8 tt -59.88 -45.07 93.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.471 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.27 -39.38 93.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.619 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -77.67 -10.34 59.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 20.4 t80 67.98 133.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.378 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.45 ' CG ' ' SG ' ' A' ' 14' ' ' CYS . 32.7 m120 -79.15 144.69 34.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.427 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.8 t80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.751 -179.657 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 CA-C-O 121.268 0.445 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.715 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.6 mp -67.79 -19.74 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.272 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -48.42 -33.11 8.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.99 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -60.87 -44.51 96.94 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.647 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.1 tt -73.75 -39.22 64.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.412 0.625 . . . . 0.0 110.28 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -56.66 -25.28 53.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.506 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -53.15 -36.95 61.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.479 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.18 -47.91 83.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.019 0.438 . . . . 0.0 110.598 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.8 t -60.75 -41.59 95.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.011 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.62 -42.61 99.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.287 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.7 t -83.62 -5.68 59.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.664 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 17' ' ' LEU . 2.5 tt -74.81 96.45 3.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.754 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -71.08 150.51 45.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.321 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.425 HG21 ' HD2' ' A' ' 22' ' ' LYS . 62.6 m -94.92 120.38 35.04 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.482 0.658 . . . . 0.0 110.942 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -68.9 139.34 55.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.323 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.65 2.23 84.82 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HD2' HG21 ' A' ' 19' ' ' THR . 99.4 mttt -137.17 155.38 49.63 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.501 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.48 149.28 95.41 Favored Pre-proline 0 N--CA 1.451 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.387 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.37 163.46 29.45 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.805 2.336 . . . . 0.0 111.768 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.36 166.7 29.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 26' ' ' ILE . 16.0 tt -128.61 91.74 42.61 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 121.069 0.461 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.67 133.69 14.4 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.479 2.12 . . . . 0.0 111.727 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.7 tp -138.45 145.59 41.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.218 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -88.79 136.06 33.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.466 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.7 145.9 37.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.347 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.62 110.63 22.87 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.908 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 47.2 mt -106.64 -38.2 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.33 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -85.51 141.98 29.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.359 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -121.85 146.3 47.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.155 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 36' ' ' GLY . 84.4 t -137.08 159.64 36.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.568 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.544 ' N ' HG12 ' A' ' 35' ' ' VAL . . . 74.76 88.34 0.22 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 36' ' ' GLY . 52.0 Cg_exo -52.97 -137.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.037 2.491 . . . . 0.0 112.585 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 39' ' ' HIS . 46.3 t -59.52 -39.52 84.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.439 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' SER . 77.9 m80 -47.29 -109.83 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.08 0.467 . . . . 0.0 110.867 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.27 136.64 32.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.549 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -86.41 116.72 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.49 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.45 ' HG1' ' C ' ' A' ' 35' ' ' VAL . 58.7 p -133.66 150.32 51.56 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.516 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -135.13 151.04 50.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.365 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.6 m -112.07 129.4 56.23 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.225 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.3 t -106.09 122.27 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.201 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.14 119.89 40.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.337 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.71 126.23 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.951 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.63 133.95 48.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.869 0.366 . . . . 0.0 110.241 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -144.52 118.51 9.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.162 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.13 18.95 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.96 12.62 73.8 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -136.59 149.56 48.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.811 0.339 . . . . 0.0 110.383 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtm-85 -67.02 139.05 57.63 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.204 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -124.62 -21.3 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.507 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.62 150.55 18.28 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 42.1 t -152.53 138.97 18.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.438 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.76 161.98 29.49 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -145.84 157.87 43.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.867 0.365 . . . . 0.0 110.789 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.58 178.58 44.58 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.8 -7.65 21.59 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.826 2.351 . . . . 0.0 111.988 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.0 t -151.61 160.15 43.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.372 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -62.16 -37.89 86.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.58 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.24 -46.89 82.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.559 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -64.26 -42.97 96.23 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.752 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.43 -42.98 95.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.778 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -61.54 -39.67 91.88 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.716 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 59.5 ttm -58.38 -50.12 74.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.324 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.86 -44.0 48.43 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.275 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.73 -49.1 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.736 0.303 . . . . 0.0 111.173 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.98 -46.74 87.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 ttt -62.1 -37.87 86.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.579 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -57.6 -46.93 83.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.21 -40.78 98.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.067 0.46 . . . . 0.0 110.42 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.63 -43.91 93.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.698 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -62.39 -39.63 93.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.917 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 77' ' ' TYR . 63.1 tttp -70.74 -28.31 64.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.331 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 5.9 t80 83.06 161.13 0.13 Allowed 'General case' 0 C--N 1.334 -0.107 0 O-C-N 123.433 0.458 . . . . 0.0 110.267 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -91.62 111.75 23.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.997 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 79' ' ' PHE . 54.8 t80 . . . . . 0 N--CA 1.463 0.202 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.735 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo . . . . . 0 N--CA 1.496 1.665 0 CA-C-O 121.433 0.514 . . . . 0.0 112.634 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.2 mp -71.3 -11.31 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.313 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.6 p -52.66 -24.6 8.8 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -61.81 -51.73 67.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.854 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.6 mt -64.41 -45.13 88.9 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 110.545 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.5 -42.46 96.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.374 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.22 -40.03 88.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.485 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.9 -40.86 94.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.349 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.48 -50.09 75.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.525 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.38 -38.38 90.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.997 0.427 . . . . 0.0 110.315 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -70.61 -24.49 62.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.426 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.36 120.83 18.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.055 0.455 . . . . 0.0 110.495 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -68.26 144.35 54.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.727 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 22' ' ' LYS . 96.6 m -98.92 127.93 44.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.02 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -67.84 125.87 27.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.48 -10.19 75.36 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 19' ' ' THR . 42.8 mmtm -137.55 144.7 42.22 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.058 0.456 . . . . 0.0 111.021 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.46 151.1 95.67 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.602 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.05 139.29 55.51 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.386 2.057 . . . . 0.0 111.825 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.72 158.33 22.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.441 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.4 mt -91.42 117.9 68.1 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.671 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.81 130.42 13.46 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.312 2.008 . . . . 0.0 112.135 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -140.73 137.41 33.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 25.3 p90 -111.76 106.18 14.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.06 0.457 . . . . 0.0 110.431 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -136.66 151.56 49.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.3 p -107.01 147.96 29.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.202 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.94 -84.08 0.42 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.41 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -83.92 144.11 29.41 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.663 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.2 p -132.34 129.01 38.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.897 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' OG1' ' A' ' 42' ' ' THR . 32.1 m -138.23 159.91 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.148 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.64 64.27 0.42 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' SER . 71.0 Cg_endo -73.94 157.09 47.55 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.864 2.376 . . . . 0.0 111.72 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.1 m 75.99 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.447 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -174.2 -36.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.599 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.83 136.63 36.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.586 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' A' ' 41' ' ' ARG . 1.5 mpt_? -80.73 139.2 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.914 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.426 ' OG1' HG23 ' A' ' 35' ' ' VAL . 80.7 p -131.38 150.58 52.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -132.85 149.38 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.387 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.1 m -109.82 128.92 55.63 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.162 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.82 149.6 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.711 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.75 126.74 13.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.311 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.0 t -87.45 131.39 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.414 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.04 138.36 40.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.191 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -144.12 123.89 13.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 54.79 29.53 12.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.22 8.54 87.13 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -132.4 135.7 46.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.876 0.369 . . . . 0.0 110.396 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -69.84 145.94 51.7 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.192 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.3 pt -114.12 -22.06 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.586 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.94 154.8 24.1 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.2 p -155.21 139.67 16.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.731 0.301 . . . . 0.0 110.495 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.63 174.67 35.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.542 ' N ' ' CD ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -146.24 162.81 37.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.523 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.89 -176.09 47.07 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.91 -29.96 83.97 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 123.005 2.47 . . . . 0.0 112.449 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -136.53 154.4 50.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 110.654 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -63.52 -41.66 98.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.509 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.92 -43.09 99.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.551 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -66.05 -38.31 88.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.531 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.44 -34.79 76.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.148 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 97.4 mttt -56.65 -31.04 63.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.519 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 68.6 mtm -59.06 -46.23 88.77 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.327 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.88 -50.61 23.12 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.309 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.5 83.87 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.982 0.42 . . . . 0.0 111.072 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 66' ' ' LYS . . . -61.94 -44.04 97.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.719 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 66.1 ttp -61.29 -38.94 88.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.811 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.96 -43.68 91.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.423 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.457 ' HB1' HD21 ' A' ' 78' ' ' ASN . . . -61.18 -45.43 94.64 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.539 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.5 -42.87 99.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.309 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.64 -39.69 95.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.445 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 77' ' ' TYR . 27.2 mtpp -79.89 -7.37 58.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.711 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' LYS . 97.9 m-85 57.4 113.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.626 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.457 HD21 ' HB1' ' A' ' 73' ' ' ALA . 32.2 m120 -80.28 146.0 31.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.659 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.7 t80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.529 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 CA-C-O 121.118 0.382 . . . . 0.0 112.311 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.622 HD13 ' SD ' ' A' ' 67' ' ' MET . 4.9 tp -64.82 -15.64 18.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.101 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 t -47.99 -18.86 0.21 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.65 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' A' ' 7' ' ' ILE . 61.8 tt0 -61.39 -57.14 13.47 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.19 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 74' ' ' LEU . 85.1 mt -64.66 -41.36 96.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.358 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.592 ' O ' HD13 ' A' ' 15' ' ' LEU . 10.6 tp-100 -61.38 -54.35 44.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -65.43 -43.22 91.19 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.166 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t -61.96 -49.07 77.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.482 ' SG ' ' OD1' ' A' ' 78' ' ' ASN . 47.6 t -61.1 -45.09 96.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.695 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.592 HD13 ' O ' ' A' ' 11' ' ' GLN . 7.1 mp -61.78 -40.1 94.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.378 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.4 m -69.64 -38.31 77.12 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.346 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.2 tp 42.76 78.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.251 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -69.78 116.83 10.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.412 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.2 m -139.31 124.22 18.71 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.406 0.622 . . . . 0.0 110.695 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -67.3 142.98 56.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.45 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.09 -5.0 85.97 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.3 134.71 48.97 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 110.076 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 46.1 mp0 -70.34 151.58 95.72 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.03 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -51.25 141.43 39.55 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.059 1.839 . . . . 0.0 112.016 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.54 -174.54 5.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.242 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 pt -116.78 91.7 35.92 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.56 139.09 66.78 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.453 2.102 . . . . 0.0 111.588 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 tp -133.94 124.91 27.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.301 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.553 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 46.0 p90 -131.23 113.2 13.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.247 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -152.69 138.84 18.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.598 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.8 p -75.04 153.18 38.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.298 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.87 -65.67 0.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.411 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 34' ' ' THR . 17.9 tm0? -162.55 144.36 10.55 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.155 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.568 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 97.0 m -98.71 130.96 45.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.394 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.06 158.31 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.221 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 38' ' ' SER . . . -148.58 79.79 0.21 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.538 ' O ' ' CD2' ' A' ' 39' ' ' HIS . 52.4 Cg_exo -52.33 73.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.834 2.356 . . . . 0.0 112.276 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 36' ' ' GLY . 49.2 m 46.16 31.82 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.489 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 37' ' ' PRO . 85.5 m-70 -148.7 -131.54 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.589 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.03 149.28 28.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.504 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -71.0 142.54 50.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.052 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.1 m -126.99 130.59 50.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.145 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.93 140.03 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.204 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -125.8 131.06 52.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.926 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.0 142.76 36.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.283 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.38 125.54 14.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.363 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.31 138.1 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.342 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.83 113.37 24.13 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.956 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CZ ' ' NZ ' ' A' ' 50' ' ' LYS . 66.2 t80 -101.4 115.05 29.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.311 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' NZ ' ' CZ ' ' A' ' 49' ' ' PHE . 61.6 mttp 52.39 37.74 23.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.823 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.83 25.11 70.32 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -137.57 136.32 37.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.019 0.438 . . . . 0.0 110.343 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 76.0 ttt-85 -62.46 126.66 28.1 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.479 ' CD1' HD21 ' A' ' 78' ' ' ASN . 15.9 tt -111.35 -35.69 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.702 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.9 148.5 10.94 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 31.3 p -155.19 156.0 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.2 162.19 31.67 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -149.54 156.17 41.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 110.603 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.38 177.68 44.63 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.07 -6.78 19.97 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.074 2.516 . . . . 0.0 112.192 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 t -147.91 152.37 37.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.122 0.486 . . . . 0.0 110.415 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -60.83 -36.18 78.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.451 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.95 -42.96 91.07 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.683 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -66.24 -39.93 89.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.404 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.17 99.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.598 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.7 -40.41 94.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.453 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.622 ' SD ' HD13 ' A' ' 7' ' ' ILE . 60.9 tpp -60.32 -49.1 78.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.492 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.27 -41.45 79.0 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.54 72.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.288 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 11' ' ' GLN . . . -64.36 -46.79 81.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.273 0.558 . . . . 0.0 110.943 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.1 ttp -62.23 -38.3 88.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.619 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 53' ' ' ARG . 7.8 t0 -58.56 -49.96 75.54 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.302 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB1' ' SG ' ' A' ' 14' ' ' CYS . . . -63.46 -41.19 98.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.515 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 10' ' ' LEU . 50.9 tp -59.36 -46.44 88.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.579 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.91 -41.28 97.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.443 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -71.14 -34.19 70.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.514 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 61.99 130.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.57 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.482 ' OD1' ' SG ' ' A' ' 14' ' ' CYS . 30.3 m120 -83.78 140.03 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.513 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.246 179.526 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.496 1.624 0 CA-C-O 121.126 0.386 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.8 mp -67.74 -12.2 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.728 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.7 p -59.25 -23.63 62.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.64 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -64.31 -55.5 20.86 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.167 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -64.28 -47.57 79.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.403 0.62 . . . . 0.0 110.977 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -58.76 -24.13 61.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.32 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -56.26 -45.95 79.86 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.16 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.3 m -65.27 -42.48 93.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.104 0.478 . . . . 0.0 110.439 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.63 -42.77 99.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.769 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.9 -40.73 94.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.564 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 17' ' ' LEU . 46.6 p -72.67 -31.51 65.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.829 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 16' ' ' THR . 1.3 tt 34.6 71.48 0.11 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.278 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -70.42 119.33 14.43 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.23 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -139.13 121.66 16.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.525 0.678 . . . . 0.0 110.837 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.19 142.85 54.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.375 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.38 2.37 89.09 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -141.88 126.89 18.35 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.029 0.442 . . . . 0.0 110.04 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.28 120.46 76.99 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.784 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.03 143.48 32.64 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.152 1.901 . . . . 0.0 112.112 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -82.99 176.93 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.041 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.47 88.93 25.54 Favored Pre-proline 0 C--O 1.232 0.168 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.83 130.31 6.64 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.79 2.327 . . . . 0.0 111.79 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 28' ' ' LEU . 20.5 tp -140.48 142.5 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.433 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -90.78 135.07 33.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.298 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -146.35 142.84 28.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.836 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.505 HG21 ' HZ2' ' A' ' 62' ' ' LYS . 67.5 p -73.0 149.72 43.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.468 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.7 mt -104.59 -58.41 1.89 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.534 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -162.28 165.12 27.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.586 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.4 p -90.48 146.73 23.89 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.112 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.558 HG22 ' N ' ' A' ' 36' ' ' GLY . 14.9 p -143.48 162.52 16.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.762 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.558 ' N ' HG22 ' A' ' 35' ' ' VAL . . . 73.76 60.68 3.58 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.48 -24.73 78.81 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.6 2.2 . . . . 0.0 112.004 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.5 m -64.47 144.51 57.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.5 m80 48.43 -123.87 1.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.362 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.7 138.55 33.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.311 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -77.88 153.95 32.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.235 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.4 p -127.61 149.45 50.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.996 0.427 . . . . 0.0 110.025 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -104.63 140.13 38.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.145 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -96.66 132.66 42.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.244 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.0 t -132.18 132.17 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.79 118.97 16.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.108 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.8 t -88.49 136.5 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.136 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -115.8 147.66 40.74 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.091 0.472 . . . . 0.0 110.008 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -144.43 114.78 7.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.231 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 tttp 67.73 20.15 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.55 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.54 13.86 59.22 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -133.78 145.6 49.93 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.755 0.312 . . . . 0.0 110.222 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.65 126.0 27.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.004 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.0 tt -105.54 -26.39 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.811 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.41 155.58 26.89 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.6 t -154.97 139.68 17.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.686 0.279 . . . . 0.0 110.457 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.99 166.78 32.09 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -148.85 162.28 40.15 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.023 0.44 . . . . 0.0 110.655 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.66 177.36 46.42 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.144 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.53 -33.01 97.72 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.856 2.371 . . . . 0.0 112.477 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.5 m -120.42 153.54 36.42 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.096 0.474 . . . . 0.0 110.605 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.505 ' HZ2' HG21 ' A' ' 31' ' ' THR . 68.1 mttm -62.4 -40.54 96.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.704 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -60.75 -36.91 80.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -67.78 -41.89 82.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.452 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.85 97.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.283 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -62.28 -42.41 99.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.27 0.557 . . . . 0.0 109.782 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 67' ' ' MET . 18.7 tmm? -61.31 -42.54 98.83 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.046 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.45 -41.28 98.07 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.19 99.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 0.0 110.508 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.57 96.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.111 0.481 . . . . 0.0 110.583 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 ttt -61.69 -38.89 89.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.639 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.45 ' OD1' ' NZ ' ' A' ' 76' ' ' LYS . 67.9 t0 -59.54 -46.56 88.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.166 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 77' ' ' TYR . . . -62.73 -41.67 99.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.972 0.415 . . . . 0.0 110.416 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 74' ' ' LEU . 6.5 tt -60.89 -48.31 82.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.492 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.86 -44.9 94.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.835 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 72' ' ' ASP . 62.4 mttp -76.61 -23.15 53.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.026 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 73' ' ' ALA . 35.2 t80 41.87 90.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.469 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.43 116.26 21.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.046 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.167 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.496 1.63 0 CA-C-O 121.038 0.349 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.56 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.8 mp -66.58 -21.33 28.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.875 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.7 p -56.08 -31.84 63.58 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.51 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -60.7 -48.79 80.2 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.497 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.532 ' O ' HD13 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -65.03 -45.83 83.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.183 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -58.2 -39.99 80.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.222 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -60.13 -40.09 88.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.522 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.8 m -60.75 -40.43 92.44 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.164 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.577 ' SG ' ' CZ ' ' A' ' 79' ' ' PHE . 35.3 t -60.89 -39.38 89.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.082 0.468 . . . . 0.0 110.381 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.67 -41.26 94.7 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.4 p -82.98 -7.23 59.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.904 0.383 . . . . 0.0 110.703 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 tt -76.99 129.19 35.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -66.85 142.16 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.732 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' LYS . 85.5 m -91.18 111.24 22.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.225 0.536 . . . . 0.0 110.258 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -67.99 136.92 54.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.766 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.68 -11.81 69.09 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 19' ' ' THR . 56.8 mtmt -144.31 158.73 43.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 110.73 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -67.07 149.12 98.68 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.604 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.22 132.05 26.7 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.125 1.883 . . . . 0.0 111.941 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -93.43 172.36 8.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.153 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.5 mm -115.92 90.84 28.99 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.19 130.93 7.47 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.649 2.233 . . . . 0.0 112.057 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.1 tp -139.27 126.6 21.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.131 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 53.2 p90 -90.86 128.7 36.83 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.219 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -150.31 134.22 16.84 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.354 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 31' ' ' THR . 0.2 OUTLIER -55.37 134.15 50.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.449 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.2 mt -90.76 -46.11 8.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.696 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.02 165.21 22.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.548 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 t -90.63 147.26 23.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.157 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.56 150.61 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.642 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.577 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 70.36 42.08 66.14 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 36' ' ' GLY . 42.8 Cg_endo -65.16 -21.11 62.87 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.596 2.197 . . . . 0.0 111.882 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 95.7 p -63.27 -25.67 68.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.0 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.703 ' CD2' ' H ' ' A' ' 40' ' ' ALA . 25.3 p-80 -135.34 -113.89 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.663 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.703 ' H ' ' CD2' ' A' ' 39' ' ' HIS . . . -74.1 139.8 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.047 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.7 mmm-85 -81.21 127.19 32.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.502 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.4 p -126.91 149.13 49.94 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -108.25 141.46 39.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.416 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.2 m -105.6 124.07 48.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.78 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.7 t -121.59 128.16 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.388 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 123.82 23.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.903 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.416 HG11 HD11 ' A' ' 54' ' ' ILE . 94.2 t -87.48 130.76 36.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.318 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -109.23 140.94 42.2 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.174 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -144.72 130.74 19.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.985 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? 55.25 26.04 8.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.684 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.74 15.35 77.96 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -135.95 138.7 42.59 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 110.312 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.45 135.97 52.53 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.091 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.528 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 44.8 pt -110.54 -21.64 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.575 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.85 152.37 21.94 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.7 t -150.24 133.2 16.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.905 0.384 . . . . 0.0 110.599 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.38 166.6 32.75 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -147.16 163.16 37.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.56 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.39 177.13 46.03 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.79 -9.51 23.21 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.906 2.404 . . . . 0.0 111.953 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 m -146.91 150.01 34.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.074 0.464 . . . . 0.0 110.495 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -62.01 -39.07 90.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.714 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -59.5 -46.51 88.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.224 0.535 . . . . 0.0 110.424 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -64.95 -40.56 95.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.217 0.532 . . . . 0.0 110.534 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.91 97.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.893 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 67' ' ' MET . 0.0 OUTLIER -60.95 -40.46 93.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.402 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 62.1 mtt -59.52 -44.0 93.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.31 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.59 -43.94 74.14 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.073 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.02 98.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.052 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.86 87.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.153 0.501 . . . . 0.0 110.744 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.6 ttp -62.86 -37.39 86.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.509 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -58.83 -49.0 79.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.365 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 54' ' ' ILE . . . -62.69 -40.18 96.31 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.3 -48.86 79.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.621 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.73 -41.2 98.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.539 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -82.71 -10.67 58.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.431 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.495 ' N ' ' O ' ' A' ' 73' ' ' ALA . 98.9 m-85 43.53 45.19 5.49 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.331 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.525 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 98.5 m-20 -81.83 118.38 22.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.56 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CZ ' ' SG ' ' A' ' 14' ' ' CYS . 2.0 m-85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.046 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo . . . . . 0 N--CA 1.497 1.688 0 CA-C-O 120.943 0.31 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.5 mp -66.44 -18.22 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.852 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 t -49.2 -30.57 7.11 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -59.99 -50.66 72.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.569 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -67.66 -47.77 68.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.27 0.557 . . . . 0.0 110.094 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -58.73 -39.77 81.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.301 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -64.29 -39.15 93.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.895 0.379 . . . . 0.0 110.486 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.6 m -60.29 -33.57 72.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.64 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.0 m -57.89 -35.93 71.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.48 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 15' ' ' LEU . 10.3 mp -59.4 -22.61 61.68 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.545 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.4 p -81.15 1.35 32.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.814 0.34 . . . . 0.0 110.386 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.1 47.06 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.383 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -70.28 116.92 11.18 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.161 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.4 m -140.29 135.43 32.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.346 0.593 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -65.21 132.93 50.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.063 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.15 4.39 62.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -80.93 156.97 25.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.931 0.396 . . . . 0.0 110.07 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -62.66 149.42 89.04 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.21 164.62 31.57 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.564 2.176 . . . . 0.0 111.895 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 69.41 154.33 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.925 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.61 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.1 pp -138.99 153.74 71.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.592 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.75 134.47 30.27 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.218 1.946 . . . . 0.0 111.685 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.1 tp -139.8 144.45 37.35 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.022 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.539 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 44.4 p90 -89.77 117.71 28.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.302 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -151.57 160.26 43.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.463 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.7 p -84.73 132.92 34.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.125 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 32' ' ' LEU . 11.3 mp -93.15 -39.19 11.17 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.32 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.55 ' O ' HG22 ' A' ' 44' ' ' THR . 36.5 tt0 -159.6 151.95 21.07 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.793 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.4 p -98.01 147.69 24.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.893 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.98 151.56 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.084 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.43 68.09 0.55 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.61 -9.23 21.2 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.571 2.18 . . . . 0.0 111.957 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.2 p -146.07 -169.92 3.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -60.11 -42.77 95.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.57 147.35 27.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.541 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.91 151.19 33.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.477 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.3 p -130.44 151.12 51.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.093 0.473 . . . . 0.0 110.341 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -123.89 145.81 48.86 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.264 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 33' ' ' GLN . 7.0 t -111.95 141.15 45.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.812 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.6 152.55 37.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.899 0.381 . . . . 0.0 110.273 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.68 128.09 14.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.713 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.59 127.65 40.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.709 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 48' ' ' TYR . 44.4 p90 -118.6 113.48 21.32 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.247 0.546 . . . . 0.0 110.115 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.644 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 1.4 t80 -102.09 133.2 47.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.937 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? 41.76 27.25 0.06 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.043 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.48 25.57 38.84 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.377 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' PHE . 3.9 tm-20 -136.69 119.56 16.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.952 0.406 . . . . 0.0 110.213 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.425 ' O ' ' OE1' ' A' ' 52' ' ' GLU . 8.3 tmm_? -70.53 128.43 36.09 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.398 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.6 pt -132.09 7.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.6 141.2 6.96 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.32 137.15 14.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.0 110.333 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.65 165.68 33.09 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -149.69 159.59 44.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 110.423 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.12 -178.72 45.86 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.96 -10.8 29.26 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.586 2.191 . . . . 0.0 112.017 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.5 m -147.24 142.95 27.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -63.89 -30.69 71.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.639 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.42 -45.46 94.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.53 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -64.42 -42.5 96.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 0.0 110.464 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.471 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' CE ' ' CD1' ' A' ' 29' ' ' TYR . 66.8 mttt -59.6 -58.97 6.29 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.812 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -57.7 -41.17 81.13 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.404 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.541 ' N ' ' SD ' ' A' ' 67' ' ' MET . . . -69.92 -53.55 14.81 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.178 -1.01 . . . . 0.0 111.65 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.39 97.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.363 . . . . 0.0 111.396 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.0 98.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.497 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.3 ttt -60.07 -39.75 87.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.471 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -60.93 -51.09 70.73 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.518 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.21 94.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.165 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.5 tp -60.99 -48.48 81.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.503 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -67.9 -37.84 82.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.622 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.76 -36.48 84.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -167.62 110.94 0.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.807 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -87.89 124.05 33.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.699 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.644 ' CZ ' ' CE2' ' A' ' 49' ' ' PHE . 1.7 m-85 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.639 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo . . . . . 0 N--CA 1.496 1.644 0 CA-C-O 121.057 0.357 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.794 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.9 mp -68.2 -10.37 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.636 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.6 m -55.76 -31.09 62.27 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -62.34 -52.81 62.14 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.596 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.51 -44.88 89.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.867 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -59.43 -37.99 79.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.992 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -58.81 -44.49 90.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.381 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 87.8 m -61.09 -44.2 97.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.291 -0.563 . . . . 0.0 110.327 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.3 m -64.35 -40.63 96.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.967 0.413 . . . . 0.0 111.048 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.443 ' O ' ' OD2' ' A' ' 25' ' ' ASP . 55.3 mt -61.78 -39.63 92.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.137 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.9 p -70.04 -30.67 68.01 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.654 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 tt 52.19 70.72 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.418 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.89 105.12 3.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.624 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.8 m -140.1 131.52 26.87 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.161 0.505 . . . . 0.0 110.627 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.49 141.05 58.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.281 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.07 -4.49 86.28 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -143.56 125.92 15.69 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.873 0.368 . . . . 0.0 110.168 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 35.4 mp0 -70.57 149.86 95.49 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.937 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.53 157.41 61.94 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.298 1.999 . . . . 0.0 111.697 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 15' ' ' LEU . 44.6 p-10 -80.99 -172.96 4.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.117 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 pt -128.62 90.32 46.73 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.464 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.63 155.81 27.76 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.385 2.057 . . . . 0.0 111.913 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.831 ' N ' HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -138.47 147.78 43.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.011 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -129.47 110.47 11.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.188 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -151.0 133.74 15.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.436 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.427 ' H ' HG22 ' A' ' 31' ' ' THR . 0.1 OUTLIER -59.88 148.12 36.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.378 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.1 mt -88.01 -46.47 9.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.691 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -161.69 163.68 29.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.091 0.472 . . . . 0.0 110.306 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.2 m -105.59 124.4 49.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.504 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.4 t -106.49 140.48 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.951 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.5 73.95 0.35 Allowed Glycine 0 CA--C 1.532 1.131 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.27 -12.8 21.0 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.316 2.011 . . . . 0.0 112.155 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.6 p -155.72 -177.14 6.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.697 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -51.27 -30.53 18.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.467 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.45 135.54 33.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.434 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -82.5 145.86 29.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.185 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.3 p -128.9 148.83 50.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.03 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -116.32 142.39 46.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.411 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.3 m -117.32 128.93 55.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.028 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.22 152.36 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.488 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.51 139.71 33.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.123 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.5 t -86.71 130.22 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.011 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -107.68 134.63 50.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 0.0 110.496 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -144.5 129.73 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.375 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.6 tptp 56.02 19.89 3.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.526 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.09 12.55 73.59 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -135.17 131.08 36.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.937 0.399 . . . . 0.0 110.036 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' NH2' ' SG ' ' A' ' 56' ' ' CYS . 42.6 mtm105 -66.83 140.37 57.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.283 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.1 pt -117.93 -14.67 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.228 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.83 140.41 6.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.401 ' SG ' ' NH2' ' A' ' 53' ' ' ARG . 54.5 m -146.43 133.45 20.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.736 0.303 . . . . 0.0 110.277 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.03 170.58 33.79 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.11 162.96 35.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.115 0.483 . . . . 0.0 110.509 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.08 -169.2 42.33 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.2 -30.0 59.32 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.952 2.434 . . . . 0.0 112.117 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.1 p -156.44 164.08 38.68 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.38 0.61 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -61.78 -24.77 67.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.813 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -55.86 -57.76 10.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.968 0.413 . . . . 0.0 110.58 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -64.04 -39.44 94.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.59 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.15 97.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.635 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -60.64 -42.18 96.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.989 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.8 ttp -59.3 -49.2 78.74 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.28 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.64 -44.18 64.63 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.502 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.09 85.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.724 0.297 . . . . 0.0 111.187 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.05 -44.24 96.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.094 0.473 . . . . 0.0 110.456 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.5 ttt -62.48 -38.14 88.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.928 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -59.83 -46.22 89.94 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.414 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.63 -41.24 96.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 110.577 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.79 -45.59 91.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.442 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -64.1 -39.92 95.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.495 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -75.72 -20.19 58.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.728 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.9 t80 58.26 96.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.564 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 53.4 p-10 -80.05 147.47 31.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.643 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.0 t80 . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.496 -179.623 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo . . . . . 0 N--CA 1.488 1.16 0 CA-C-O 120.986 0.328 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.7 mp -64.11 -9.78 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 86.5 p -55.76 -27.57 51.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.325 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -63.01 -51.97 64.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.01 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.21 -37.45 87.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.936 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.474 ' O ' HD13 ' A' ' 15' ' ' LEU . 65.0 tt0 -57.17 -47.18 81.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.4 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -62.2 -45.27 94.13 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.571 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 17' ' ' LEU . 51.1 t -63.08 -46.97 84.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.39 -47.46 85.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.407 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 11' ' ' GLN . 8.9 mp -61.95 -45.9 91.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.439 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.8 p -75.41 -32.16 60.65 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.642 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 13' ' ' CYS . 30.2 tp 38.39 67.68 0.39 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.598 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -68.35 129.29 39.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.6 m -139.96 135.78 33.13 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.14 132.65 48.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.279 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.14 -10.14 75.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -137.16 123.16 20.24 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.002 0.43 . . . . 0.0 110.307 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.4 149.2 93.78 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.9 145.56 74.84 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.067 1.845 . . . . 0.0 111.902 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.504 ' OD2' ' CD1' ' A' ' 49' ' ' PHE . 43.3 p-10 -82.93 -170.25 2.92 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.237 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.77 91.06 37.9 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -81.58 145.62 14.75 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.432 2.088 . . . . 0.0 111.992 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.41 148.98 43.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.632 ' CD1' ' NZ ' ' A' ' 62' ' ' LYS . 42.5 p90 -95.63 131.39 41.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.341 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -143.45 151.29 40.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.406 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.9 p -72.19 123.81 23.7 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -87.84 -52.72 5.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -160.93 150.4 17.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.579 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -106.47 133.89 50.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -136.89 156.62 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.049 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.65 60.4 0.42 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.7 -25.75 33.65 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.472 2.114 . . . . 0.0 112.146 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.0 p -105.85 -176.18 3.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.442 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.526 ' O ' ' NH2' ' A' ' 41' ' ' ARG . 86.5 t60 -59.38 -47.73 84.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.169 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.51 145.22 28.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.594 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 39' ' ' HIS . 12.3 mpt_? -79.77 146.22 32.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.194 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 73.5 p -130.93 150.37 52.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.282 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.96 146.97 35.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.258 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.4 m -115.53 125.41 52.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.983 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.92 151.39 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.096 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.29 124.13 10.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.628 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 47' ' ' VAL . 4.8 m -87.91 151.28 3.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.895 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -128.65 154.28 46.43 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.106 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 66.0 t80 -144.67 120.46 10.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.035 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 tptp 71.2 21.87 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.35 18.34 62.64 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -137.86 143.32 40.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.819 0.343 . . . . 0.0 110.368 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -61.59 127.53 31.9 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 19.1 tt -110.34 -20.3 6.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.739 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.75 148.82 16.06 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.3 t -150.19 128.13 11.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.928 0.394 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.6 161.86 30.81 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -148.42 159.55 43.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 110.733 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.61 -172.82 45.51 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.82 -27.66 72.91 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.885 2.39 . . . . 0.0 112.106 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.4 t -155.26 155.64 34.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.531 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.632 ' NZ ' ' CD1' ' A' ' 29' ' ' TYR . 39.0 ttpt -59.75 -42.72 93.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.552 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -57.12 -39.06 74.36 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.468 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.482 ' NE2' ' CE ' ' A' ' 67' ' ' MET . 72.9 tp60 -74.33 -43.7 55.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.119 0.485 . . . . 0.0 110.911 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.25 62.9 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.945 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CG ' ' N ' ' A' ' 67' ' ' MET . 21.0 pttm -55.13 -42.93 73.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.267 -178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.491 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 78.5 mtm -60.62 -43.42 97.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.442 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.46 -47.45 62.77 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.414 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.38 83.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.117 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.34 74.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.051 0.453 . . . . 0.0 111.202 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.4 ttt -60.54 -36.46 78.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.9 -41.34 95.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 54' ' ' ILE . . . -60.34 -45.51 93.2 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.225 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.8 -43.64 98.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.388 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.3 -40.84 96.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.573 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -75.74 -31.32 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.629 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 13.4 t80 41.96 69.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.406 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 54' ' ' ILE . 94.1 m-20 -78.42 136.17 37.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.849 -179.373 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 CA-C-O 121.228 0.428 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.533 HD13 ' O ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -63.45 -27.81 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.33 -179.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 t -49.62 -26.79 3.91 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -60.34 -48.15 82.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.176 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -63.61 -51.4 65.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.143 0.496 . . . . 0.0 110.692 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -59.99 -40.15 88.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.914 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.8 -42.02 98.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.427 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.51 -46.89 88.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.485 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.4 m -61.07 -41.34 96.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -63.38 -39.86 95.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.579 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 m -78.39 -15.74 58.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.163 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.4 tp -75.49 120.04 20.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.086 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -64.77 132.0 48.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.691 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.425 HG21 ' HZ1' ' A' ' 50' ' ' LYS . 89.4 m -98.62 125.24 43.83 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.323 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.93 132.62 46.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.479 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.65 -8.19 80.33 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.77 143.45 38.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.0 0.428 . . . . 0.0 110.704 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -69.96 151.1 96.27 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.713 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -45.53 163.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.575 2.183 . . . . 0.0 111.805 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -145.86 161.39 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.201 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.1 pt -135.72 149.88 70.26 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.541 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.45 146.55 62.47 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.502 2.135 . . . . 0.0 111.821 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.31 110.52 6.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.26 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -94.18 106.05 18.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.261 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -131.74 135.42 46.8 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.429 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.2 t -123.4 142.34 51.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.494 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.46 26.39 1.3 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.283 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -159.15 147.34 17.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 t -133.2 146.94 51.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.135 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 36' ' ' GLY . 82.0 t -127.92 153.24 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.614 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.446 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 77.47 53.22 5.18 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' OG ' ' A' ' 38' ' ' SER . 56.2 Cg_endo -70.19 157.18 60.37 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.773 2.315 . . . . 0.0 111.832 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 39' ' ' HIS . 4.1 p 73.31 -60.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.501 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.51 ' N ' ' OG ' ' A' ' 38' ' ' SER . 45.2 m170 -81.13 -115.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.327 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.79 108.05 18.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.308 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -78.82 128.56 33.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.375 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 52.4 p -129.12 150.27 50.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.172 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.71 146.49 33.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.311 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.5 p -104.3 142.27 34.84 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.892 0.377 . . . . 0.0 110.159 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.38 142.01 34.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.04 119.93 15.35 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.149 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.5 t -86.93 140.63 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.328 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.13 148.33 35.54 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.926 0.393 . . . . 0.0 110.198 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.609 ' O ' ' N ' ' A' ' 52' ' ' GLU . 29.3 t80 -143.12 114.39 7.87 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.031 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.477 ' HZ2' ' CB ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER 38.22 37.84 0.18 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.557 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.88 22.63 52.41 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.621 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' A' ' 49' ' ' PHE . 80.2 mm-40 -138.12 128.26 25.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.888 0.375 . . . . 0.0 110.483 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -69.95 131.83 45.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.22 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.4 pt -128.88 10.04 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 0.0 110.805 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.34 136.68 4.3 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.474 ' N ' ' HB1' ' A' ' 69' ' ' ALA . 50.9 t -161.15 112.62 1.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.2 175.61 35.34 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -143.37 157.23 44.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 110.519 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.86 -173.94 46.43 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.56 -16.13 52.48 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.519 2.146 . . . . 0.0 111.398 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.5 m -147.77 140.32 24.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.006 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -74.37 -33.83 63.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.552 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.495 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 59.0 mtpt -60.76 -49.92 75.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.555 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -66.78 -38.99 87.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.655 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.0 66.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.908 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 5.2 ptpp? -55.12 -42.77 73.41 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.398 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.48 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 65.7 mtt -60.4 -48.75 80.4 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.792 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.07 -39.36 63.16 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.63 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' HB1' ' N ' ' A' ' 56' ' ' CYS . . . -60.18 -48.65 80.82 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.914 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.87 -48.62 79.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.82 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 66.5 ttp -61.1 -44.42 97.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.812 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -61.34 -51.52 68.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.65 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.54 94.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.983 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.53 -44.12 97.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.035 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.78 -47.03 76.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.243 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -80.13 -15.54 56.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.997 0.427 . . . . 0.0 111.077 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -158.04 91.71 1.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.546 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 26.6 p30 -97.35 145.09 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.403 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.348 179.255 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.13 -20.42 43.82 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.702 2.268 . . . . 0.0 111.981 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.78 -178.56 51.25 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -88.22 75.22 8.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.821 0.343 . . . . 0.0 110.638 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 31.4 p-10 -140.53 70.38 31.9 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.413 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.06 140.49 92.77 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.6 2.2 . . . . 0.0 111.987 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.5 mt -69.75 -12.45 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.368 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 96.2 p -59.61 -24.32 63.72 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.686 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -63.25 -51.6 65.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.824 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.24 -48.93 66.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.089 0.471 . . . . 0.0 110.943 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.403 ' O ' HD13 ' A' ' 15' ' ' LEU . 90.2 mm-40 -58.92 -20.5 52.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.676 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -56.8 -44.4 81.9 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.193 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.3 m -65.07 -39.73 93.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 110.521 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.45 ' SG ' ' CG ' ' A' ' 78' ' ' ASN . 51.8 t -59.9 -40.73 89.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.906 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 11' ' ' GLN . 6.3 mp -50.08 -47.63 53.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.176 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.4 m -71.4 -38.45 71.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.162 0.506 . . . . 0.0 110.431 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 17' ' ' LEU . 0.2 OUTLIER 48.33 75.13 0.15 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.844 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -75.85 105.44 6.89 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.268 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.1 m -139.44 133.65 31.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.92 0.39 . . . . 0.0 110.94 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -69.11 136.65 52.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.319 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.46 -8.74 76.09 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -89.28 138.19 31.65 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.926 0.393 . . . . 0.0 110.567 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -64.93 148.85 97.31 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.18 149.03 70.11 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.451 2.101 . . . . 0.0 112.105 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 26' ' ' ILE . 48.4 t0 -159.08 151.41 21.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.088 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 26' ' ' ILE . 17.3 tt -135.1 89.07 24.78 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.735 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.2 148.29 14.89 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.509 2.139 . . . . 0.0 111.695 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.2 tp -138.21 133.73 33.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.129 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.509 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 41.4 p90 -93.61 123.75 37.15 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -149.9 151.59 33.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.231 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.6 p -51.9 129.67 27.4 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 tp -87.68 -52.91 5.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.066 0.46 . . . . 0.0 110.408 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -162.43 155.52 20.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.539 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.404 HG22 ' CD2' ' A' ' 43' ' ' TYR . 73.0 p -109.31 146.81 33.71 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.2 m -138.72 165.04 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.513 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.6 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 71.38 39.48 61.61 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 36' ' ' GLY . 41.3 Cg_endo -66.47 -20.22 54.42 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.681 2.254 . . . . 0.0 111.902 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -59.66 -44.59 93.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.897 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -119.16 -108.42 0.36 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.343 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.99 131.11 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.161 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -77.96 135.87 37.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.219 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.2 p -124.38 147.67 48.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.995 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.404 ' CD2' HG22 ' A' ' 34' ' ' THR . 96.4 m-85 -113.32 131.79 55.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.649 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.7 m -113.68 126.22 55.01 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.541 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.11 148.1 33.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.39 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.19 122.91 14.28 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.241 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.33 128.69 39.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -112.8 141.27 46.8 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.488 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -144.8 130.27 18.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.559 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 mttm 59.08 17.74 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.595 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.39 13.04 62.19 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -133.53 144.05 49.13 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.811 0.338 . . . . 0.0 110.32 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -65.39 126.19 27.46 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.8 tt -104.73 -27.64 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.198 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.37 148.08 13.86 Favored Glycine 0 N--CA 1.464 0.548 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.1 t -154.15 140.27 18.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.91 0.386 . . . . 0.0 110.628 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.62 171.95 31.76 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -144.83 153.12 41.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.921 0.391 . . . . 0.0 110.49 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.93 174.22 46.9 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 -7.44 21.24 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 123.014 2.476 . . . . 0.0 112.154 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.8 p -150.06 156.57 41.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.182 0.515 . . . . 0.0 110.632 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.78 -40.72 98.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.603 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.02 -45.49 90.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.398 0.618 . . . . 0.0 110.369 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -71.01 -41.02 71.45 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.706 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.42 94.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.603 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 67' ' ' MET . 4.7 ptmm? -64.18 -39.76 94.67 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.527 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.428 ' SD ' ' C ' ' A' ' 67' ' ' MET . 19.4 tmm? -59.5 -44.65 93.06 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.848 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.31 -40.66 94.74 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.52 -45.44 94.2 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.705 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.81 99.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.205 0.526 . . . . 0.0 110.463 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.9 ttt -62.34 -37.75 86.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.548 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -59.42 -45.17 92.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 109.988 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.6 95.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.197 0.522 . . . . 0.0 109.947 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.8 tt -59.88 -45.07 93.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.471 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.27 -39.38 93.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.619 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -77.67 -10.34 59.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 20.4 t80 67.98 133.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.378 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.45 ' CG ' ' SG ' ' A' ' 14' ' ' CYS . 32.7 m120 -79.15 144.69 34.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.427 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.8 t80 42.33 67.56 3.31 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.751 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -58.16 140.69 95.13 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.792 2.328 . . . . 0.0 112.055 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -161.82 127.27 3.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.166 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.377 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -56.69 138.28 84.48 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.553 2.169 . . . . 0.0 111.903 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.44 6.48 80.71 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -140.66 117.01 10.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.801 0.334 . . . . 0.0 110.511 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -139.91 147.53 51.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.584 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.15 139.94 33.38 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.695 2.263 . . . . 0.0 112.259 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.715 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.6 mp -67.79 -19.74 25.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.272 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 t -48.42 -33.11 8.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.99 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -60.87 -44.51 96.94 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.647 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 10' ' ' LEU . 1.1 tt -73.75 -39.22 64.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.412 0.625 . . . . 0.0 110.28 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -56.66 -25.28 53.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.506 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -53.15 -36.95 61.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.479 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.18 -47.91 83.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.019 0.438 . . . . 0.0 110.598 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.8 t -60.75 -41.59 95.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.011 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.62 -42.61 99.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.287 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.7 t -83.62 -5.68 59.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.664 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 17' ' ' LEU . 2.5 tt -74.81 96.45 3.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.754 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -71.08 150.51 45.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.321 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.425 HG21 ' HD2' ' A' ' 22' ' ' LYS . 62.6 m -94.92 120.38 35.04 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.482 0.658 . . . . 0.0 110.942 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -68.9 139.34 55.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.323 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.65 2.23 84.82 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HD2' HG21 ' A' ' 19' ' ' THR . 99.4 mttt -137.17 155.38 49.63 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.501 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -64.48 149.28 95.41 Favored Pre-proline 0 N--CA 1.451 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.387 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -65.37 163.46 29.45 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.805 2.336 . . . . 0.0 111.768 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.36 166.7 29.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 26' ' ' ILE . 16.0 tt -128.61 91.74 42.61 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 121.069 0.461 . . . . 0.0 110.344 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.67 133.69 14.4 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.479 2.12 . . . . 0.0 111.727 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.7 tp -138.45 145.59 41.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.218 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -88.79 136.06 33.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.466 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.7 145.9 37.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.347 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.62 110.63 22.87 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.908 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 47.2 mt -106.64 -38.2 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.33 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -85.51 141.98 29.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.359 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 t -121.85 146.3 47.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.155 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 36' ' ' GLY . 84.4 t -137.08 159.64 36.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.568 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.544 ' N ' HG12 ' A' ' 35' ' ' VAL . . . 74.76 88.34 0.22 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 36' ' ' GLY . 52.0 Cg_exo -52.97 -137.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.037 2.491 . . . . 0.0 112.585 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 39' ' ' HIS . 46.3 t -59.52 -39.52 84.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.439 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' SER . 77.9 m80 -47.29 -109.83 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.08 0.467 . . . . 0.0 110.867 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.27 136.64 32.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.549 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -86.41 116.72 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.49 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.45 ' HG1' ' C ' ' A' ' 35' ' ' VAL . 58.7 p -133.66 150.32 51.56 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.516 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -135.13 151.04 50.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.365 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.6 m -112.07 129.4 56.23 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.225 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.3 t -106.09 122.27 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.201 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.14 119.89 40.61 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.337 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.71 126.23 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.951 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.63 133.95 48.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.869 0.366 . . . . 0.0 110.241 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -144.52 118.51 9.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.162 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.13 18.95 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.96 12.62 73.8 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -136.59 149.56 48.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.811 0.339 . . . . 0.0 110.383 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtm-85 -67.02 139.05 57.63 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.204 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.3 tt -124.62 -21.3 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.507 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.62 150.55 18.28 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 42.1 t -152.53 138.97 18.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.438 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.76 161.98 29.49 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -145.84 157.87 43.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.867 0.365 . . . . 0.0 110.789 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.58 178.58 44.58 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.8 -7.65 21.59 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.826 2.351 . . . . 0.0 111.988 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.0 t -151.61 160.15 43.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.372 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -62.16 -37.89 86.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.58 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.24 -46.89 82.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.559 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -64.26 -42.97 96.23 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.752 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.43 -42.98 95.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.778 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -61.54 -39.67 91.88 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.716 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 59.5 ttm -58.38 -50.12 74.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.324 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.86 -44.0 48.43 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.275 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.73 -49.1 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.736 0.303 . . . . 0.0 111.173 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.98 -46.74 87.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 ttt -62.1 -37.87 86.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.579 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -57.6 -46.93 83.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.21 -40.78 98.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.067 0.46 . . . . 0.0 110.42 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 tt -59.63 -43.91 93.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.698 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -62.39 -39.63 93.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.917 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 77' ' ' TYR . 63.1 tttp -70.74 -28.31 64.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.331 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 5.9 t80 83.06 161.13 0.13 Allowed 'General case' 0 C--N 1.334 -0.107 0 O-C-N 123.433 0.458 . . . . 0.0 110.267 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -91.62 111.75 23.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.997 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 79' ' ' PHE . 54.8 t80 40.91 58.32 8.39 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.735 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -62.38 -38.84 50.55 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.486 2.124 . . . . 0.0 111.992 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 38.79 49.65 1.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.768 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 97.6 mtp . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.896 -1.049 . . . . 0.0 110.437 -179.678 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.39 146.63 89.23 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.918 2.412 . . . . 0.0 111.942 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.13 112.43 4.04 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 5' ' ' ASP . 99.2 m-20 -63.16 -39.62 95.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.149 -0.221 . . . . 0.0 110.773 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 4' ' ' ASN . 63.4 t0 -35.84 99.12 0.17 Allowed Pre-proline 0 CA--C 1.533 0.296 0 O-C-N 123.498 0.499 . . . . 0.0 110.665 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.39 135.61 61.12 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.514 2.143 . . . . 0.0 112.634 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.2 mp -71.3 -11.31 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.313 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.6 p -52.66 -24.6 8.8 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -61.81 -51.73 67.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.854 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.6 mt -64.41 -45.13 88.9 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 110.545 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -60.5 -42.46 96.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.374 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.22 -40.03 88.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.485 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 90.8 m -60.9 -40.86 94.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.349 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.48 -50.09 75.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.525 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.38 -38.38 90.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.997 0.427 . . . . 0.0 110.315 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -70.61 -24.49 62.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.426 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 tt -72.36 120.83 18.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.055 0.455 . . . . 0.0 110.495 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -68.26 144.35 54.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.727 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 22' ' ' LYS . 96.6 m -98.92 127.93 44.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.02 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -67.84 125.87 27.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.48 -10.19 75.36 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 19' ' ' THR . 42.8 mmtm -137.55 144.7 42.22 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.058 0.456 . . . . 0.0 111.021 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -70.46 151.1 95.67 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.602 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.05 139.29 55.51 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.386 2.057 . . . . 0.0 111.825 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.72 158.33 22.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.441 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.4 mt -91.42 117.9 68.1 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.671 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.81 130.42 13.46 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.312 2.008 . . . . 0.0 112.135 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -140.73 137.41 33.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.54 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 25.3 p90 -111.76 106.18 14.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.06 0.457 . . . . 0.0 110.431 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -136.66 151.56 49.43 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.3 p -107.01 147.96 29.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.202 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.94 -84.08 0.42 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.41 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -83.92 144.11 29.41 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.663 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.2 p -132.34 129.01 38.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.897 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG23 ' OG1' ' A' ' 42' ' ' THR . 32.1 m -138.23 159.91 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.148 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.64 64.27 0.42 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' SER . 71.0 Cg_endo -73.94 157.09 47.55 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.864 2.376 . . . . 0.0 111.72 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.1 m 75.99 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.447 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -174.2 -36.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.599 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.83 136.63 36.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.586 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' A' ' 41' ' ' ARG . 1.5 mpt_? -80.73 139.2 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.914 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.426 ' OG1' HG23 ' A' ' 35' ' ' VAL . 80.7 p -131.38 150.58 52.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -132.85 149.38 52.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.387 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.1 m -109.82 128.92 55.63 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.162 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.82 149.6 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.711 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.75 126.74 13.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.311 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.0 t -87.45 131.39 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.414 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -104.04 138.36 40.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.191 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -144.12 123.89 13.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 54.79 29.53 12.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.22 8.54 87.13 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -132.4 135.7 46.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.876 0.369 . . . . 0.0 110.396 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -69.84 145.94 51.7 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.192 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.3 pt -114.12 -22.06 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.586 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.94 154.8 24.1 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.2 p -155.21 139.67 16.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.731 0.301 . . . . 0.0 110.495 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.63 174.67 35.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.542 ' N ' ' CD ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -146.24 162.81 37.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.523 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.89 -176.09 47.07 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.91 -29.96 83.97 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 123.005 2.47 . . . . 0.0 112.449 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -136.53 154.4 50.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 110.654 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -63.52 -41.66 98.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.509 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -60.92 -43.09 99.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.551 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -66.05 -38.31 88.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.531 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.44 -34.79 76.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.148 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 70' ' ' ALA . 97.4 mttt -56.65 -31.04 63.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.519 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 68.6 mtm -59.06 -46.23 88.77 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.327 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.88 -50.61 23.12 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.309 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.5 83.87 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.982 0.42 . . . . 0.0 111.072 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 66' ' ' LYS . . . -61.94 -44.04 97.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.719 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 66.1 ttp -61.29 -38.94 88.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.811 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.96 -43.68 91.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.423 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.457 ' HB1' HD21 ' A' ' 78' ' ' ASN . . . -61.18 -45.43 94.64 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.539 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.5 -42.87 99.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.309 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.64 -39.69 95.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.445 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 77' ' ' TYR . 27.2 mtpp -79.89 -7.37 58.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.711 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' LYS . 97.9 m-85 57.4 113.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.626 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.457 HD21 ' HB1' ' A' ' 73' ' ' ALA . 32.2 m120 -80.28 146.0 31.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.659 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.414 ' N ' ' CD ' ' A' ' 80' ' ' PRO . 37.7 t80 45.63 56.14 15.3 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.529 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 79' ' ' PHE . 38.1 Cg_endo -68.29 151.73 76.27 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.627 2.218 . . . . 0.0 112.107 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -161.16 160.99 30.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.562 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 79.4 mtm . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.456 -179.796 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.14 -33.76 85.18 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.993 2.462 . . . . 0.0 111.789 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.77 61.09 2.5 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.91 -38.76 89.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.798 0.332 . . . . 0.0 110.703 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -130.5 81.52 67.67 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.32 -176.82 3.12 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.632 2.221 . . . . 0.0 112.311 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.622 HD13 ' SD ' ' A' ' 67' ' ' MET . 4.9 tp -64.82 -15.64 18.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.101 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 t -47.99 -18.86 0.21 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.65 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' A' ' 7' ' ' ILE . 61.8 tt0 -61.39 -57.14 13.47 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.19 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 74' ' ' LEU . 85.1 mt -64.66 -41.36 96.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.358 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.592 ' O ' HD13 ' A' ' 15' ' ' LEU . 10.6 tp-100 -61.38 -54.35 44.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -65.43 -43.22 91.19 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.166 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t -61.96 -49.07 77.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.482 ' SG ' ' OD1' ' A' ' 78' ' ' ASN . 47.6 t -61.1 -45.09 96.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.695 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.592 HD13 ' O ' ' A' ' 11' ' ' GLN . 7.1 mp -61.78 -40.1 94.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.378 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 96.4 m -69.64 -38.31 77.12 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.346 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.2 tp 42.76 78.77 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.251 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -69.78 116.83 10.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.412 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.2 m -139.31 124.22 18.71 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.406 0.622 . . . . 0.0 110.695 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -67.3 142.98 56.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.45 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.09 -5.0 85.97 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.3 134.71 48.97 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 110.076 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 46.1 mp0 -70.34 151.58 95.72 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.03 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -51.25 141.43 39.55 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.059 1.839 . . . . 0.0 112.016 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -81.54 -174.54 5.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.242 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 pt -116.78 91.7 35.92 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.56 139.09 66.78 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.453 2.102 . . . . 0.0 111.588 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 tp -133.94 124.91 27.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.301 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.553 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 46.0 p90 -131.23 113.2 13.55 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.247 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -152.69 138.84 18.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.598 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.8 p -75.04 153.18 38.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.298 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.87 -65.67 0.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.411 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.568 ' NE2' ' O ' ' A' ' 34' ' ' THR . 17.9 tm0? -162.55 144.36 10.55 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.155 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.568 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 97.0 m -98.71 130.96 45.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.394 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.06 158.31 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.221 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 38' ' ' SER . . . -148.58 79.79 0.21 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.538 ' O ' ' CD2' ' A' ' 39' ' ' HIS . 52.4 Cg_exo -52.33 73.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.834 2.356 . . . . 0.0 112.276 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 36' ' ' GLY . 49.2 m 46.16 31.82 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.489 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 37' ' ' PRO . 85.5 m-70 -148.7 -131.54 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.589 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.03 149.28 28.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.504 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -71.0 142.54 50.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.052 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.1 m -126.99 130.59 50.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.145 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.93 140.03 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.204 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -125.8 131.06 52.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.926 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.0 142.76 36.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.283 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.38 125.54 14.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.363 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.31 138.1 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.342 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.83 113.37 24.13 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.956 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CZ ' ' NZ ' ' A' ' 50' ' ' LYS . 66.2 t80 -101.4 115.05 29.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.311 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' NZ ' ' CZ ' ' A' ' 49' ' ' PHE . 61.6 mttp 52.39 37.74 23.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.823 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.83 25.11 70.32 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -137.57 136.32 37.47 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.019 0.438 . . . . 0.0 110.343 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' A' ' 72' ' ' ASP . 76.0 ttt-85 -62.46 126.66 28.1 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.479 ' CD1' HD21 ' A' ' 78' ' ' ASN . 15.9 tt -111.35 -35.69 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.702 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.9 148.5 10.94 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 31.3 p -155.19 156.0 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.2 162.19 31.67 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -149.54 156.17 41.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 110.603 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.38 177.68 44.63 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.07 -6.78 19.97 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.074 2.516 . . . . 0.0 112.192 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 t -147.91 152.37 37.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.122 0.486 . . . . 0.0 110.415 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -60.83 -36.18 78.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.451 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -58.95 -42.96 91.07 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.683 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -66.24 -39.93 89.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.404 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.17 99.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.598 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.7 -40.41 94.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.453 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.622 ' SD ' HD13 ' A' ' 7' ' ' ILE . 60.9 tpp -60.32 -49.1 78.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.492 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.27 -41.45 79.0 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.54 72.7 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.288 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 11' ' ' GLN . . . -64.36 -46.79 81.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.273 0.558 . . . . 0.0 110.943 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.1 ttp -62.23 -38.3 88.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.619 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 53' ' ' ARG . 7.8 t0 -58.56 -49.96 75.54 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.302 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB1' ' SG ' ' A' ' 14' ' ' CYS . . . -63.46 -41.19 98.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.016 0.436 . . . . 0.0 110.515 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 10' ' ' LEU . 50.9 tp -59.36 -46.44 88.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.579 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.91 -41.28 97.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.443 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -71.14 -34.19 70.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.514 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 61.99 130.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.57 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.482 ' OD1' ' SG ' ' A' ' 14' ' ' CYS . 30.3 m120 -83.78 140.03 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.513 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -159.03 70.71 3.52 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.246 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.43 -41.81 72.33 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.728 2.285 . . . . 0.0 111.965 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 45.92 35.48 2.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.482 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 C--O 1.219 -0.552 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.595 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.77 -32.26 90.86 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.847 2.364 . . . . 0.0 111.888 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.55 -131.05 51.86 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 51.27 46.27 26.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 110.28 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.68 147.43 95.77 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.867 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.81 156.37 63.4 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.648 2.232 . . . . 0.0 111.991 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.8 mp -67.74 -12.2 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.728 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.7 p -59.25 -23.63 62.51 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.64 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -64.31 -55.5 20.86 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.167 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.1 tp -64.28 -47.57 79.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.403 0.62 . . . . 0.0 110.977 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -58.76 -24.13 61.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.32 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -56.26 -45.95 79.86 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.16 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 94.3 m -65.27 -42.48 93.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.104 0.478 . . . . 0.0 110.439 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.8 t -61.63 -42.77 99.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.769 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.9 -40.73 94.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.564 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 17' ' ' LEU . 46.6 p -72.67 -31.51 65.12 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.829 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 16' ' ' THR . 1.3 tt 34.6 71.48 0.11 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.278 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -70.42 119.33 14.43 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.23 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.3 m -139.13 121.66 16.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.525 0.678 . . . . 0.0 110.837 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.19 142.85 54.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.375 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.38 2.37 89.09 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -141.88 126.89 18.35 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.029 0.442 . . . . 0.0 110.04 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.28 120.46 76.99 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.784 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.03 143.48 32.64 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.152 1.901 . . . . 0.0 112.112 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -82.99 176.93 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.041 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.47 88.93 25.54 Favored Pre-proline 0 C--O 1.232 0.168 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.83 130.31 6.64 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.79 2.327 . . . . 0.0 111.79 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 28' ' ' LEU . 20.5 tp -140.48 142.5 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.433 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -90.78 135.07 33.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.862 0.363 . . . . 0.0 110.298 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -146.35 142.84 28.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.836 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.505 HG21 ' HZ2' ' A' ' 62' ' ' LYS . 67.5 p -73.0 149.72 43.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.468 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.7 mt -104.59 -58.41 1.89 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.534 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -162.28 165.12 27.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.586 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.4 p -90.48 146.73 23.89 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.112 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.558 HG22 ' N ' ' A' ' 36' ' ' GLY . 14.9 p -143.48 162.52 16.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.762 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.558 ' N ' HG22 ' A' ' 35' ' ' VAL . . . 73.76 60.68 3.58 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.48 -24.73 78.81 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.6 2.2 . . . . 0.0 112.004 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.5 m -64.47 144.51 57.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.5 m80 48.43 -123.87 1.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.362 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.7 138.55 33.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.311 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -77.88 153.95 32.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.235 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.4 p -127.61 149.45 50.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.996 0.427 . . . . 0.0 110.025 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -104.63 140.13 38.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.145 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -96.66 132.66 42.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.244 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.0 t -132.18 132.17 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.79 118.97 16.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.108 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.8 t -88.49 136.5 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.136 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -115.8 147.66 40.74 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.091 0.472 . . . . 0.0 110.008 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -144.43 114.78 7.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.231 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.7 tttp 67.73 20.15 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.55 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.54 13.86 59.22 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -133.78 145.6 49.93 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.755 0.312 . . . . 0.0 110.222 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.65 126.0 27.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.004 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.0 tt -105.54 -26.39 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.811 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -166.41 155.58 26.89 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.6 t -154.97 139.68 17.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.686 0.279 . . . . 0.0 110.457 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.99 166.78 32.09 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -148.85 162.28 40.15 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.023 0.44 . . . . 0.0 110.655 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.66 177.36 46.42 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.144 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.53 -33.01 97.72 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.856 2.371 . . . . 0.0 112.477 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.5 m -120.42 153.54 36.42 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.096 0.474 . . . . 0.0 110.605 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.505 ' HZ2' HG21 ' A' ' 31' ' ' THR . 68.1 mttm -62.4 -40.54 96.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.704 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -60.75 -36.91 80.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -67.78 -41.89 82.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.452 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.85 97.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.283 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -62.28 -42.41 99.32 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.27 0.557 . . . . 0.0 109.782 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 67' ' ' MET . 18.7 tmm? -61.31 -42.54 98.83 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.046 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.45 -41.28 98.07 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.19 99.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 0.0 110.508 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.57 96.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.111 0.481 . . . . 0.0 110.583 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.2 ttt -61.69 -38.89 89.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.639 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.45 ' OD1' ' NZ ' ' A' ' 76' ' ' LYS . 67.9 t0 -59.54 -46.56 88.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.166 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 77' ' ' TYR . . . -62.73 -41.67 99.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.972 0.415 . . . . 0.0 110.416 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 74' ' ' LEU . 6.5 tt -60.89 -48.31 82.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.492 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -62.86 -44.9 94.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.835 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 72' ' ' ASP . 62.4 mttp -76.61 -23.15 53.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.026 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 73' ' ' ALA . 35.2 t80 41.87 90.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.469 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.43 116.26 21.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.046 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -72.85 149.51 90.21 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.167 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.78 -17.13 58.63 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.686 2.257 . . . . 0.0 112.216 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -155.99 156.51 34.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.306 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.2 tpt . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.547 -179.659 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.42 149.61 62.91 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.63 2.22 . . . . 0.0 112.005 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 4' ' ' ASN . . . 160.55 -77.31 0.18 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 3' ' ' GLY . 65.9 t30 50.8 177.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.33 . . . . 0.0 110.45 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -91.51 147.97 36.45 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.798 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.28 162.98 40.33 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.592 2.194 . . . . 0.0 111.875 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.56 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.8 mp -66.58 -21.33 28.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.875 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.7 p -56.08 -31.84 63.58 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.51 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -60.7 -48.79 80.2 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.497 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -65.03 -45.83 83.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.183 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -58.2 -39.99 80.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.222 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -60.13 -40.09 88.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.522 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.8 m -60.75 -40.43 92.44 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.164 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.577 ' SG ' ' CZ ' ' A' ' 79' ' ' PHE . 35.3 t -60.89 -39.38 89.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.082 0.468 . . . . 0.0 110.381 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.67 -41.26 94.7 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.4 p -82.98 -7.23 59.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.904 0.383 . . . . 0.0 110.703 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 tt -76.99 129.19 35.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -66.85 142.16 57.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.732 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' LYS . 85.5 m -91.18 111.24 22.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.225 0.536 . . . . 0.0 110.258 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -67.99 136.92 54.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.766 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.68 -11.81 69.09 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 19' ' ' THR . 56.8 mtmt -144.31 158.73 43.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 110.73 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -67.07 149.12 98.68 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.604 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.22 132.05 26.7 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.125 1.883 . . . . 0.0 111.941 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -93.43 172.36 8.33 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.153 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.5 mm -115.92 90.84 28.99 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.19 130.93 7.47 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 122.649 2.233 . . . . 0.0 112.057 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.1 tp -139.27 126.6 21.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.131 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 53.2 p90 -90.86 128.7 36.83 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.219 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -150.31 134.22 16.84 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.354 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 31' ' ' THR . 0.2 OUTLIER -55.37 134.15 50.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.449 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.2 mt -90.76 -46.11 8.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.696 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -164.02 165.21 22.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.548 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 t -90.63 147.26 23.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.157 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.56 150.61 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.642 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.577 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 70.36 42.08 66.14 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 36' ' ' GLY . 42.8 Cg_endo -65.16 -21.11 62.87 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.596 2.197 . . . . 0.0 111.882 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 95.7 p -63.27 -25.67 68.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.0 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.703 ' CD2' ' H ' ' A' ' 40' ' ' ALA . 25.3 p-80 -135.34 -113.89 0.2 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.663 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.703 ' H ' ' CD2' ' A' ' 39' ' ' HIS . . . -74.1 139.8 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.047 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.7 mmm-85 -81.21 127.19 32.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.502 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.4 p -126.91 149.13 49.94 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -108.25 141.46 39.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.416 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.2 m -105.6 124.07 48.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.78 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.7 t -121.59 128.16 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.388 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.04 123.82 23.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.903 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.416 HG11 HD11 ' A' ' 54' ' ' ILE . 94.2 t -87.48 130.76 36.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.318 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -109.23 140.94 42.2 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.174 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -144.72 130.74 19.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.985 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? 55.25 26.04 8.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.684 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.74 15.35 77.96 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -135.95 138.7 42.59 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 110.312 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.45 135.97 52.53 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.091 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.528 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 44.8 pt -110.54 -21.64 5.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.575 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.85 152.37 21.94 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.7 t -150.24 133.2 16.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.905 0.384 . . . . 0.0 110.599 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.38 166.6 32.75 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -147.16 163.16 37.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.56 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.39 177.13 46.03 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.79 -9.51 23.21 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.906 2.404 . . . . 0.0 111.953 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.4 m -146.91 150.01 34.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.074 0.464 . . . . 0.0 110.495 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -62.01 -39.07 90.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.714 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -59.5 -46.51 88.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.224 0.535 . . . . 0.0 110.424 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -64.95 -40.56 95.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.217 0.532 . . . . 0.0 110.534 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.91 97.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.893 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 67' ' ' MET . 0.0 OUTLIER -60.95 -40.46 93.38 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.402 ' N ' ' HG2' ' A' ' 66' ' ' LYS . 62.1 mtt -59.52 -44.0 93.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.31 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.59 -43.94 74.14 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.073 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.02 98.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.052 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.86 87.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.153 0.501 . . . . 0.0 110.744 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.6 ttp -62.86 -37.39 86.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.509 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -58.83 -49.0 79.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.365 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 54' ' ' ILE . . . -62.69 -40.18 96.31 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.3 -48.86 79.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.621 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -63.73 -41.2 98.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.539 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -82.71 -10.67 58.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.431 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.495 ' N ' ' O ' ' A' ' 73' ' ' ALA . 98.9 m-85 43.53 45.19 5.49 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.331 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.525 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 98.5 m-20 -81.83 118.38 22.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.56 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CZ ' ' SG ' ' A' ' 14' ' ' CYS . 2.0 m-85 -167.24 -62.46 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.046 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 79' ' ' PHE . 37.4 Cg_endo -63.54 151.03 86.94 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.326 2.018 . . . . 0.0 111.835 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' A' ' 81' ' ' GLN . 5.1 pp0? -159.49 14.77 0.15 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.588 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 C--O 1.222 -0.364 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.009 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -53.5 -39.89 80.68 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.759 2.306 . . . . 0.0 111.83 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.68 -41.16 1.65 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -83.07 -1.32 52.47 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.736 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -135.1 151.04 74.58 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.029 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.8 146.2 21.63 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.049 1.833 . . . . 0.0 112.123 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.5 mp -66.44 -18.22 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.852 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.8 t -49.2 -30.57 7.11 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -59.99 -50.66 72.87 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.569 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -67.66 -47.77 68.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.27 0.557 . . . . 0.0 110.094 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -58.73 -39.77 81.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.301 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -64.29 -39.15 93.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.895 0.379 . . . . 0.0 110.486 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.6 m -60.29 -33.57 72.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.64 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.0 m -57.89 -35.93 71.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.48 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 15' ' ' LEU . 10.3 mp -59.4 -22.61 61.68 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.545 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.4 p -81.15 1.35 32.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.814 0.34 . . . . 0.0 110.386 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.1 47.06 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.383 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -70.28 116.92 11.18 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.161 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.4 m -140.29 135.43 32.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.346 0.593 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -65.21 132.93 50.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.063 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.15 4.39 62.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -80.93 156.97 25.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.931 0.396 . . . . 0.0 110.07 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -62.66 149.42 89.04 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.21 164.62 31.57 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.564 2.176 . . . . 0.0 111.895 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 69.41 154.33 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.925 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.61 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.1 pp -138.99 153.74 71.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.592 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.75 134.47 30.27 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.218 1.946 . . . . 0.0 111.685 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.1 tp -139.8 144.45 37.35 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.022 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.539 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 44.4 p90 -89.77 117.71 28.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.302 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -151.57 160.26 43.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.463 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.7 p -84.73 132.92 34.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.125 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 32' ' ' LEU . 11.3 mp -93.15 -39.19 11.17 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.32 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.55 ' O ' HG22 ' A' ' 44' ' ' THR . 36.5 tt0 -159.6 151.95 21.07 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.793 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.4 p -98.01 147.69 24.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.893 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.98 151.56 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.084 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.43 68.09 0.55 Allowed Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.61 -9.23 21.2 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.571 2.18 . . . . 0.0 111.957 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.2 p -146.07 -169.92 3.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -60.11 -42.77 95.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.57 147.35 27.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.541 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.91 151.19 33.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.477 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.3 p -130.44 151.12 51.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.093 0.473 . . . . 0.0 110.341 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -123.89 145.81 48.86 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.264 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 33' ' ' GLN . 7.0 t -111.95 141.15 45.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.812 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.6 152.55 37.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.899 0.381 . . . . 0.0 110.273 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.68 128.09 14.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.713 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.59 127.65 40.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.709 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 48' ' ' TYR . 44.4 p90 -118.6 113.48 21.32 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.247 0.546 . . . . 0.0 110.115 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.644 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 1.4 t80 -102.09 133.2 47.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.937 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? 41.76 27.25 0.06 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.043 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.48 25.57 38.84 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.377 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 49' ' ' PHE . 3.9 tm-20 -136.69 119.56 16.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.952 0.406 . . . . 0.0 110.213 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.425 ' O ' ' OE1' ' A' ' 52' ' ' GLU . 8.3 tmm_? -70.53 128.43 36.09 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.398 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.6 pt -132.09 7.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.6 141.2 6.96 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.32 137.15 14.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.0 110.333 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.65 165.68 33.09 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -149.69 159.59 44.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 110.423 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.12 -178.72 45.86 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.96 -10.8 29.26 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.586 2.191 . . . . 0.0 112.017 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.5 m -147.24 142.95 27.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.027 0.441 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -63.89 -30.69 71.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.639 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -61.42 -45.46 94.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.53 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.6 tm0? -64.42 -42.5 96.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 0.0 110.464 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.93 -32.84 71.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.471 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' CE ' ' CD1' ' A' ' 29' ' ' TYR . 66.8 mttt -59.6 -58.97 6.29 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.812 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.541 ' SD ' ' N ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -57.7 -41.17 81.13 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.404 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.541 ' N ' ' SD ' ' A' ' 67' ' ' MET . . . -69.92 -53.55 14.81 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.178 -1.01 . . . . 0.0 111.65 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.39 97.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.363 . . . . 0.0 111.396 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.0 98.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.497 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 28.3 ttt -60.07 -39.75 87.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.471 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -60.93 -51.09 70.73 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.518 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.53 -44.21 94.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.165 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.5 tp -60.99 -48.48 81.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.503 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -67.9 -37.84 82.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.622 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.76 -36.48 84.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -167.62 110.94 0.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.807 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -87.89 124.05 33.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.699 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.644 ' CZ ' ' CE2' ' A' ' 49' ' ' PHE . 1.7 m-85 -74.38 -60.17 1.46 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.639 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 79' ' ' PHE . 34.9 Cg_endo -62.82 138.84 71.17 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.902 1.735 . . . . 0.0 111.921 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -70.72 -40.27 72.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.605 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.517 179.826 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.77 -21.85 57.67 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.792 2.328 . . . . 0.0 111.92 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.98 -158.79 48.69 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -84.33 -174.38 5.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.774 0.321 . . . . 0.0 110.305 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -126.47 81.91 67.19 Favored Pre-proline 0 N--CA 1.467 0.388 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.426 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.46 145.35 88.81 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.804 2.336 . . . . 0.0 112.059 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.794 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.9 mp -68.2 -10.37 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.636 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.6 m -55.76 -31.09 62.27 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -62.34 -52.81 62.14 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.596 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 mt -64.51 -44.88 89.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.867 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -59.43 -37.99 79.5 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.992 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -58.81 -44.49 90.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.381 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 87.8 m -61.09 -44.2 97.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.291 -0.563 . . . . 0.0 110.327 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 90.3 m -64.35 -40.63 96.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.967 0.413 . . . . 0.0 111.048 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.443 ' O ' ' OD2' ' A' ' 25' ' ' ASP . 55.3 mt -61.78 -39.63 92.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.137 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.9 p -70.04 -30.67 68.01 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.654 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 tt 52.19 70.72 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.418 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.89 105.12 3.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.624 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.8 m -140.1 131.52 26.87 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.161 0.505 . . . . 0.0 110.627 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.49 141.05 58.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.281 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.07 -4.49 86.28 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -143.56 125.92 15.69 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.873 0.368 . . . . 0.0 110.168 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 23' ' ' GLU . 35.4 mp0 -70.57 149.86 95.49 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.937 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.53 157.41 61.94 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.298 1.999 . . . . 0.0 111.697 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 15' ' ' LEU . 44.6 p-10 -80.99 -172.96 4.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.117 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 pt -128.62 90.32 46.73 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.464 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.63 155.81 27.76 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.385 2.057 . . . . 0.0 111.913 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.831 ' N ' HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -138.47 147.78 43.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.011 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -129.47 110.47 11.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.188 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -151.0 133.74 15.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.436 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.427 ' H ' HG22 ' A' ' 31' ' ' THR . 0.1 OUTLIER -59.88 148.12 36.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.378 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.1 mt -88.01 -46.47 9.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.691 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -161.69 163.68 29.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.091 0.472 . . . . 0.0 110.306 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.2 m -105.59 124.4 49.5 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.504 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.4 t -106.49 140.48 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.951 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.5 73.95 0.35 Allowed Glycine 0 CA--C 1.532 1.131 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.27 -12.8 21.0 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.316 2.011 . . . . 0.0 112.155 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.6 p -155.72 -177.14 6.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.697 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -51.27 -30.53 18.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.467 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.45 135.54 33.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.434 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -82.5 145.86 29.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.185 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.3 p -128.9 148.83 50.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.03 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -116.32 142.39 46.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.411 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.3 m -117.32 128.93 55.53 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.028 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.22 152.36 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.488 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.51 139.71 33.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.123 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.5 t -86.71 130.22 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.011 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -107.68 134.63 50.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 0.0 110.496 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -144.5 129.73 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.375 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.6 tptp 56.02 19.89 3.97 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.526 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.09 12.55 73.59 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -135.17 131.08 36.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.937 0.399 . . . . 0.0 110.036 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.401 ' NH2' ' SG ' ' A' ' 56' ' ' CYS . 42.6 mtm105 -66.83 140.37 57.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.283 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 44.1 pt -117.93 -14.67 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.228 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.83 140.41 6.5 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.401 ' SG ' ' NH2' ' A' ' 53' ' ' ARG . 54.5 m -146.43 133.45 20.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.736 0.303 . . . . 0.0 110.277 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.03 170.58 33.79 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.11 162.96 35.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.115 0.483 . . . . 0.0 110.509 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.08 -169.2 42.33 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.2 -30.0 59.32 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.952 2.434 . . . . 0.0 112.117 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.1 p -156.44 164.08 38.68 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.38 0.61 . . . . 0.0 110.678 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -61.78 -24.77 67.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.813 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -55.86 -57.76 10.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.968 0.413 . . . . 0.0 110.58 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -64.04 -39.44 94.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.59 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.7 -41.15 97.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.635 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -60.64 -42.18 96.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.989 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.8 ttp -59.3 -49.2 78.74 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.28 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.64 -44.18 64.63 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.502 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.09 85.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.724 0.297 . . . . 0.0 111.187 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.05 -44.24 96.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.094 0.473 . . . . 0.0 110.456 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.5 ttt -62.48 -38.14 88.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.928 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -59.83 -46.22 89.94 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.414 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.63 -41.24 96.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 110.577 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.9 tp -59.79 -45.59 91.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.442 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -64.1 -39.92 95.09 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.495 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -75.72 -20.19 58.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.728 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.9 t80 58.26 96.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.564 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 53.4 p-10 -80.05 147.47 31.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.643 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.0 t80 50.48 57.7 17.44 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.496 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' A' ' 82' ' ' MET . 46.6 Cg_endo -71.34 38.83 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.656 2.237 . . . . 0.0 112.45 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 70.0 -42.98 0.53 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.434 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.469 ' H ' ' C ' ' A' ' 80' ' ' PRO . 50.7 tpp . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.361 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -53.03 -38.31 80.01 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.746 2.297 . . . . 0.0 112.053 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.17 -19.26 73.85 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.416 ' CG ' ' H ' ' A' ' 5' ' ' ASP . 61.1 t30 -75.35 -178.07 3.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.846 0.355 . . . . 0.0 110.434 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.416 ' H ' ' CG ' ' A' ' 4' ' ' ASN . 61.9 t0 -131.98 73.68 77.94 Favored Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.57 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -80.4 -158.51 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.707 2.272 . . . . 0.0 111.839 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 7' ' ' ILE . 1.7 mp -64.11 -9.78 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 86.5 p -55.76 -27.57 51.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.325 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -63.01 -51.97 64.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.01 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.21 -37.45 87.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.936 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.474 ' O ' HD13 ' A' ' 15' ' ' LEU . 65.0 tt0 -57.17 -47.18 81.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.4 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -62.2 -45.27 94.13 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.571 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 17' ' ' LEU . 51.1 t -63.08 -46.97 84.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.1 t -60.39 -47.46 85.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.407 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 11' ' ' GLN . 8.9 mp -61.95 -45.9 91.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.439 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 73.8 p -75.41 -32.16 60.65 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.642 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 13' ' ' CYS . 30.2 tp 38.39 67.68 0.39 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.598 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -68.35 129.29 39.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 87.6 m -139.96 135.78 33.13 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.71 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.14 132.65 48.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.279 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.14 -10.14 75.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -137.16 123.16 20.24 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.002 0.43 . . . . 0.0 110.307 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.4 149.2 93.78 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.9 145.56 74.84 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.067 1.845 . . . . 0.0 111.902 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.504 ' OD2' ' CD1' ' A' ' 49' ' ' PHE . 43.3 p-10 -82.93 -170.25 2.92 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.237 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.77 91.06 37.9 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -81.58 145.62 14.75 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.432 2.088 . . . . 0.0 111.992 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.41 148.98 43.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.632 ' CD1' ' NZ ' ' A' ' 62' ' ' LYS . 42.5 p90 -95.63 131.39 41.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.341 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -143.45 151.29 40.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.406 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.9 p -72.19 123.81 23.7 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -87.84 -52.72 5.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -160.93 150.4 17.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.579 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -106.47 133.89 50.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -136.89 156.62 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.049 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.65 60.4 0.42 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.7 -25.75 33.65 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.472 2.114 . . . . 0.0 112.146 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.0 p -105.85 -176.18 3.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.442 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.526 ' O ' ' NH2' ' A' ' 41' ' ' ARG . 86.5 t60 -59.38 -47.73 84.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.169 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.51 145.22 28.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.594 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 39' ' ' HIS . 12.3 mpt_? -79.77 146.22 32.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.194 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 73.5 p -130.93 150.37 52.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.282 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.96 146.97 35.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.258 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.4 m -115.53 125.41 52.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.983 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.92 151.39 35.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.096 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.29 124.13 10.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.628 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 47' ' ' VAL . 4.8 m -87.91 151.28 3.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.895 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -128.65 154.28 46.43 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.106 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 66.0 t80 -144.67 120.46 10.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.035 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.0 tptp 71.2 21.87 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.35 18.34 62.64 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -137.86 143.32 40.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.819 0.343 . . . . 0.0 110.368 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -61.59 127.53 31.9 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 19.1 tt -110.34 -20.3 6.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.739 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.75 148.82 16.06 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 51.3 t -150.19 128.13 11.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.928 0.394 . . . . 0.0 110.634 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.6 161.86 30.81 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -148.42 159.55 43.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 0.0 110.733 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.61 -172.82 45.51 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.82 -27.66 72.91 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.885 2.39 . . . . 0.0 112.106 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.4 t -155.26 155.64 34.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.531 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.632 ' NZ ' ' CD1' ' A' ' 29' ' ' TYR . 39.0 ttpt -59.75 -42.72 93.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.552 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -57.12 -39.06 74.36 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.468 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.482 ' NE2' ' CE ' ' A' ' 67' ' ' MET . 72.9 tp60 -74.33 -43.7 55.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.119 0.485 . . . . 0.0 110.911 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.25 62.9 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.945 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CG ' ' N ' ' A' ' 67' ' ' MET . 21.0 pttm -55.13 -42.93 73.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.267 -178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.491 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 78.5 mtm -60.62 -43.42 97.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.442 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.46 -47.45 62.77 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.414 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.38 83.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.117 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.39 -49.34 74.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.051 0.453 . . . . 0.0 111.202 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 27.4 ttt -60.54 -36.46 78.48 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.9 -41.34 95.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 54' ' ' ILE . . . -60.34 -45.51 93.2 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.225 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.8 -43.64 98.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.388 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.3 -40.84 96.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.573 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -75.74 -31.32 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.629 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 13.4 t80 41.96 69.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.406 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 54' ' ' ILE . 94.1 m-20 -78.42 136.17 37.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -75.35 145.58 79.96 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.849 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.09 -26.65 21.23 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.407 2.071 . . . . 0.0 112.221 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -77.89 152.17 33.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.666 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.574 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -57.15 140.07 91.76 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.762 2.308 . . . . 0.0 111.852 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.57 94.19 0.57 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -158.97 178.24 10.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.856 0.36 . . . . 0.0 110.493 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.62 150.02 96.83 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.443 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.25 -167.49 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.752 2.301 . . . . 0.0 112.038 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.533 HD13 ' O ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -63.45 -27.81 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.33 -179.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 t -49.62 -26.79 3.91 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -60.34 -48.15 82.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.176 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -63.61 -51.4 65.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.143 0.496 . . . . 0.0 110.692 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -59.99 -40.15 88.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.914 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.8 -42.02 98.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.427 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -60.51 -46.89 88.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.485 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.4 m -61.07 -41.34 96.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -63.38 -39.86 95.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.579 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 m -78.39 -15.74 58.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.163 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.4 tp -75.49 120.04 20.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.086 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -64.77 132.0 48.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.691 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.425 HG21 ' HZ1' ' A' ' 50' ' ' LYS . 89.4 m -98.62 125.24 43.83 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.323 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.93 132.62 46.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.479 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.65 -8.19 80.33 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.77 143.45 38.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.0 0.428 . . . . 0.0 110.704 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -69.96 151.1 96.27 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.713 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -45.53 163.32 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.575 2.183 . . . . 0.0 111.805 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -145.86 161.39 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.201 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.1 pt -135.72 149.88 70.26 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.541 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.45 146.55 62.47 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.502 2.135 . . . . 0.0 111.821 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.31 110.52 6.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.26 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -94.18 106.05 18.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.261 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -131.74 135.42 46.8 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.429 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.2 t -123.4 142.34 51.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.494 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.46 26.39 1.3 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.283 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -159.15 147.34 17.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 t -133.2 146.94 51.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.135 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 36' ' ' GLY . 82.0 t -127.92 153.24 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.614 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' N ' ' CD ' ' A' ' 37' ' ' PRO . . . 77.47 53.22 5.18 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' OG ' ' A' ' 38' ' ' SER . 56.2 Cg_endo -70.19 157.18 60.37 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.773 2.315 . . . . 0.0 111.832 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 39' ' ' HIS . 4.1 p 73.31 -60.53 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.501 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.51 ' N ' ' OG ' ' A' ' 38' ' ' SER . 45.2 m170 -81.13 -115.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.327 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.79 108.05 18.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.308 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -78.82 128.56 33.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.375 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 52.4 p -129.12 150.27 50.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.172 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.71 146.49 33.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.311 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.5 p -104.3 142.27 34.84 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.892 0.377 . . . . 0.0 110.159 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.0 p -139.38 142.01 34.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.04 119.93 15.35 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.149 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.5 t -86.93 140.63 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.328 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.13 148.33 35.54 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.926 0.393 . . . . 0.0 110.198 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.609 ' O ' ' N ' ' A' ' 52' ' ' GLU . 29.3 t80 -143.12 114.39 7.87 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.031 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.477 ' HZ2' ' CB ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER 38.22 37.84 0.18 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.557 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.88 22.63 52.41 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.621 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.609 ' N ' ' O ' ' A' ' 49' ' ' PHE . 80.2 mm-40 -138.12 128.26 25.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.888 0.375 . . . . 0.0 110.483 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -69.95 131.83 45.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.22 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 32.4 pt -128.88 10.04 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 0.0 110.805 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.34 136.68 4.3 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.474 ' N ' ' HB1' ' A' ' 69' ' ' ALA . 50.9 t -161.15 112.62 1.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.2 175.61 35.34 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -143.37 157.23 44.64 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 110.519 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.86 -173.94 46.43 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.56 -16.13 52.48 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.519 2.146 . . . . 0.0 111.398 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.5 m -147.77 140.32 24.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.006 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -74.37 -33.83 63.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.552 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.495 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 59.0 mtpt -60.76 -49.92 75.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.555 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -66.78 -38.99 87.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.655 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.0 66.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.908 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 5.2 ptpp? -55.12 -42.77 73.41 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.398 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.48 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 65.7 mtt -60.4 -48.75 80.4 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.792 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.07 -39.36 63.16 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.63 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' HB1' ' N ' ' A' ' 56' ' ' CYS . . . -60.18 -48.65 80.82 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.914 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.87 -48.62 79.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.82 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 66.5 ttp -61.1 -44.42 97.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.812 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -61.34 -51.52 68.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.65 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.54 94.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.983 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.1 tp -62.53 -44.12 97.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.035 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.78 -47.03 76.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.243 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -80.13 -15.54 56.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.997 0.427 . . . . 0.0 111.077 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -158.04 91.71 1.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.546 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 78' ' ' ASN . 26.6 p30 -97.35 145.09 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.403 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -158.52 59.55 1.55 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.348 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -70.42 167.01 26.52 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.936 2.424 . . . . 0.0 111.876 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -70.63 124.3 23.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.161 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.551 -179.896 . . . . . . . . 0 0 . 1 stop_ save_